[{"arc":[[51.3384704589844,12.3797702789307],[47.3191909790039,5.06463003158569]],"countries":["Germany","France"],"title":"Supplementary Information An eco-epidemiological study of Morbilli-related paramyxovirus infection in Madagascar bats reveals host-switching as the dominant macro-evolutionary mechanism"},{"arc":[[29.7107791900635,-95.3966522216797],[29.7107791900635,-95.3966522216797]],"countries":["United States"],"title":"BMC Microbiology Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays"},{"arc":[[29.7107791900635,-95.3966522216797],[46.3597984313965,6.93042707443237]],"countries":["United States","Switzerland"],"title":"BMC Microbiology Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays"},{"arc":[[29.7107791900635,-95.3966522216797],[52.1751708984375,0.140450000762939]],"countries":["United States","United Kingdom"],"title":"BMC Microbiology Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays"},{"arc":[[29.7107791900635,-95.3966522216797],[42.9547386169434,-78.8192367553711]],"countries":["United States"],"title":"BMC Microbiology Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays"},{"arc":[[29.7107791900635,-95.3966522216797],[29.7035694122314,-95.4028930664062]],"countries":["United States"],"title":"BMC Microbiology Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays"},{"arc":[[46.3597984313965,6.93042707443237],[52.1751708984375,0.140450000762939]],"countries":["Switzerland","United Kingdom"],"title":"BMC Microbiology Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays"},{"arc":[[46.3597984313965,6.93042707443237],[29.7107791900635,-95.3966522216797]],"countries":["United States","Switzerland"],"title":"BMC Microbiology Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays"},{"arc":[[46.3597984313965,6.93042707443237],[42.9547386169434,-78.8192367553711]],"countries":["United States","Switzerland"],"title":"BMC Microbiology Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays"},{"arc":[[46.3597984313965,6.93042707443237],[46.3597984313965,6.93042707443237]],"countries":["Switzerland"],"title":"BMC Microbiology Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays"},{"arc":[[46.3597984313965,6.93042707443237],[29.7035694122314,-95.4028930664062]],"countries":["Switzerland","United States"],"title":"BMC Microbiology Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays"},{"arc":[[52.1751708984375,0.140450000762939],[29.7107791900635,-95.3966522216797]],"countries":["United States","United Kingdom"],"title":"BMC Microbiology Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays"},{"arc":[[52.1751708984375,0.140450000762939],[42.9547386169434,-78.8192367553711]],"countries":["United States","United Kingdom"],"title":"BMC Microbiology Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays"},{"arc":[[52.1751708984375,0.140450000762939],[46.3597984313965,6.93042707443237]],"countries":["Switzerland","United Kingdom"],"title":"BMC Microbiology Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays"},{"arc":[[52.1751708984375,0.140450000762939],[29.7035694122314,-95.4028930664062]],"countries":["United Kingdom","United States"],"title":"BMC Microbiology Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays"},{"arc":[[42.9547386169434,-78.8192367553711],[46.3597984313965,6.93042707443237]],"countries":["United States","Switzerland"],"title":"BMC Microbiology Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays"},{"arc":[[42.9547386169434,-78.8192367553711],[42.9547386169434,-78.8192367553711]],"countries":["United States"],"title":"BMC Microbiology Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays"},{"arc":[[42.9547386169434,-78.8192367553711],[29.7035694122314,-95.4028930664062]],"countries":["United States"],"title":"BMC Microbiology Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays"},{"arc":[[29.7035694122314,-95.4028930664062],[46.3597984313965,6.93042707443237]],"countries":["Switzerland","United States"],"title":"BMC Microbiology Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays"},{"arc":[[37.4378814697266,-122.166603088379],[37.4378814697266,-122.166603088379]],"countries":["United States"],"title":"Title: Viruses are a dominant driver of protein adaptation in mammals"},{"arc":[[8.51776,76.94091],[41.6771812438965,123.463096618652]],"countries":["India","China"],"title":"Citation: Identification of Diverse Bat Alphacoronaviruses and Betacoronaviruses in China Provides New Insights Into the Evolution and Origin of Coronavirus-Related Diseases"},{"arc":[[8.51776,76.94091],[40.9215507507324,-81.105842590332]],"countries":["India","United States"],"title":"Citation: Identification of Diverse Bat Alphacoronaviruses and Betacoronaviruses in China Provides New Insights Into the Evolution and Origin of Coronavirus-Related Diseases"},{"arc":[[8.51776,76.94091],[8.51776,76.94091]],"countries":["India"],"title":"Citation: Identification of Diverse Bat Alphacoronaviruses and Betacoronaviruses in China Provides New Insights Into the Evolution and Origin of Coronavirus-Related Diseases"},{"arc":[[8.51776,76.94091],[51.0766296386719,-114.13208770752]],"countries":["India","Canada"],"title":"Citation: Identification of Diverse Bat Alphacoronaviruses and Betacoronaviruses in China Provides New Insights Into the Evolution and Origin of Coronavirus-Related Diseases"},{"arc":[[41.6771812438965,123.463096618652],[40.9215507507324,-81.105842590332]],"countries":["China","United States"],"title":"Citation: Identification of Diverse Bat Alphacoronaviruses and Betacoronaviruses in China Provides New Insights Into the Evolution and Origin of Coronavirus-Related Diseases"},{"arc":[[41.6771812438965,123.463096618652],[8.51776,76.94091]],"countries":["India","China"],"title":"Citation: Identification of Diverse Bat Alphacoronaviruses and Betacoronaviruses in China Provides New Insights Into the Evolution and Origin of Coronavirus-Related Diseases"},{"arc":[[41.6771812438965,123.463096618652],[51.0766296386719,-114.13208770752]],"countries":["China","Canada"],"title":"Citation: Identification of Diverse Bat Alphacoronaviruses and Betacoronaviruses in China Provides New Insights Into the Evolution and Origin of Coronavirus-Related Diseases"},{"arc":[[40.9215507507324,-81.105842590332],[8.51776,76.94091]],"countries":["India","United States"],"title":"Citation: Identification of Diverse Bat Alphacoronaviruses and Betacoronaviruses in China Provides New Insights Into the Evolution and Origin of Coronavirus-Related Diseases"},{"arc":[[40.9215507507324,-81.105842590332],[51.0766296386719,-114.13208770752]],"countries":["United States","Canada"],"title":"Citation: Identification of Diverse Bat Alphacoronaviruses and Betacoronaviruses in China Provides New Insights Into the Evolution and Origin of Coronavirus-Related Diseases"},{"arc":[[51.0766296386719,-114.13208770752],[8.51776,76.94091]],"countries":["India","Canada"],"title":"Citation: Identification of Diverse Bat Alphacoronaviruses and Betacoronaviruses in China Provides New Insights Into the Evolution and Origin of Coronavirus-Related Diseases"},{"arc":[[39.840518951416,-86.1728286743164],[33.7483100891113,-84.39111328125]],"countries":["United States"],"title":"MINI REVIEW Rhinovirus Biology, Antigenic Diversity, and Advancements in the Design of a Human Rhinovirus Vaccine"},{"arc":[[39.840518951416,-86.1728286743164],[39.840518951416,-86.1728286743164]],"countries":["United States"],"title":"MINI REVIEW Rhinovirus Biology, Antigenic Diversity, and Advancements in the Design of a Human Rhinovirus Vaccine"},{"arc":[[33.7483100891113,-84.39111328125],[39.840518951416,-86.1728286743164]],"countries":["United States"],"title":"MINI REVIEW Rhinovirus Biology, Antigenic Diversity, and Advancements in the Design of a Human Rhinovirus Vaccine"},{"arc":[[37.7697296142578,-122.466094970703],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"a new immunosuppressive Molecule emodin induces both cD4 + FoxP3 + and cD8 + cD122 + regulatory T cells and suppresses Murine allograft rejection"},{"arc":[[41.3864898681641,2.16403007507324],[41.3864898681641,2.16403007507324]],"countries":["Spain"],"title":"Pattern formation in multiplex networks OPEN"},{"arc":[[43.6319427490234,3.86388897895813],[43.6319427490234,3.86388897895813]],"countries":["France"],"title":"TALC: Transcription Aware Long Read Correction"},{"arc":[[43.6319427490234,3.86388897895813],[43.6108589172363,3.87612009048462]],"countries":["France"],"title":"TALC: Transcription Aware Long Read Correction"},{"arc":[[43.6108589172363,3.87612009048462],[43.6319427490234,3.86388897895813]],"countries":["France"],"title":"TALC: Transcription Aware Long Read Correction"},{"arc":[[43.6108589172363,3.87612009048462],[43.6108589172363,3.87612009048462]],"countries":["France"],"title":"TALC: Transcription Aware Long Read Correction"},{"arc":[[50.8101806640625,8.77422046661377],[52.08896,5.1784]],"countries":["Netherlands","Germany"],"title":"The 2 nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin- neuraminidase-receptor balance"},{"arc":[[50.8101806640625,8.77422046661377],[50.8101806640625,8.77422046661377]],"countries":["Germany"],"title":"The 2 nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin- neuraminidase-receptor balance"},{"arc":[[52.08896,5.1784],[50.8101806640625,8.77422046661377]],"countries":["Netherlands","Germany"],"title":"The 2 nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin- neuraminidase-receptor balance"},{"arc":[[52.08896,5.1784],[52.08896,5.1784]],"countries":["Netherlands"],"title":"The 2 nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin- neuraminidase-receptor balance"},{"arc":[[53.9120407104492,15.1994600296021],[38.7528991699219,-9.1576099395752]],"countries":["Poland","Portugal"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[53.9120407104492,15.1994600296021],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","Poland"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[53.9120407104492,15.1994600296021],[-29.82341,30.95186]],"countries":["Poland","South Africa"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[53.9120407104492,15.1994600296021],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Poland"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[53.9120407104492,15.1994600296021],[53.9120407104492,15.1994600296021]],"countries":["Poland"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[53.9120407104492,15.1994600296021],[-22.881010055542,-43.352668762207]],"countries":["Poland","Brazil"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[53.9120407104492,15.1994600296021],[50.8360481262207,4.3706259727478]],"countries":["Poland","Belgium"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[38.7528991699219,-9.1576099395752],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","Portugal"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[38.7528991699219,-9.1576099395752],[-29.82341,30.95186]],"countries":["Portugal","South Africa"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[38.7528991699219,-9.1576099395752],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Portugal"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[38.7528991699219,-9.1576099395752],[53.9120407104492,15.1994600296021]],"countries":["Poland","Portugal"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[38.7528991699219,-9.1576099395752],[-22.881010055542,-43.352668762207]],"countries":["Portugal","Brazil"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[38.7528991699219,-9.1576099395752],[50.8360481262207,4.3706259727478]],"countries":["Portugal","Belgium"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[51.7589988708496,-1.26400005817413],[-29.82341,30.95186]],"countries":["United Kingdom","South Africa"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[51.7589988708496,-1.26400005817413],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United Kingdom"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[51.7589988708496,-1.26400005817413],[53.9120407104492,15.1994600296021]],"countries":["United Kingdom","Poland"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[51.7589988708496,-1.26400005817413],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[51.7589988708496,-1.26400005817413],[-22.881010055542,-43.352668762207]],"countries":["United Kingdom","Brazil"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[51.7589988708496,-1.26400005817413],[50.8360481262207,4.3706259727478]],"countries":["United Kingdom","Belgium"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[-29.82341,30.95186],[-29.82341,30.95186]],"countries":["South Africa"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[-29.82341,30.95186],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Africa"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[-29.82341,30.95186],[53.9120407104492,15.1994600296021]],"countries":["Poland","South Africa"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[-29.82341,30.95186],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","South Africa"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[-29.82341,30.95186],[-22.881010055542,-43.352668762207]],"countries":["South Africa","Brazil"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[-29.82341,30.95186],[50.8360481262207,4.3706259727478]],"countries":["South Africa","Belgium"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[40.9437103271484,40.2619209289551],[53.9120407104492,15.1994600296021]],"countries":["Turkey","Poland"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[40.9437103271484,40.2619209289551],[51.7589988708496,-1.26400005817413]],"countries":["Turkey","United Kingdom"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[40.9437103271484,40.2619209289551],[-22.881010055542,-43.352668762207]],"countries":["Turkey","Brazil"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[40.9437103271484,40.2619209289551],[50.8360481262207,4.3706259727478]],"countries":["Turkey","Belgium"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[-22.881010055542,-43.352668762207],[-22.881010055542,-43.352668762207]],"countries":["Brazil"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[-22.881010055542,-43.352668762207],[50.8360481262207,4.3706259727478]],"countries":["Brazil","Belgium"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[-22.881010055542,-43.352668762207],[53.9120407104492,15.1994600296021]],"countries":["Poland","Brazil"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[50.8360481262207,4.3706259727478],[50.8360481262207,4.3706259727478]],"countries":["Belgium"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[50.8360481262207,4.3706259727478],[53.9120407104492,15.1994600296021]],"countries":["Poland","Belgium"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[50.8360481262207,4.3706259727478],[-22.881010055542,-43.352668762207]],"countries":["Brazil","Belgium"],"title":"A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes Author summary"},{"arc":[[36.4511566162109,127.861145019531],[36.4511566162109,127.861145019531]],"countries":["South Korea"],"title":"Immunosuppression of the Trimellitic Anhydride-Induced Th2 Response by Novel Nonanatural Products Mixture in Mice"},{"arc":[[29.5647106170654,106.550727844238],[29.5647106170654,106.550727844238]],"countries":["China"],"title":"Single detection of human bocavirus 1 with a high viral load in severe respiratory tract infections in previously healthy children"},{"arc":[[29.5647106170654,106.550727844238],[44.9734497070312,-93.2378997802734]],"countries":["China","United States"],"title":"Single detection of human bocavirus 1 with a high viral load in severe respiratory tract infections in previously healthy children"},{"arc":[[39.0048141479492,-77.0975341796875],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 6"},{"arc":[[39.0048141479492,-77.0975341796875],[43.9649963378906,-112.343688964844]],"countries":["United States","NOCOUNTRY"],"title":"Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 6"},{"arc":[[39.0048141479492,-77.0975341796875],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 6"},{"arc":[[39.0048141479492,-77.0975341796875],[40.3495407104492,-74.6600875854492]],"countries":["United States"],"title":"Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 6"},{"arc":[[43.9649963378906,-112.343688964844],[37.8056831359863,-122.268104553223]],"countries":["United States","NOCOUNTRY"],"title":"Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 6"},{"arc":[[43.9649963378906,-112.343688964844],[39.0048141479492,-77.0975341796875]],"countries":["United States","NOCOUNTRY"],"title":"Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 6"},{"arc":[[43.9649963378906,-112.343688964844],[43.9649963378906,-112.343688964844]],"countries":["NOCOUNTRY"],"title":"Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 6"},{"arc":[[43.9649963378906,-112.343688964844],[40.3495407104492,-74.6600875854492]],"countries":["United States","NOCOUNTRY"],"title":"Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 6"},{"arc":[[37.8056831359863,-122.268104553223],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 6"},{"arc":[[37.8056831359863,-122.268104553223],[43.9649963378906,-112.343688964844]],"countries":["United States","NOCOUNTRY"],"title":"Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 6"},{"arc":[[37.8056831359863,-122.268104553223],[40.3495407104492,-74.6600875854492]],"countries":["United States"],"title":"Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 6"},{"arc":[[36.0000915527344,-78.9306488037109],[36.0000915527344,-78.9306488037109]],"countries":["United States"],"title":"A host gene expression approach for identifying triggers of asthma exacerbations"},{"arc":[[40.9437103271484,40.2619209289551],[-37.8466987609863,145.120620727539]],"countries":["Turkey","Australia"],"title":"Investigation of the Plasmodium falciparum Food Vacuole through Inducible Expression of the Chloroquine Resistance Transporter (PfCRT)"},{"arc":[[40.9437103271484,40.2619209289551],[-37.797981262207,144.959045410156]],"countries":["Turkey","Australia"],"title":"Investigation of the Plasmodium falciparum Food Vacuole through Inducible Expression of the Chloroquine Resistance Transporter (PfCRT)"},{"arc":[[-37.8466987609863,145.120620727539],[-37.797981262207,144.959045410156]],"countries":["Australia"],"title":"Investigation of the Plasmodium falciparum Food Vacuole through Inducible Expression of the Chloroquine Resistance Transporter (PfCRT)"},{"arc":[[-37.797981262207,144.959045410156],[-37.797981262207,144.959045410156]],"countries":["Australia"],"title":"Investigation of the Plasmodium falciparum Food Vacuole through Inducible Expression of the Chloroquine Resistance Transporter (PfCRT)"},{"arc":[[40.033260345459,-79.6622619628906],[34.39375,-87.11915]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[40.033260345459,-79.6622619628906],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[40.033260345459,-79.6622619628906],[40.4292984008789,-86.914436340332]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[40.033260345459,-79.6622619628906],[29.7095108032227,-95.3981781005859]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[40.033260345459,-79.6622619628906],[40.8081588745117,-73.9636535644531]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[40.033260345459,-79.6622619628906],[52.598876953125,-1.46688103675842]],"countries":["United Kingdom","United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[34.39375,-87.11915],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[34.39375,-87.11915],[40.4292984008789,-86.914436340332]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[34.39375,-87.11915],[34.39375,-87.11915]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[34.39375,-87.11915],[29.7095108032227,-95.3981781005859]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[34.39375,-87.11915],[40.8081588745117,-73.9636535644531]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[34.39375,-87.11915],[52.598876953125,-1.46688103675842]],"countries":["United Kingdom","United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[35.9053153991699,-79.0477142333984],[40.4292984008789,-86.914436340332]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[35.9053153991699,-79.0477142333984],[34.39375,-87.11915]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[35.9053153991699,-79.0477142333984],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[35.9053153991699,-79.0477142333984],[29.7095108032227,-95.3981781005859]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[35.9053153991699,-79.0477142333984],[40.8081588745117,-73.9636535644531]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[35.9053153991699,-79.0477142333984],[52.598876953125,-1.46688103675842]],"countries":["United Kingdom","United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[40.4292984008789,-86.914436340332],[34.39375,-87.11915]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[40.4292984008789,-86.914436340332],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[40.4292984008789,-86.914436340332],[40.4292984008789,-86.914436340332]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[40.4292984008789,-86.914436340332],[29.7095108032227,-95.3981781005859]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[40.4292984008789,-86.914436340332],[40.8081588745117,-73.9636535644531]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[40.4292984008789,-86.914436340332],[52.598876953125,-1.46688103675842]],"countries":["United Kingdom","United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[29.7095108032227,-95.3981781005859],[40.8081588745117,-73.9636535644531]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[29.7095108032227,-95.3981781005859],[40.4292984008789,-86.914436340332]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[29.7095108032227,-95.3981781005859],[52.598876953125,-1.46688103675842]],"countries":["United Kingdom","United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[29.7095108032227,-95.3981781005859],[29.7095108032227,-95.3981781005859]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[40.8081588745117,-73.9636535644531],[40.4292984008789,-86.914436340332]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[40.8081588745117,-73.9636535644531],[52.598876953125,-1.46688103675842]],"countries":["United Kingdom","United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[40.8081588745117,-73.9636535644531],[29.7095108032227,-95.3981781005859]],"countries":["United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[52.598876953125,-1.46688103675842],[40.4292984008789,-86.914436340332]],"countries":["United Kingdom","United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[52.598876953125,-1.46688103675842],[29.7095108032227,-95.3981781005859]],"countries":["United Kingdom","United States"],"title":"A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant"},{"arc":[[50.3743896484375,-4.13887977600098],[43.6486892700195,-79.3854370117188]],"countries":["Canada","United Kingdom"],"title":"Critical care capacity in Canada: results of a national cross-sectional study"},{"arc":[[22.3796997070312,114.201698303223],[42.9547386169434,-78.8192367553711]],"countries":["United States","Hong Kong SAR"],"title":"Acute Encephalopathy Associated with Infl uenza A Infection in Adults"},{"arc":[[22.3796997070312,114.201698303223],[22.3796997070312,114.201698303223]],"countries":["Hong Kong SAR"],"title":"Acute Encephalopathy Associated with Infl uenza A Infection in Adults"},{"arc":[[42.9547386169434,-78.8192367553711],[22.3796997070312,114.201698303223]],"countries":["United States","Hong Kong SAR"],"title":"Acute Encephalopathy Associated with Infl uenza A Infection in Adults"},{"arc":[[39.7207984924316,43.0507698059082],[39.7207984924316,43.0507698059082]],"countries":["Turkey"],"title":"Complete Genome Sequences of Porcine Epidemic Diarrhea Virus Strains JSLS-1/2015 and JS-2/2015 Isolated from China"},{"arc":[[22.333080291748,114.191223144531],[22.333080291748,114.191223144531]],"countries":["Hong Kong SAR"],"title":"NA"},{"arc":[[22.333080291748,114.191223144531],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"NA"},{"arc":[[40.9437103271484,40.2619209289551],[29.7095108032227,-95.3981781005859]],"countries":["Turkey","United States"],"title":"β 2 -Adrenergic receptor promoter haplotype influences the severity of acute viral respiratory tract infection during infancy: a prospective cohort study"},{"arc":[[43.383487701416,142.571090698242],[43.383487701416,142.571090698242]],"countries":["Japan"],"title":"Uncertainty and sensitivity analysis of the basic reproduction number of diphtheria: a case study of a Rohingya refugee camp in Bangladesh"},{"arc":[[37.4599990844727,126.949996948242],[37.4599990844727,126.949996948242]],"countries":["South Korea"],"title":"Comparison of viral infection in healthcare- associated pneumonia (HCAP) and community-acquired pneumonia (CAP)"},{"arc":[[37.4599990844727,126.949996948242],[37.374783,127.131108]],"countries":["South Korea"],"title":"Comparison of viral infection in healthcare- associated pneumonia (HCAP) and community-acquired pneumonia (CAP)"},{"arc":[[37.374783,127.131108],[37.4599990844727,126.949996948242]],"countries":["South Korea"],"title":"Comparison of viral infection in healthcare- associated pneumonia (HCAP) and community-acquired pneumonia (CAP)"},{"arc":[[40.900821685791,-73.7810974121094],[40.900821685791,-73.7810974121094]],"countries":["United States"],"title":"Isothermal Amplification Methods for the Detection of Nucleic Acids in Microfluidic Devices"},{"arc":[[-37.797981262207,144.959045410156],[-37.7035598754883,145.180358886719]],"countries":["Australia"],"title":"The \"sweet\" side of a long pentraxin: how glycosylation affects PTX3 functions in innate immunity and inflammation"},{"arc":[[-37.7035598754883,145.180358886719],[-37.7035598754883,145.180358886719]],"countries":["Australia"],"title":"The \"sweet\" side of a long pentraxin: how glycosylation affects PTX3 functions in innate immunity and inflammation"},{"arc":[[57.6986312866211,11.9708204269409],[51.9735984802246,5.66384315490723]],"countries":["Sweden","Netherlands"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6986312866211,11.9708204269409],[52.5014038085938,13.4023313522339]],"countries":["Sweden","Germany"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6986312866211,11.9708204269409],[57.6894683837891,11.9732599258423]],"countries":["Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6986312866211,11.9708204269409],[57.6986312866211,11.9708204269409]],"countries":["Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6986312866211,11.9708204269409],[47.4264907836914,9.37360954284668]],"countries":["Sweden","Switzerland"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6986312866211,11.9708204269409],[50.7338905334473,7.10222196578979]],"countries":["Germany","Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6986312866211,11.9708204269409],[55.84738,-4.25425]],"countries":["Sweden","United Kingdom"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[51.9735984802246,5.66384315490723],[52.5014038085938,13.4023313522339]],"countries":["Netherlands","Germany"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[51.9735984802246,5.66384315490723],[57.6894683837891,11.9732599258423]],"countries":["Netherlands","Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[51.9735984802246,5.66384315490723],[57.6986312866211,11.9708204269409]],"countries":["Sweden","Netherlands"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[51.9735984802246,5.66384315490723],[47.4264907836914,9.37360954284668]],"countries":["Netherlands","Switzerland"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[51.9735984802246,5.66384315490723],[50.7338905334473,7.10222196578979]],"countries":["Germany","Netherlands"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[51.9735984802246,5.66384315490723],[55.84738,-4.25425]],"countries":["Netherlands","United Kingdom"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[52.5014038085938,13.4023313522339],[57.6894683837891,11.9732599258423]],"countries":["Germany","Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[52.5014038085938,13.4023313522339],[57.6986312866211,11.9708204269409]],"countries":["Sweden","Germany"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[52.5014038085938,13.4023313522339],[47.4264907836914,9.37360954284668]],"countries":["Germany","Switzerland"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[52.5014038085938,13.4023313522339],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[52.5014038085938,13.4023313522339],[55.84738,-4.25425]],"countries":["Germany","United Kingdom"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6894683837891,11.9732599258423],[57.6986312866211,11.9708204269409]],"countries":["Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6894683837891,11.9732599258423],[47.4264907836914,9.37360954284668]],"countries":["Sweden","Switzerland"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6894683837891,11.9732599258423],[50.7338905334473,7.10222196578979]],"countries":["Germany","Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6894683837891,11.9732599258423],[55.84738,-4.25425]],"countries":["Sweden","United Kingdom"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[47.4264907836914,9.37360954284668],[50.7338905334473,7.10222196578979]],"countries":["Germany","Switzerland"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[47.4264907836914,9.37360954284668],[55.84738,-4.25425]],"countries":["Switzerland","United Kingdom"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[47.4264907836914,9.37360954284668],[57.6986312866211,11.9708204269409]],"countries":["Sweden","Switzerland"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[50.7338905334473,7.10222196578979],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[50.7338905334473,7.10222196578979],[55.84738,-4.25425]],"countries":["Germany","United Kingdom"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[50.7338905334473,7.10222196578979],[57.6986312866211,11.9708204269409]],"countries":["Germany","Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[55.84738,-4.25425],[57.6986312866211,11.9708204269409]],"countries":["Sweden","United Kingdom"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[52.2355995178223,21.0103702545166],[52.2355995178223,21.0103702545166]],"countries":["Poland"],"title":"CELLULAR & MOLECULAR BIOLOGY LETTERS Abbreviations used: 3D -three dimensional; BIND -Biomolecular Interaction Network Database; BLAST -Basic Local Alignment Search Tool; CAPRI -Critical Assessment of PRediction of Interactions; DBID -database of interacting domains; DIP -Database of Interacting Proteins; DNA -deoxyribonucleic acid; GO -Gene Ontology; HPRD -Human Protein Reference Database; KEGG -Kyoto Encyclopedia of Genes and Genomes; KO - KEGG Orthology; MetaBASIC -Bilaterally Amplified Sequence Information Comparison; MINT -Molecular Interaction Database; OPHID -Online Predicted Human Interaction Database; PDB -Protein Data Bank; RNA -ribonucleic acid Mini review THE INTERACTOME: PREDICTING THE PROTEIN-PROTEIN INTERACTIONS IN CELLS"},{"arc":[[39.4959106445312,-98.9899826049805],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"Emerging Microbes & Infections (2017) 6, e101"},{"arc":[[39.4959106445312,-98.9899826049805],[41.7278709411621,44.764778137207]],"countries":["Georgia","United States"],"title":"Emerging Microbes & Infections (2017) 6, e101"},{"arc":[[39.4959106445312,-98.9899826049805],[32.0583801269531,118.79647064209]],"countries":["United States","China"],"title":"Emerging Microbes & Infections (2017) 6, e101"},{"arc":[[39.4959106445312,-98.9899826049805],[-33.8852996826172,151.188766479492]],"countries":["United States","Australia"],"title":"Emerging Microbes & Infections (2017) 6, e101"},{"arc":[[41.7278709411621,44.764778137207],[32.0583801269531,118.79647064209]],"countries":["Georgia","China"],"title":"Emerging Microbes & Infections (2017) 6, e101"},{"arc":[[41.7278709411621,44.764778137207],[-33.8852996826172,151.188766479492]],"countries":["Georgia","Australia"],"title":"Emerging Microbes & Infections (2017) 6, e101"},{"arc":[[32.0583801269531,118.79647064209],[-33.8852996826172,151.188766479492]],"countries":["China","Australia"],"title":"Emerging Microbes & Infections (2017) 6, e101"},{"arc":[[50.6069984436035,3.13899993896484],[50.6069984436035,3.13899993896484]],"countries":["France"],"title":"Caspase cleavage of viral proteins, another way for viruses to make the best of apoptosis"},{"arc":[[52.1974906921387,-2.2442901134491],[51.8757591247559,0.943660020828247]],"countries":["United Kingdom"],"title":"Environmental Health Outdoor environments and human pathogens in air"},{"arc":[[52.1974906921387,-2.2442901134491],[51.5235214233398,-0.132312998175621]],"countries":["United Kingdom"],"title":"Environmental Health Outdoor environments and human pathogens in air"},{"arc":[[51.8757591247559,0.943660020828247],[51.5235214233398,-0.132312998175621]],"countries":["United Kingdom"],"title":"Environmental Health Outdoor environments and human pathogens in air"},{"arc":[[40.6830215454102,-76.2544097900391],[40.6830215454102,-76.2544097900391]],"countries":["United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[40.6830215454102,-76.2544097900391],[60.3831596374512,5.33134984970093]],"countries":["Norway","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[40.6830215454102,-76.2544097900391],[58.3811416625977,26.7203407287598]],"countries":["Estonia","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[40.6830215454102,-76.2544097900391],[36.4511566162109,127.861145019531]],"countries":["South Korea","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[40.6830215454102,-76.2544097900391],[41.507,-81.60666]],"countries":["United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[40.6830215454102,-76.2544097900391],[60.1698989868164,24.9490509033203]],"countries":["Finland","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[40.6830215454102,-76.2544097900391],[47.3764152526855,8.54810237884521]],"countries":["United States","Switzerland"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[40.6830215454102,-76.2544097900391],[59.8583488464355,17.6295890808105]],"countries":["Sweden","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[40.6830215454102,-76.2544097900391],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[40.6830215454102,-76.2544097900391],[55.3373107910156,23.883544921875]],"countries":["United States","Lithuania"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[60.3831596374512,5.33134984970093],[58.3811416625977,26.7203407287598]],"countries":["Estonia","Norway"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[60.3831596374512,5.33134984970093],[36.4511566162109,127.861145019531]],"countries":["South Korea","Norway"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[60.3831596374512,5.33134984970093],[40.6830215454102,-76.2544097900391]],"countries":["Norway","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[60.3831596374512,5.33134984970093],[41.507,-81.60666]],"countries":["Norway","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[60.3831596374512,5.33134984970093],[60.1698989868164,24.9490509033203]],"countries":["Finland","Norway"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[60.3831596374512,5.33134984970093],[47.3764152526855,8.54810237884521]],"countries":["Norway","Switzerland"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[60.3831596374512,5.33134984970093],[59.8583488464355,17.6295890808105]],"countries":["Sweden","Norway"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[60.3831596374512,5.33134984970093],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","Norway"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[60.3831596374512,5.33134984970093],[55.3373107910156,23.883544921875]],"countries":["Norway","Lithuania"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[58.3811416625977,26.7203407287598],[36.4511566162109,127.861145019531]],"countries":["Estonia","South Korea"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[58.3811416625977,26.7203407287598],[40.6830215454102,-76.2544097900391]],"countries":["Estonia","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[58.3811416625977,26.7203407287598],[41.507,-81.60666]],"countries":["Estonia","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[58.3811416625977,26.7203407287598],[60.1698989868164,24.9490509033203]],"countries":["Estonia","Finland"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[58.3811416625977,26.7203407287598],[47.3764152526855,8.54810237884521]],"countries":["Estonia","Switzerland"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[58.3811416625977,26.7203407287598],[59.8583488464355,17.6295890808105]],"countries":["Estonia","Sweden"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[58.3811416625977,26.7203407287598],[58.3811416625977,26.7203407287598]],"countries":["Estonia"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[58.3811416625977,26.7203407287598],[52.421459197998,-1.43792998790741]],"countries":["Estonia","United Kingdom"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[58.3811416625977,26.7203407287598],[55.3373107910156,23.883544921875]],"countries":["Estonia","Lithuania"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[36.4511566162109,127.861145019531],[40.6830215454102,-76.2544097900391]],"countries":["South Korea","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[36.4511566162109,127.861145019531],[41.507,-81.60666]],"countries":["South Korea","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[36.4511566162109,127.861145019531],[60.1698989868164,24.9490509033203]],"countries":["South Korea","Finland"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[36.4511566162109,127.861145019531],[47.3764152526855,8.54810237884521]],"countries":["South Korea","Switzerland"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[36.4511566162109,127.861145019531],[36.4511566162109,127.861145019531]],"countries":["South Korea"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[36.4511566162109,127.861145019531],[59.8583488464355,17.6295890808105]],"countries":["South Korea","Sweden"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[36.4511566162109,127.861145019531],[58.3811416625977,26.7203407287598]],"countries":["Estonia","South Korea"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[36.4511566162109,127.861145019531],[52.421459197998,-1.43792998790741]],"countries":["South Korea","United Kingdom"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[36.4511566162109,127.861145019531],[55.3373107910156,23.883544921875]],"countries":["South Korea","Lithuania"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[41.507,-81.60666],[60.1698989868164,24.9490509033203]],"countries":["Finland","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[41.507,-81.60666],[40.6830215454102,-76.2544097900391]],"countries":["United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[41.507,-81.60666],[47.3764152526855,8.54810237884521]],"countries":["United States","Switzerland"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[41.507,-81.60666],[36.4511566162109,127.861145019531]],"countries":["South Korea","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[41.507,-81.60666],[59.8583488464355,17.6295890808105]],"countries":["Sweden","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[41.507,-81.60666],[58.3811416625977,26.7203407287598]],"countries":["Estonia","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[41.507,-81.60666],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[41.507,-81.60666],[55.3373107910156,23.883544921875]],"countries":["United States","Lithuania"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[60.1698989868164,24.9490509033203],[40.6830215454102,-76.2544097900391]],"countries":["Finland","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[60.1698989868164,24.9490509033203],[60.1698989868164,24.9490509033203]],"countries":["Finland"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[60.1698989868164,24.9490509033203],[47.3764152526855,8.54810237884521]],"countries":["Finland","Switzerland"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[60.1698989868164,24.9490509033203],[36.4511566162109,127.861145019531]],"countries":["South Korea","Finland"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[60.1698989868164,24.9490509033203],[59.8583488464355,17.6295890808105]],"countries":["Sweden","Finland"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[60.1698989868164,24.9490509033203],[58.3811416625977,26.7203407287598]],"countries":["Estonia","Finland"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[60.1698989868164,24.9490509033203],[52.421459197998,-1.43792998790741]],"countries":["Finland","United Kingdom"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[60.1698989868164,24.9490509033203],[55.3373107910156,23.883544921875]],"countries":["Finland","Lithuania"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[47.3764152526855,8.54810237884521],[60.1698989868164,24.9490509033203]],"countries":["Finland","Switzerland"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[47.3764152526855,8.54810237884521],[36.4511566162109,127.861145019531]],"countries":["South Korea","Switzerland"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[47.3764152526855,8.54810237884521],[40.6830215454102,-76.2544097900391]],"countries":["United States","Switzerland"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[47.3764152526855,8.54810237884521],[59.8583488464355,17.6295890808105]],"countries":["Sweden","Switzerland"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[47.3764152526855,8.54810237884521],[58.3811416625977,26.7203407287598]],"countries":["Estonia","Switzerland"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[47.3764152526855,8.54810237884521],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","Switzerland"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[47.3764152526855,8.54810237884521],[55.3373107910156,23.883544921875]],"countries":["Switzerland","Lithuania"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[59.8583488464355,17.6295890808105],[58.3811416625977,26.7203407287598]],"countries":["Estonia","Sweden"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[59.8583488464355,17.6295890808105],[52.421459197998,-1.43792998790741]],"countries":["Sweden","United Kingdom"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[59.8583488464355,17.6295890808105],[40.6830215454102,-76.2544097900391]],"countries":["Sweden","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[59.8583488464355,17.6295890808105],[55.3373107910156,23.883544921875]],"countries":["Sweden","Lithuania"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[52.421459197998,-1.43792998790741],[40.6830215454102,-76.2544097900391]],"countries":["United Kingdom","United States"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[52.421459197998,-1.43792998790741],[58.3811416625977,26.7203407287598]],"countries":["Estonia","United Kingdom"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[52.421459197998,-1.43792998790741],[55.3373107910156,23.883544921875]],"countries":["United Kingdom","Lithuania"],"title":"Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis"},{"arc":[[32.2318115234375,-110.955078125],[32.2318115234375,-110.955078125]],"countries":["United States"],"title":"Interaction of the HIV-1 frameshift signal with the ribosome"},{"arc":[[28.7162494659424,77.2728576660156],[42.9547386169434,-78.8192367553711]],"countries":["United States","India"],"title":"Health System Resource Gaps and Associated Mortality from Pandemic Influenza across Six Asian Territories"},{"arc":[[28.7162494659424,77.2728576660156],[16.1676921844482,107.839050292969]],"countries":["India","Vietnam"],"title":"Health System Resource Gaps and Associated Mortality from Pandemic Influenza across Six Asian Territories"},{"arc":[[28.7162494659424,77.2728576660156],[40.9437103271484,40.2619209289551]],"countries":["Turkey","India"],"title":"Health System Resource Gaps and Associated Mortality from Pandemic Influenza across Six Asian Territories"},{"arc":[[28.7162494659424,77.2728576660156],[53.5561904907227,10.0217695236206]],"countries":["India","Germany"],"title":"Health System Resource Gaps and Associated Mortality from Pandemic Influenza across Six Asian Territories"},{"arc":[[42.9547386169434,-78.8192367553711],[16.1676921844482,107.839050292969]],"countries":["United States","Vietnam"],"title":"Health System Resource Gaps and Associated Mortality from Pandemic Influenza across Six Asian Territories"},{"arc":[[42.9547386169434,-78.8192367553711],[40.9437103271484,40.2619209289551]],"countries":["United States","Turkey"],"title":"Health System Resource Gaps and Associated Mortality from Pandemic Influenza across Six Asian Territories"},{"arc":[[42.9547386169434,-78.8192367553711],[53.5561904907227,10.0217695236206]],"countries":["United States","Germany"],"title":"Health System Resource Gaps and Associated Mortality from Pandemic Influenza across Six Asian Territories"},{"arc":[[16.1676921844482,107.839050292969],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Vietnam"],"title":"Health System Resource Gaps and Associated Mortality from Pandemic Influenza across Six Asian Territories"},{"arc":[[16.1676921844482,107.839050292969],[53.5561904907227,10.0217695236206]],"countries":["Vietnam","Germany"],"title":"Health System Resource Gaps and Associated Mortality from Pandemic Influenza across Six Asian Territories"},{"arc":[[40.9437103271484,40.2619209289551],[53.5561904907227,10.0217695236206]],"countries":["Turkey","Germany"],"title":"Health System Resource Gaps and Associated Mortality from Pandemic Influenza across Six Asian Territories"},{"arc":[[33.9102592468262,132.183929443359],[36.6533355712891,137.981689453125]],"countries":["Japan"],"title":"Genetic diversity of group A rotaviruses associated with repeated outbreaks of diarrhea in a farrow-to- finish farm: identification of a porcine rotavirus strain bearing a novel VP7 genotype, G26"},{"arc":[[60.1698989868164,24.9490509033203],[60.1698989868164,24.9490509033203]],"countries":["Finland"],"title":"Validation and automation of a high-throughput multi-targeted method for semi-quantification of 2 endogenous metabolites from different biological matrices using tandem mass spectrometry 4"},{"arc":[[41.5059089660645,-81.6090927124023],[41.5047302246094,-81.6907424926758]],"countries":["United States"],"title":"Network-based Drug Repurposing for Human Coronavirus"},{"arc":[[41.5047302246094,-81.6907424926758],[41.5047302246094,-81.6907424926758]],"countries":["United States"],"title":"Network-based Drug Repurposing for Human Coronavirus"},{"arc":[[36.5631141662598,103.735809326172],[36.5631141662598,103.735809326172]],"countries":["China"],"title":"SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-β1 via ROS/ p38 MAPK/STAT3 pathway OPEN"},{"arc":[[36.5631141662598,103.735809326172],[18.5423393249512,73.828727722168]],"countries":["China","India"],"title":"SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-β1 via ROS/ p38 MAPK/STAT3 pathway OPEN"},{"arc":[[36.5631141662598,103.735809326172],[33.2227516174316,107.54564666748]],"countries":["China"],"title":"SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-β1 via ROS/ p38 MAPK/STAT3 pathway OPEN"},{"arc":[[18.5423393249512,73.828727722168],[33.2227516174316,107.54564666748]],"countries":["China","India"],"title":"SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-β1 via ROS/ p38 MAPK/STAT3 pathway OPEN"},{"arc":[[18.5423393249512,73.828727722168],[36.5631141662598,103.735809326172]],"countries":["China","India"],"title":"SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-β1 via ROS/ p38 MAPK/STAT3 pathway OPEN"},{"arc":[[33.2227516174316,107.54564666748],[36.5631141662598,103.735809326172]],"countries":["China"],"title":"SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-β1 via ROS/ p38 MAPK/STAT3 pathway OPEN"},{"arc":[[34.1358985900879,-118.126533508301],[34.1358985900879,-118.126533508301]],"countries":["United States"],"title":"Supplementary Information Multifunctional biophotonic nanostructures inspired by longtail glasswing butterfly for medical devices"},{"arc":[[34.1358985900879,-118.126533508301],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Supplementary Information Multifunctional biophotonic nanostructures inspired by longtail glasswing butterfly for medical devices"},{"arc":[[34.1358985900879,-118.126533508301],[23.2024116516113,113.38606262207]],"countries":["China","United States"],"title":"Supplementary Information Multifunctional biophotonic nanostructures inspired by longtail glasswing butterfly for medical devices"},{"arc":[[37.8056831359863,-122.268104553223],[23.2024116516113,113.38606262207]],"countries":["United States","China"],"title":"Supplementary Information Multifunctional biophotonic nanostructures inspired by longtail glasswing butterfly for medical devices"},{"arc":[[37.8056831359863,-122.268104553223],[34.1358985900879,-118.126533508301]],"countries":["United States"],"title":"Supplementary Information Multifunctional biophotonic nanostructures inspired by longtail glasswing butterfly for medical devices"},{"arc":[[23.2024116516113,113.38606262207],[34.1358985900879,-118.126533508301]],"countries":["China","United States"],"title":"Supplementary Information Multifunctional biophotonic nanostructures inspired by longtail glasswing butterfly for medical devices"},{"arc":[[31.3202800750732,48.6691703796387],[31.3202800750732,48.6691703796387]],"countries":["Iran"],"title":"NA"},{"arc":[[40.9437103271484,40.2619209289551],[60.1698989868164,24.9490509033203]],"countries":["Turkey","Finland"],"title":"Toxoplasma gondii seroprevalence varies by cat breed Kä rt Must"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Toxoplasma gondii seroprevalence varies by cat breed Kä rt Must"},{"arc":[[60.1698989868164,24.9490509033203],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Finland"],"title":"Toxoplasma gondii seroprevalence varies by cat breed Kä rt Must"},{"arc":[[39.0048141479492,-77.0975341796875],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"A Review and Update on Waterborne Viral Diseases Associated with Swimming Pools"},{"arc":[[47.38234,8.54819],[55.8721008300781,-4.28659009933472]],"countries":["Switzerland","United Kingdom"],"title":"Environmental Contamination and Hygienic Measures After Feline Calicivirus Field Strain Infections of Cats in a Research Facility"},{"arc":[[47.38234,8.54819],[47.38234,8.54819]],"countries":["Switzerland"],"title":"Environmental Contamination and Hygienic Measures After Feline Calicivirus Field Strain Infections of Cats in a Research Facility"},{"arc":[[55.8721008300781,-4.28659009933472],[47.38234,8.54819]],"countries":["Switzerland","United Kingdom"],"title":"Environmental Contamination and Hygienic Measures After Feline Calicivirus Field Strain Infections of Cats in a Research Facility"},{"arc":[[55.8721008300781,-4.28659009933472],[55.8721008300781,-4.28659009933472]],"countries":["United Kingdom"],"title":"Environmental Contamination and Hygienic Measures After Feline Calicivirus Field Strain Infections of Cats in a Research Facility"},{"arc":[[62.8217849731445,16.7353801727295],[62.8217849731445,16.7353801727295]],"countries":["Sweden"],"title":"NA"},{"arc":[[28.6292324066162,77.373779296875],[1.29041004180908,103.852111816406]],"countries":["Singapore","India"],"title":"Elucidating the Interacting Domains of Chandipura Virus Nucleocapsid Protein"},{"arc":[[28.6292324066162,77.373779296875],[28.6292324066162,77.373779296875]],"countries":["India"],"title":"Elucidating the Interacting Domains of Chandipura Virus Nucleocapsid Protein"},{"arc":[[28.6292324066162,77.373779296875],[28.5892791748047,77.1662979125977]],"countries":["India"],"title":"Elucidating the Interacting Domains of Chandipura Virus Nucleocapsid Protein"},{"arc":[[1.29041004180908,103.852111816406],[28.6292324066162,77.373779296875]],"countries":["Singapore","India"],"title":"Elucidating the Interacting Domains of Chandipura Virus Nucleocapsid Protein"},{"arc":[[1.29041004180908,103.852111816406],[28.5892791748047,77.1662979125977]],"countries":["Singapore","India"],"title":"Elucidating the Interacting Domains of Chandipura Virus Nucleocapsid Protein"},{"arc":[[28.5892791748047,77.1662979125977],[28.5892791748047,77.1662979125977]],"countries":["India"],"title":"Elucidating the Interacting Domains of Chandipura Virus Nucleocapsid Protein"},{"arc":[[28.5892791748047,77.1662979125977],[28.6292324066162,77.373779296875]],"countries":["India"],"title":"Elucidating the Interacting Domains of Chandipura Virus Nucleocapsid Protein"},{"arc":[[52.5173797607422,13.3937997817993],[31.9044609069824,34.8084716796875]],"countries":["Germany","Israel"],"title":"The HIV-1 Envelope Transmembrane Domain Binds TLR2 through a Distinct Dimerization Motif and Inhibits TLR2- Mediated Responses"},{"arc":[[52.5173797607422,13.3937997817993],[52.5173797607422,13.3937997817993]],"countries":["Germany"],"title":"The HIV-1 Envelope Transmembrane Domain Binds TLR2 through a Distinct Dimerization Motif and Inhibits TLR2- Mediated Responses"},{"arc":[[31.9044609069824,34.8084716796875],[31.9044609069824,34.8084716796875]],"countries":["Israel"],"title":"The HIV-1 Envelope Transmembrane Domain Binds TLR2 through a Distinct Dimerization Motif and Inhibits TLR2- Mediated Responses"},{"arc":[[31.9044609069824,34.8084716796875],[52.5173797607422,13.3937997817993]],"countries":["Germany","Israel"],"title":"The HIV-1 Envelope Transmembrane Domain Binds TLR2 through a Distinct Dimerization Motif and Inhibits TLR2- Mediated Responses"},{"arc":[[42.373161315918,-71.1181182861328],[42.373161315918,-71.1181182861328]],"countries":["United States"],"title":"Hepatitis B: Prevalence, Hope"},{"arc":[[28.8037395477295,79.2010192871094],[39.8202781677246,-105.649436950684]],"countries":["United States","India"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[28.8037395477295,79.2010192871094],[52.3687591552734,4.89012002944946]],"countries":["Netherlands","India"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[28.8037395477295,79.2010192871094],[28.8037395477295,79.2010192871094]],"countries":["India"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[28.8037395477295,79.2010192871094],[0.537028014659882,37.8567771911621]],"countries":["Kenya","India"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[28.8037395477295,79.2010192871094],[44.9948196411133,-93.41455078125]],"countries":["United States","India"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[28.8037395477295,79.2010192871094],[36.708869934082,-119.556427001953]],"countries":["India","United States"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[39.8202781677246,-105.649436950684],[52.3687591552734,4.89012002944946]],"countries":["Netherlands","United States"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[39.8202781677246,-105.649436950684],[28.8037395477295,79.2010192871094]],"countries":["United States","India"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[39.8202781677246,-105.649436950684],[0.537028014659882,37.8567771911621]],"countries":["United States","Kenya"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[39.8202781677246,-105.649436950684],[44.9948196411133,-93.41455078125]],"countries":["United States"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[39.8202781677246,-105.649436950684],[36.708869934082,-119.556427001953]],"countries":["United States"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[52.3687591552734,4.89012002944946],[28.8037395477295,79.2010192871094]],"countries":["Netherlands","India"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[52.3687591552734,4.89012002944946],[0.537028014659882,37.8567771911621]],"countries":["Netherlands","Kenya"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[52.3687591552734,4.89012002944946],[44.9948196411133,-93.41455078125]],"countries":["United States","Netherlands"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[52.3687591552734,4.89012002944946],[36.708869934082,-119.556427001953]],"countries":["Netherlands","United States"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[0.537028014659882,37.8567771911621],[0.537028014659882,37.8567771911621]],"countries":["Kenya"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[0.537028014659882,37.8567771911621],[44.9948196411133,-93.41455078125]],"countries":["United States","Kenya"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[0.537028014659882,37.8567771911621],[28.8037395477295,79.2010192871094]],"countries":["Kenya","India"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[0.537028014659882,37.8567771911621],[36.708869934082,-119.556427001953]],"countries":["Kenya","United States"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[44.9948196411133,-93.41455078125],[0.537028014659882,37.8567771911621]],"countries":["United States","Kenya"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[44.9948196411133,-93.41455078125],[44.9948196411133,-93.41455078125]],"countries":["United States"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[44.9948196411133,-93.41455078125],[28.8037395477295,79.2010192871094]],"countries":["United States","India"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[44.9948196411133,-93.41455078125],[36.708869934082,-119.556427001953]],"countries":["United States"],"title":"Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya"},{"arc":[[49.6230316162109,6.11113023757935],[49.7768325805664,6.09233999252319]],"countries":["Luxembourg"],"title":"Gene Regulatory Network Inference of Immunoresponsive Gene 1 (IRG1) Identifies Interferon Regulatory Factor 1 (IRF1) as Its Transcriptional Regulator in Mammalian Macrophages"},{"arc":[[49.6230316162109,6.11113023757935],[49.6230316162109,6.11113023757935]],"countries":["Luxembourg"],"title":"Gene Regulatory Network Inference of Immunoresponsive Gene 1 (IRG1) Identifies Interferon Regulatory Factor 1 (IRF1) as Its Transcriptional Regulator in Mammalian Macrophages"},{"arc":[[49.7768325805664,6.09233999252319],[49.6230316162109,6.11113023757935]],"countries":["Luxembourg"],"title":"Gene Regulatory Network Inference of Immunoresponsive Gene 1 (IRG1) Identifies Interferon Regulatory Factor 1 (IRF1) as Its Transcriptional Regulator in Mammalian Macrophages"},{"arc":[[34.751293182373,-92.3201065063477],[34.751293182373,-92.3201065063477]],"countries":["United States"],"title":"Comparative genomics of hepatitis A virus, hepatitis C virus, and hepatitis E virus provides insights into the evolutionary history of Hepatovirus species"},{"arc":[[39.0048141479492,-77.0975341796875],[43.9649963378906,-112.343688964844]],"countries":["United States","NOCOUNTRY"],"title":"Recent advances in understanding Crimean-Congo hemorrhagic fever virus [version 1; referees: 4 approved]"},{"arc":[[32.0479011535645,34.8450317382812],[32.0479011535645,34.8450317382812]],"countries":["Israel"],"title":"Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1"},{"arc":[[32.0479011535645,34.8450317382812],[31.2638492584229,34.7986907958984]],"countries":["Israel"],"title":"Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1"},{"arc":[[32.0479011535645,34.8450317382812],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Israel"],"title":"Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1"},{"arc":[[31.2638492584229,34.7986907958984],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Israel"],"title":"Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1"},{"arc":[[31.2638492584229,34.7986907958984],[32.0479011535645,34.8450317382812]],"countries":["Israel"],"title":"Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1"},{"arc":[[40.9437103271484,40.2619209289551],[32.0479011535645,34.8450317382812]],"countries":["Turkey","Israel"],"title":"Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1"},{"arc":[[35.6887702941895,51.4150314331055],[35.6887702941895,51.4150314331055]],"countries":["Iran"],"title":"of the Creative Commons Attribution Non-Commercial 4.0 License (CC BY-NC 4.0). Iranian Emergency Medical Service Response in Disaster; Report of three Earthquakes"},{"arc":[[51.5365982055664,-0.13400000333786],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[51.5365982055664,-0.13400000333786],[51.5235214233398,-0.132312998175621]],"countries":["United Kingdom"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[51.5365982055664,-0.13400000333786],[39.8202781677246,-105.649436950684]],"countries":["United Kingdom","United States"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[51.5365982055664,-0.13400000333786],[51.42041,-0.17665]],"countries":["United Kingdom"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[51.5365982055664,-0.13400000333786],[-33.8852996826172,151.188766479492]],"countries":["United Kingdom","Australia"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[51.5002288818359,-0.178939998149872],[51.5235214233398,-0.132312998175621]],"countries":["United Kingdom"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[51.5002288818359,-0.178939998149872],[39.8202781677246,-105.649436950684]],"countries":["United Kingdom","United States"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[51.5002288818359,-0.178939998149872],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[51.5002288818359,-0.178939998149872],[51.42041,-0.17665]],"countries":["United Kingdom"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[51.5002288818359,-0.178939998149872],[-33.8852996826172,151.188766479492]],"countries":["United Kingdom","Australia"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[51.5235214233398,-0.132312998175621],[39.8202781677246,-105.649436950684]],"countries":["United States","United Kingdom"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[51.5235214233398,-0.132312998175621],[51.5235214233398,-0.132312998175621]],"countries":["United Kingdom"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[51.5235214233398,-0.132312998175621],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[51.5235214233398,-0.132312998175621],[51.42041,-0.17665]],"countries":["United Kingdom"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[51.5235214233398,-0.132312998175621],[-33.8852996826172,151.188766479492]],"countries":["United Kingdom","Australia"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[39.8202781677246,-105.649436950684],[51.5235214233398,-0.132312998175621]],"countries":["United States","United Kingdom"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[39.8202781677246,-105.649436950684],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom","United States"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[39.8202781677246,-105.649436950684],[51.42041,-0.17665]],"countries":["United States","United Kingdom"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[39.8202781677246,-105.649436950684],[-33.8852996826172,151.188766479492]],"countries":["United States","Australia"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[51.42041,-0.17665],[51.5235214233398,-0.132312998175621]],"countries":["United Kingdom"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[51.42041,-0.17665],[-33.8852996826172,151.188766479492]],"countries":["Australia","United Kingdom"],"title":"Comparative analysis reveals adaptive evolution of bat IFITMs and a novel 1 antiviral determinant"},{"arc":[[36.5631141662598,103.735809326172],[36.5631141662598,103.735809326172]],"countries":["China"],"title":"Emergency Department Response to SARS, Taiwan Emergency Department Response to SARS, Taiwan Emerging Infectious Diseases • www Past Issues on SARS"},{"arc":[[52.1658325195312,4.47749996185303],[52.1658325195312,4.47749996185303]],"countries":["Netherlands"],"title":"Virology Journal Mutagenesis of the transmembrane domain of the SARS coronavirus spike glycoprotein: refinement of the requirements for SARS coronavirus cell entry"},{"arc":[[43.5278816223145,-80.2231063842773],[43.5278816223145,-80.2231063842773]],"countries":["Canada"],"title":"Local Innate Responses to TLR Ligands in the Chicken Trachea"},{"arc":[[36.5631141662598,103.735809326172],[39.2973403930664,-76.6152191162109]],"countries":["China","United States"],"title":"Risk Factors for SARS among Persons without Known Contact with SARS Patients, Beijing, China EMERGENCE OF SARS"},{"arc":[[36.5631141662598,103.735809326172],[36.5631141662598,103.735809326172]],"countries":["China"],"title":"Risk Factors for SARS among Persons without Known Contact with SARS Patients, Beijing, China EMERGENCE OF SARS"},{"arc":[[39.2973403930664,-76.6152191162109],[36.5631141662598,103.735809326172]],"countries":["China","United States"],"title":"Risk Factors for SARS among Persons without Known Contact with SARS Patients, Beijing, China EMERGENCE OF SARS"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Selection of reference genes for qRT-PCR examination of wild populations of Atlantic cod Gadus morhua"},{"arc":[[31.0254402160645,121.436302185059],[37.7697296142578,-122.466094970703]],"countries":["United States","China"],"title":"Rapid detection of the common avian leukosis virus subgroups by real-time loop-mediated isothermal amplification"},{"arc":[[31.0254402160645,121.436302185059],[23.8029747009277,108.794311523438]],"countries":["China"],"title":"Rapid detection of the common avian leukosis virus subgroups by real-time loop-mediated isothermal amplification"},{"arc":[[37.7697296142578,-122.466094970703],[23.8029747009277,108.794311523438]],"countries":["United States","China"],"title":"Rapid detection of the common avian leukosis virus subgroups by real-time loop-mediated isothermal amplification"},{"arc":[[37.6757011413574,-121.758560180664],[37.6757011413574,-121.758560180664]],"countries":["United States"],"title":"Multiplex primer prediction software for divergent targets"},{"arc":[[37.7697296142578,-122.466094970703],[31.2148895263672,121.564643859863]],"countries":["United States","China"],"title":"Fine epitope mapping of glycoprotein Gn in Guertu virus"},{"arc":[[37.7697296142578,-122.466094970703],[41.118278503418,85.1935272216797]],"countries":["United States","China"],"title":"Fine epitope mapping of glycoprotein Gn in Guertu virus"},{"arc":[[37.7697296142578,-122.466094970703],[36.5631141662598,103.735809326172]],"countries":["United States","China"],"title":"Fine epitope mapping of glycoprotein Gn in Guertu virus"},{"arc":[[37.7697296142578,-122.466094970703],[21.1991405487061,81.2897262573242]],"countries":["United States","India"],"title":"Fine epitope mapping of glycoprotein Gn in Guertu virus"},{"arc":[[31.2148895263672,121.564643859863],[41.118278503418,85.1935272216797]],"countries":["China"],"title":"Fine epitope mapping of glycoprotein Gn in Guertu virus"},{"arc":[[31.2148895263672,121.564643859863],[36.5631141662598,103.735809326172]],"countries":["China"],"title":"Fine epitope mapping of glycoprotein Gn in Guertu virus"},{"arc":[[31.2148895263672,121.564643859863],[21.1991405487061,81.2897262573242]],"countries":["China","India"],"title":"Fine epitope mapping of glycoprotein Gn in Guertu virus"},{"arc":[[41.118278503418,85.1935272216797],[41.118278503418,85.1935272216797]],"countries":["China"],"title":"Fine epitope mapping of glycoprotein Gn in Guertu virus"},{"arc":[[41.118278503418,85.1935272216797],[36.5631141662598,103.735809326172]],"countries":["China"],"title":"Fine epitope mapping of glycoprotein Gn in Guertu virus"},{"arc":[[41.118278503418,85.1935272216797],[21.1991405487061,81.2897262573242]],"countries":["India","China"],"title":"Fine epitope mapping of glycoprotein Gn in Guertu virus"},{"arc":[[36.5631141662598,103.735809326172],[41.118278503418,85.1935272216797]],"countries":["China"],"title":"Fine epitope mapping of glycoprotein Gn in Guertu virus"},{"arc":[[36.5631141662598,103.735809326172],[21.1991405487061,81.2897262573242]],"countries":["China","India"],"title":"Fine epitope mapping of glycoprotein Gn in Guertu virus"},{"arc":[[36.5631141662598,103.735809326172],[36.5631141662598,103.735809326172]],"countries":["China"],"title":"Fine epitope mapping of glycoprotein Gn in Guertu virus"},{"arc":[[21.1991405487061,81.2897262573242],[36.5631141662598,103.735809326172]],"countries":["China","India"],"title":"Fine epitope mapping of glycoprotein Gn in Guertu virus"},{"arc":[[41.6771812438965,123.463096618652],[40.9215507507324,-81.105842590332]],"countries":["China","United States"],"title":"Review of Bats and SARS"},{"arc":[[41.6771812438965,123.463096618652],[37.7697296142578,-122.466094970703]],"countries":["United States","China"],"title":"Review of Bats and SARS"},{"arc":[[40.9215507507324,-81.105842590332],[37.7697296142578,-122.466094970703]],"countries":["United States"],"title":"Review of Bats and SARS"},{"arc":[[40.1861572265625,116.418983459473],[40.1861572265625,116.418983459473]],"countries":["China"],"title":"Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus OPEN"},{"arc":[[40.1861572265625,116.418983459473],[9.36855030059814,-83.6394882202148]],"countries":["China","Costa Rica"],"title":"Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus OPEN"},{"arc":[[40.1861572265625,116.418983459473],[39.1343116760254,-84.5163192749023]],"countries":["China","United States"],"title":"Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus OPEN"},{"arc":[[9.36855030059814,-83.6394882202148],[40.1861572265625,116.418983459473]],"countries":["China","Costa Rica"],"title":"Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus OPEN"},{"arc":[[9.36855030059814,-83.6394882202148],[9.36855030059814,-83.6394882202148]],"countries":["Costa Rica"],"title":"Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus OPEN"},{"arc":[[9.36855030059814,-83.6394882202148],[39.1343116760254,-84.5163192749023]],"countries":["Costa Rica","United States"],"title":"Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus OPEN"},{"arc":[[32.9546966552734,131.391983032227],[43.0670013427734,-89.4000015258789]],"countries":["United States","Japan"],"title":"A Novel MVA Vectored Chikungunya Virus Vaccine Elicits Protective Immunity in Mice"},{"arc":[[32.9546966552734,131.391983032227],[32.9546966552734,131.391983032227]],"countries":["Japan"],"title":"A Novel MVA Vectored Chikungunya Virus Vaccine Elicits Protective Immunity in Mice"},{"arc":[[43.0670013427734,-89.4000015258789],[32.9546966552734,131.391983032227]],"countries":["United States","Japan"],"title":"A Novel MVA Vectored Chikungunya Virus Vaccine Elicits Protective Immunity in Mice"},{"arc":[[43.0670013427734,-89.4000015258789],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"A Novel MVA Vectored Chikungunya Virus Vaccine Elicits Protective Immunity in Mice"},{"arc":[[36.2640419006348,2.75382995605469],[36.2640419006348,2.75382995605469]],"countries":["Algeria"],"title":"The first evidence of a new genotype of nephropathogenic infectious bronchitis virus circulating in vaccinated and unvaccinated broiler flocks in Algeria"},{"arc":[[36.2640419006348,2.75382995605469],[36.4724082946777,2.83239006996155]],"countries":["Algeria"],"title":"The first evidence of a new genotype of nephropathogenic infectious bronchitis virus circulating in vaccinated and unvaccinated broiler flocks in Algeria"},{"arc":[[36.2640419006348,2.75382995605469],[33.5566825866699,23.774206161499]],"countries":["NOCOUNTRY","Algeria"],"title":"The first evidence of a new genotype of nephropathogenic infectious bronchitis virus circulating in vaccinated and unvaccinated broiler flocks in Algeria"},{"arc":[[36.4724082946777,2.83239006996155],[33.5566825866699,23.774206161499]],"countries":["NOCOUNTRY","Algeria"],"title":"The first evidence of a new genotype of nephropathogenic infectious bronchitis virus circulating in vaccinated and unvaccinated broiler flocks in Algeria"},{"arc":[[43.7031517028809,-72.2894134521484],[43.7031517028809,-72.2894134521484]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[43.7031517028809,-72.2894134521484],[47.6035690307617,-122.329452514648]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[43.7031517028809,-72.2894134521484],[37.5514907836914,-77.4517974853516]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[43.7031517028809,-72.2894134521484],[38.8465995788574,-104.824287414551]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[43.7031517028809,-72.2894134521484],[44.9948196411133,-93.41455078125]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[47.6035690307617,-122.329452514648],[43.7031517028809,-72.2894134521484]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[47.6035690307617,-122.329452514648],[37.5514907836914,-77.4517974853516]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[47.6035690307617,-122.329452514648],[38.8465995788574,-104.824287414551]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[47.6035690307617,-122.329452514648],[44.9948196411133,-93.41455078125]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[37.5514907836914,-77.4517974853516],[38.8465995788574,-104.824287414551]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[37.5514907836914,-77.4517974853516],[43.7031517028809,-72.2894134521484]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[37.5514907836914,-77.4517974853516],[44.9948196411133,-93.41455078125]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[38.8465995788574,-104.824287414551],[43.7031517028809,-72.2894134521484]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[38.8465995788574,-104.824287414551],[44.9948196411133,-93.41455078125]],"countries":["United States"],"title":"Cybercare 2.0: meeting the challenge of the global burden of disease in 2030"},{"arc":[[39.9530487060547,-75.1940231323242],[29.7095108032227,-95.3981781005859]],"countries":["United States"],"title":"Mouse hepatitis virus nsp14 exoribonuclease activity is required for"},{"arc":[[39.9530487060547,-75.1940231323242],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Mouse hepatitis virus nsp14 exoribonuclease activity is required for"},{"arc":[[39.9530487060547,-75.1940231323242],[35.2072563171387,-85.9198150634766]],"countries":["United States"],"title":"Mouse hepatitis virus nsp14 exoribonuclease activity is required for"},{"arc":[[29.7095108032227,-95.3981781005859],[29.7095108032227,-95.3981781005859]],"countries":["United States"],"title":"Mouse hepatitis virus nsp14 exoribonuclease activity is required for"},{"arc":[[29.7095108032227,-95.3981781005859],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Mouse hepatitis virus nsp14 exoribonuclease activity is required for"},{"arc":[[29.7095108032227,-95.3981781005859],[35.2072563171387,-85.9198150634766]],"countries":["United States"],"title":"Mouse hepatitis virus nsp14 exoribonuclease activity is required for"},{"arc":[[38.987850189209,-76.9389038085938],[52.1658325195312,4.47749996185303]],"countries":["United States","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[38.987850189209,-76.9389038085938],[55.6972007751465,37.5378494262695]],"countries":["United States","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[38.987850189209,-76.9389038085938],[51.9100685119629,4.46534013748169]],"countries":["United States","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[38.987850189209,-76.9389038085938],[50.5807495117188,8.67675018310547]],"countries":["United States","Germany"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[38.987850189209,-76.9389038085938],[51.4414596557617,-0.947839975357056]],"countries":["United States","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[38.987850189209,-76.9389038085938],[52.08896,5.1784]],"countries":["Netherlands","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[38.987850189209,-76.9389038085938],[50.7338905334473,7.10222196578979]],"countries":["United States","Germany"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[38.987850189209,-76.9389038085938],[41.9982795715332,-87.6571731567383]],"countries":["United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[55.6972007751465,37.5378494262695]],"countries":["Netherlands","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[51.9100685119629,4.46534013748169]],"countries":["Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[50.5807495117188,8.67675018310547]],"countries":["Germany","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[51.4414596557617,-0.947839975357056]],"countries":["Netherlands","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[52.1658325195312,4.47749996185303]],"countries":["Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[52.08896,5.1784]],"countries":["Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[50.7338905334473,7.10222196578979]],"countries":["Germany","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.1658325195312,4.47749996185303],[41.9982795715332,-87.6571731567383]],"countries":["United States","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[55.6972007751465,37.5378494262695],[55.6972007751465,37.5378494262695]],"countries":["Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[55.6972007751465,37.5378494262695],[51.9100685119629,4.46534013748169]],"countries":["Netherlands","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[55.6972007751465,37.5378494262695],[50.5807495117188,8.67675018310547]],"countries":["Germany","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[55.6972007751465,37.5378494262695],[51.4414596557617,-0.947839975357056]],"countries":["United Kingdom","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[55.6972007751465,37.5378494262695],[52.1658325195312,4.47749996185303]],"countries":["Netherlands","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[55.6972007751465,37.5378494262695],[52.08896,5.1784]],"countries":["Netherlands","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[55.6972007751465,37.5378494262695],[50.7338905334473,7.10222196578979]],"countries":["Germany","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[55.6972007751465,37.5378494262695],[41.9982795715332,-87.6571731567383]],"countries":["United States","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[50.5807495117188,8.67675018310547]],"countries":["Netherlands","Germany"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[51.4414596557617,-0.947839975357056]],"countries":["Netherlands","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[52.1658325195312,4.47749996185303]],"countries":["Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[52.08896,5.1784]],"countries":["Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[50.7338905334473,7.10222196578979]],"countries":["Netherlands","Germany"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[41.9982795715332,-87.6571731567383]],"countries":["Netherlands","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.9100685119629,4.46534013748169],[55.6972007751465,37.5378494262695]],"countries":["Netherlands","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[51.4414596557617,-0.947839975357056]],"countries":["Germany","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[52.1658325195312,4.47749996185303]],"countries":["Germany","Netherlands"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[52.08896,5.1784]],"countries":["Netherlands","Germany"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[41.9982795715332,-87.6571731567383]],"countries":["Germany","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.5807495117188,8.67675018310547],[55.6972007751465,37.5378494262695]],"countries":["Germany","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.4414596557617,-0.947839975357056],[52.1658325195312,4.47749996185303]],"countries":["Netherlands","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.4414596557617,-0.947839975357056],[52.08896,5.1784]],"countries":["Netherlands","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.4414596557617,-0.947839975357056],[50.7338905334473,7.10222196578979]],"countries":["Germany","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.4414596557617,-0.947839975357056],[41.9982795715332,-87.6571731567383]],"countries":["United States","United Kingdom"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[51.4414596557617,-0.947839975357056],[55.6972007751465,37.5378494262695]],"countries":["United Kingdom","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.08896,5.1784],[50.7338905334473,7.10222196578979]],"countries":["Netherlands","Germany"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.08896,5.1784],[41.9982795715332,-87.6571731567383]],"countries":["Netherlands","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[52.08896,5.1784],[55.6972007751465,37.5378494262695]],"countries":["Netherlands","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.7338905334473,7.10222196578979],[41.9982795715332,-87.6571731567383]],"countries":["Germany","United States"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[50.7338905334473,7.10222196578979],[55.6972007751465,37.5378494262695]],"countries":["Germany","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[41.9982795715332,-87.6571731567383],[55.6972007751465,37.5378494262695]],"countries":["United States","Russia"],"title":"Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group"},{"arc":[[53.3750495910645,5.25634002685547],[53.3750495910645,5.25634002685547]],"countries":["Netherlands"],"title":"Network Clustering Revealed the Systemic Alterations of Mitochondrial Protein Expression"},{"arc":[[53.3750495910645,5.25634002685547],[36.0378684997559,129.366271972656]],"countries":["Netherlands","South Korea"],"title":"Network Clustering Revealed the Systemic Alterations of Mitochondrial Protein Expression"},{"arc":[[53.3750495910645,5.25634002685547],[36.4511566162109,127.861145019531]],"countries":["South Korea","Netherlands"],"title":"Network Clustering Revealed the Systemic Alterations of Mitochondrial Protein Expression"},{"arc":[[36.0378684997559,129.366271972656],[53.3750495910645,5.25634002685547]],"countries":["Netherlands","South Korea"],"title":"Network Clustering Revealed the Systemic Alterations of Mitochondrial Protein Expression"},{"arc":[[36.0378684997559,129.366271972656],[36.4511566162109,127.861145019531]],"countries":["South Korea"],"title":"Network Clustering Revealed the Systemic Alterations of Mitochondrial Protein Expression"},{"arc":[[36.0378684997559,129.366271972656],[36.0378684997559,129.366271972656]],"countries":["South Korea"],"title":"Network Clustering Revealed the Systemic Alterations of Mitochondrial Protein Expression"},{"arc":[[36.4511566162109,127.861145019531],[53.3750495910645,5.25634002685547]],"countries":["South Korea","Netherlands"],"title":"Network Clustering Revealed the Systemic Alterations of Mitochondrial Protein Expression"},{"arc":[[36.4511566162109,127.861145019531],[36.0378684997559,129.366271972656]],"countries":["South Korea"],"title":"Network Clustering Revealed the Systemic Alterations of Mitochondrial Protein Expression"},{"arc":[[36.4511566162109,127.861145019531],[36.4511566162109,127.861145019531]],"countries":["South Korea"],"title":"Network Clustering Revealed the Systemic Alterations of Mitochondrial Protein Expression"},{"arc":[[42.9547386169434,-78.8192367553711],[15.040599822998,120.937843322754]],"countries":["United States","Philippines"],"title":"Strategies in regulating glioblastoma signaling pathways and anti-invasion therapy"},{"arc":[[42.9547386169434,-78.8192367553711],[42.9547386169434,-78.8192367553711]],"countries":["United States"],"title":"Strategies in regulating glioblastoma signaling pathways and anti-invasion therapy"},{"arc":[[15.040599822998,120.937843322754],[42.9547386169434,-78.8192367553711]],"countries":["United States","Philippines"],"title":"Strategies in regulating glioblastoma signaling pathways and anti-invasion therapy"},{"arc":[[42.6500015258789,-7.33330011367798],[1.29041004180908,103.852111816406]],"countries":["Spain","Singapore"],"title":"Open Access Optimization and clinical validation of a pathogen detection microarray"},{"arc":[[41.7278709411621,44.764778137207],[32.0583801269531,118.79647064209]],"countries":["Georgia","China"],"title":"Selection of reference genes for the quantitative real-time PCR normalization of gene expression in Isatis indigotica fortune"},{"arc":[[32.0583801269531,118.79647064209],[32.0583801269531,118.79647064209]],"countries":["China"],"title":"Selection of reference genes for the quantitative real-time PCR normalization of gene expression in Isatis indigotica fortune"},{"arc":[[38.0361785888672,-78.5016174316406],[37.4599990844727,126.949996948242]],"countries":["South Korea","United States"],"title":"The Roles of Histidines and Charged Residues as Potential Triggers of a Conformational Change in the Fusion Loop of Ebola Virus Glycoprotein"},{"arc":[[38.0361785888672,-78.5016174316406],[38.0361785888672,-78.5016174316406]],"countries":["United States"],"title":"The Roles of Histidines and Charged Residues as Potential Triggers of a Conformational Change in the Fusion Loop of Ebola Virus Glycoprotein"},{"arc":[[37.4599990844727,126.949996948242],[38.0361785888672,-78.5016174316406]],"countries":["South Korea","United States"],"title":"The Roles of Histidines and Charged Residues as Potential Triggers of a Conformational Change in the Fusion Loop of Ebola Virus Glycoprotein"},{"arc":[[53.7908592224121,-1.76340997219086],[53.7908592224121,-1.76340997219086]],"countries":["United Kingdom"],"title":"Anti-inflammatory activity of electron-deficient organometallics"},{"arc":[[26.7066898345947,88.3561019897461],[43.6486892700195,-79.3854370117188]],"countries":["Canada","India"],"title":"Communication of bed allocation decisions in a critical care unit and accountability for reasonableness"},{"arc":[[43.6486892700195,-79.3854370117188],[43.6486892700195,-79.3854370117188]],"countries":["Canada"],"title":"Communication of bed allocation decisions in a critical care unit and accountability for reasonableness"},{"arc":[[42.0617485046387,-87.6770706176758],[42.0617485046387,-87.6770706176758]],"countries":["United States"],"title":"Full-length Ebola glycoprotein accumulates in the endoplasmic reticulum"},{"arc":[[41.3144607543945,-72.9232711791992],[40.7652282714844,-111.849472045898]],"countries":["United States"],"title":"Enrichment of Retroviral Sequences in Brain Tissue from Patients with Severe Demyelinating Diseases"},{"arc":[[40.7652282714844,-111.849472045898],[40.7652282714844,-111.849472045898]],"countries":["United States"],"title":"Enrichment of Retroviral Sequences in Brain Tissue from Patients with Severe Demyelinating Diseases"},{"arc":[[40.9437103271484,40.2619209289551],[-33.9181594848633,151.228820800781]],"countries":["Turkey","Australia"],"title":"The presence of fever in adults with influenza and other viral respiratory infections"},{"arc":[[-33.9181594848633,151.228820800781],[-33.9181594848633,151.228820800781]],"countries":["Australia"],"title":"The presence of fever in adults with influenza and other viral respiratory infections"},{"arc":[[29.5528106689453,-95.0937881469727],[52.4481086730957,13.2859802246094]],"countries":["Germany","United States"],"title":"Three-Dimensional Normal Human Neural Progenitor Tissue-Like Assemblies: A Model of Persistent Varicella- Zoster Virus Infection"},{"arc":[[29.5528106689453,-95.0937881469727],[40.0039215087891,-105.26683807373]],"countries":["United States"],"title":"Three-Dimensional Normal Human Neural Progenitor Tissue-Like Assemblies: A Model of Persistent Varicella- Zoster Virus Infection"},{"arc":[[29.5528106689453,-95.0937881469727],[29.5528106689453,-95.0937881469727]],"countries":["United States"],"title":"Three-Dimensional Normal Human Neural Progenitor Tissue-Like Assemblies: A Model of Persistent Varicella- Zoster Virus Infection"},{"arc":[[29.5528106689453,-95.0937881469727],[42.4463500976562,-76.4826889038086]],"countries":["United States"],"title":"Three-Dimensional Normal Human Neural Progenitor Tissue-Like Assemblies: A Model of Persistent Varicella- Zoster Virus Infection"},{"arc":[[52.4481086730957,13.2859802246094],[40.0039215087891,-105.26683807373]],"countries":["United States","Germany"],"title":"Three-Dimensional Normal Human Neural Progenitor Tissue-Like Assemblies: A Model of Persistent Varicella- Zoster Virus Infection"},{"arc":[[52.4481086730957,13.2859802246094],[29.5528106689453,-95.0937881469727]],"countries":["Germany","United States"],"title":"Three-Dimensional Normal Human Neural Progenitor Tissue-Like Assemblies: A Model of Persistent Varicella- Zoster Virus Infection"},{"arc":[[52.4481086730957,13.2859802246094],[42.4463500976562,-76.4826889038086]],"countries":["United States","Germany"],"title":"Three-Dimensional Normal Human Neural Progenitor Tissue-Like Assemblies: A Model of Persistent Varicella- Zoster Virus Infection"},{"arc":[[40.0039215087891,-105.26683807373],[29.5528106689453,-95.0937881469727]],"countries":["United States"],"title":"Three-Dimensional Normal Human Neural Progenitor Tissue-Like Assemblies: A Model of Persistent Varicella- Zoster Virus Infection"},{"arc":[[40.0039215087891,-105.26683807373],[42.4463500976562,-76.4826889038086]],"countries":["United States"],"title":"Three-Dimensional Normal Human Neural Progenitor Tissue-Like Assemblies: A Model of Persistent Varicella- Zoster Virus Infection"},{"arc":[[40.8126945495605,14.2059698104858],[21.1394691467285,79.0602798461914]],"countries":["India","Italy"],"title":"Characterization of respiratory infection viruses in hospitalized children from Naples province in Southern Italy"},{"arc":[[40.8126945495605,14.2059698104858],[40.8126945495605,14.2059698104858]],"countries":["Italy"],"title":"Characterization of respiratory infection viruses in hospitalized children from Naples province in Southern Italy"},{"arc":[[21.1394691467285,79.0602798461914],[40.8126945495605,14.2059698104858]],"countries":["India","Italy"],"title":"Characterization of respiratory infection viruses in hospitalized children from Naples province in Southern Italy"},{"arc":[[21.1394691467285,79.0602798461914],[21.1394691467285,79.0602798461914]],"countries":["India"],"title":"Characterization of respiratory infection viruses in hospitalized children from Naples province in Southern Italy"},{"arc":[[36.611458,127.325192],[42.9547386169434,-78.8192367553711]],"countries":["United States","South Korea"],"title":"Selection and Characterization of Monoclonal Antibodies Targeting Middle East Respiratory Syndrome Coronavirus through a Human Synthetic Fab Phage Display Library Panning"},{"arc":[[36.611458,127.325192],[36.611458,127.325192]],"countries":["South Korea"],"title":"Selection and Characterization of Monoclonal Antibodies Targeting Middle East Respiratory Syndrome Coronavirus through a Human Synthetic Fab Phage Display Library Panning"},{"arc":[[42.9547386169434,-78.8192367553711],[36.611458,127.325192]],"countries":["United States","South Korea"],"title":"Selection and Characterization of Monoclonal Antibodies Targeting Middle East Respiratory Syndrome Coronavirus through a Human Synthetic Fab Phage Display Library Panning"},{"arc":[[51.4414596557617,-0.947839975357056],[51.4414596557617,-0.947839975357056]],"countries":["United Kingdom"],"title":"A Fusion Peptide in the Spike Protein of MERS Coronavirus"},{"arc":[[49.0121917724609,0.703100025653839],[49.0121917724609,0.703100025653839]],"countries":["France"],"title":"Structural insights into the Middle East respiratory syndrome coronavirus 4a protein and its dsRNA binding mechanism OPEN"},{"arc":[[29.31842,47.97301],[29.31842,47.97301]],"countries":["Kuwait"],"title":"Anti-Inflammatory Action of Angiotensin 1-7 in Experimental Colitis"},{"arc":[[50.877628326416,4.70719003677368],[50.877628326416,4.70719003677368]],"countries":["Belgium"],"title":"Emerging Concepts of Data Integration in Pathogen Phylodynamics"},{"arc":[[50.877628326416,4.70719003677368],[51.7723388671875,19.4748992919922]],"countries":["Belgium","Poland"],"title":"Acyclic nucleoside phosphonates containing the amide bond"},{"arc":[[50.877628326416,4.70719003677368],[50.877628326416,4.70719003677368]],"countries":["Belgium"],"title":"Acyclic nucleoside phosphonates containing the amide bond"},{"arc":[[51.7723388671875,19.4748992919922],[51.7723388671875,19.4748992919922]],"countries":["Poland"],"title":"Acyclic nucleoside phosphonates containing the amide bond"},{"arc":[[51.7723388671875,19.4748992919922],[50.877628326416,4.70719003677368]],"countries":["Belgium","Poland"],"title":"Acyclic nucleoside phosphonates containing the amide bond"},{"arc":[[37.57612,-77.38019],[37.57612,-77.38019]],"countries":["United States"],"title":"Virology Journal The involvement of survival signaling pathways in rubella-virus induced apoptosis"},{"arc":[[35.7868995666504,-93.9436416625977],[-35.2755393981934,149.121124267578]],"countries":["Australia","United States"],"title":"Exploring a Proposed WHO Method to Determine Thresholds for Seasonal Influenza Surveillance"},{"arc":[[45,-75],[45.4225616455078,-75.6843109130859]],"countries":["Canada"],"title":"Genetic Vaccines and Therapy A combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses"},{"arc":[[45,-75],[45,-75]],"countries":["Canada"],"title":"Genetic Vaccines and Therapy A combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses"},{"arc":[[45.4225616455078,-75.6843109130859],[45,-75]],"countries":["Canada"],"title":"Genetic Vaccines and Therapy A combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses"},{"arc":[[51.5365982055664,-0.13400000333786],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[51.5365982055664,-0.13400000333786],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[51.5365982055664,-0.13400000333786],[50.8659515380859,-0.0823199972510338]],"countries":["United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[51.5365982055664,-0.13400000333786],[42.9547386169434,-78.8192367553711]],"countries":["United States","United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[51.5365982055664,-0.13400000333786],[51.5365982055664,-0.13400000333786]],"countries":["United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[51.5365982055664,-0.13400000333786],[35.7868995666504,-93.9436416625977]],"countries":["United Kingdom","United States"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[51.5365982055664,-0.13400000333786],[35.9053153991699,-79.0477142333984]],"countries":["United Kingdom","United States"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[51.7589988708496,-1.26400005817413],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[51.7589988708496,-1.26400005817413],[50.8659515380859,-0.0823199972510338]],"countries":["United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[51.7589988708496,-1.26400005817413],[42.9547386169434,-78.8192367553711]],"countries":["United States","United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[51.7589988708496,-1.26400005817413],[51.5365982055664,-0.13400000333786]],"countries":["United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[51.7589988708496,-1.26400005817413],[35.7868995666504,-93.9436416625977]],"countries":["United States","United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[51.7589988708496,-1.26400005817413],[35.9053153991699,-79.0477142333984]],"countries":["United States","United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[51.5002288818359,-0.178939998149872],[50.8659515380859,-0.0823199972510338]],"countries":["United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[51.5002288818359,-0.178939998149872],[42.9547386169434,-78.8192367553711]],"countries":["United States","United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[51.5002288818359,-0.178939998149872],[51.5365982055664,-0.13400000333786]],"countries":["United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[51.5002288818359,-0.178939998149872],[35.7868995666504,-93.9436416625977]],"countries":["United States","United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[51.5002288818359,-0.178939998149872],[35.9053153991699,-79.0477142333984]],"countries":["United States","United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[50.8659515380859,-0.0823199972510338],[42.9547386169434,-78.8192367553711]],"countries":["United States","United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[50.8659515380859,-0.0823199972510338],[51.5365982055664,-0.13400000333786]],"countries":["United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[50.8659515380859,-0.0823199972510338],[50.8659515380859,-0.0823199972510338]],"countries":["United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[50.8659515380859,-0.0823199972510338],[35.7868995666504,-93.9436416625977]],"countries":["United States","United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[50.8659515380859,-0.0823199972510338],[35.9053153991699,-79.0477142333984]],"countries":["United States","United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[42.9547386169434,-78.8192367553711],[51.5365982055664,-0.13400000333786]],"countries":["United States","United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[42.9547386169434,-78.8192367553711],[50.8659515380859,-0.0823199972510338]],"countries":["United States","United Kingdom"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[42.9547386169434,-78.8192367553711],[35.7868995666504,-93.9436416625977]],"countries":["United States"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[42.9547386169434,-78.8192367553711],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[35.7868995666504,-93.9436416625977],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"Commentary Understanding and Managing Zoonotic Risk in the New Livestock Industries"},{"arc":[[37.559331,126.938658],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Korea"],"title":"Evaluation of Three Automated Nucleic Acid Extraction Systems for Identification of Respiratory Viruses in Clinical Specimens by Multiplex Real-Time PCR"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Evaluation of Three Automated Nucleic Acid Extraction Systems for Identification of Respiratory Viruses in Clinical Specimens by Multiplex Real-Time PCR"},{"arc":[[30.6250877380371,102.697288513184],[30.6250877380371,102.697288513184]],"countries":["China"],"title":"Isolation and Selection of Duck Primary Cells as Pathogenic and Innate Immunologic Cell Models for Duck Plague Virus"},{"arc":[[30.6250877380371,102.697288513184],[40.9437103271484,40.2619209289551]],"countries":["Turkey","China"],"title":"Isolation and Selection of Duck Primary Cells as Pathogenic and Innate Immunologic Cell Models for Duck Plague Virus"},{"arc":[[30.6250877380371,102.697288513184],[44.9734497070312,-93.2378997802734]],"countries":["China","United States"],"title":"Isolation and Selection of Duck Primary Cells as Pathogenic and Innate Immunologic Cell Models for Duck Plague Virus"},{"arc":[[40.9437103271484,40.2619209289551],[30.6250877380371,102.697288513184]],"countries":["Turkey","China"],"title":"Isolation and Selection of Duck Primary Cells as Pathogenic and Innate Immunologic Cell Models for Duck Plague Virus"},{"arc":[[40.9437103271484,40.2619209289551],[44.9734497070312,-93.2378997802734]],"countries":["Turkey","United States"],"title":"Isolation and Selection of Duck Primary Cells as Pathogenic and Innate Immunologic Cell Models for Duck Plague Virus"},{"arc":[[44.9734497070312,-93.2378997802734],[30.6250877380371,102.697288513184]],"countries":["China","United States"],"title":"Isolation and Selection of Duck Primary Cells as Pathogenic and Innate Immunologic Cell Models for Duck Plague Virus"},{"arc":[[28.7162494659424,77.2728576660156],[31.2148895263672,121.564643859863]],"countries":["India","China"],"title":"Development and evaluation of recombinase-aided amplification assays incorporating competitive internal controls for detection of human adenovirus serotypes 3 and 7"},{"arc":[[-27.4965896606445,153.012985229492],[-37.797981262207,144.959045410156]],"countries":["Australia"],"title":"Direct nanopore sequencing of mRNA reveals landscape of transcript isoforms in apicomplexan parasites"},{"arc":[[-27.4965896606445,153.012985229492],[-37.7994003295898,144.957412719727]],"countries":["Australia"],"title":"Direct nanopore sequencing of mRNA reveals landscape of transcript isoforms in apicomplexan parasites"},{"arc":[[-27.4965896606445,153.012985229492],[-27.4965896606445,153.012985229492]],"countries":["Australia"],"title":"Direct nanopore sequencing of mRNA reveals landscape of transcript isoforms in apicomplexan parasites"},{"arc":[[-37.797981262207,144.959045410156],[-37.797981262207,144.959045410156]],"countries":["Australia"],"title":"Direct nanopore sequencing of mRNA reveals landscape of transcript isoforms in apicomplexan parasites"},{"arc":[[-37.797981262207,144.959045410156],[-37.7994003295898,144.957412719727]],"countries":["Australia"],"title":"Direct nanopore sequencing of mRNA reveals landscape of transcript isoforms in apicomplexan parasites"},{"arc":[[-37.797981262207,144.959045410156],[-27.4965896606445,153.012985229492]],"countries":["Australia"],"title":"Direct nanopore sequencing of mRNA reveals landscape of transcript isoforms in apicomplexan parasites"},{"arc":[[-37.7994003295898,144.957412719727],[-37.7994003295898,144.957412719727]],"countries":["Australia"],"title":"Direct nanopore sequencing of mRNA reveals landscape of transcript isoforms in apicomplexan parasites"},{"arc":[[-37.7994003295898,144.957412719727],[-27.4965896606445,153.012985229492]],"countries":["Australia"],"title":"Direct nanopore sequencing of mRNA reveals landscape of transcript isoforms in apicomplexan parasites"},{"arc":[[39.6785011291504,-104.966621398926],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[39.6785011291504,-104.966621398926],[40.4118385314941,-104.692291259766]],"countries":["United States"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[39.6785011291504,-104.966621398926],[39.6785011291504,-104.966621398926]],"countries":["United States"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[39.6785011291504,-104.966621398926],[43.9649963378906,-112.343688964844]],"countries":["NOCOUNTRY","United States"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[39.0048141479492,-77.0975341796875],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[39.0048141479492,-77.0975341796875],[40.4118385314941,-104.692291259766]],"countries":["United States"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[39.0048141479492,-77.0975341796875],[39.6785011291504,-104.966621398926]],"countries":["United States"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[39.0048141479492,-77.0975341796875],[43.9649963378906,-112.343688964844]],"countries":["United States","NOCOUNTRY"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[40.4118385314941,-104.692291259766],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[40.4118385314941,-104.692291259766],[39.6785011291504,-104.966621398926]],"countries":["United States"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[40.4118385314941,-104.692291259766],[43.9649963378906,-112.343688964844]],"countries":["NOCOUNTRY","United States"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[43.9649963378906,-112.343688964844],[39.6785011291504,-104.966621398926]],"countries":["NOCOUNTRY","United States"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[43.9649963378906,-112.343688964844],[39.0048141479492,-77.0975341796875]],"countries":["United States","NOCOUNTRY"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[43.9649963378906,-112.343688964844],[43.9649963378906,-112.343688964844]],"countries":["NOCOUNTRY"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[24.7343902587891,46.6319313049316],[31.7554702758789,76.5339202880859]],"countries":["Saudi Arabia","India"],"title":"Medical residents' attitudes and emotions related to Middle East respiratory syndrome in Saudi Arabia A cross-sectional study"},{"arc":[[24.7343902587891,46.6319313049316],[21.4919700622559,39.2515716552734]],"countries":["Saudi Arabia"],"title":"Medical residents' attitudes and emotions related to Middle East respiratory syndrome in Saudi Arabia A cross-sectional study"},{"arc":[[24.7343902587891,46.6319313049316],[37.8698387145996,32.485668182373]],"countries":["Saudi Arabia","Turkey"],"title":"Medical residents' attitudes and emotions related to Middle East respiratory syndrome in Saudi Arabia A cross-sectional study"},{"arc":[[24.7343902587891,46.6319313049316],[24.7343902587891,46.6319313049316]],"countries":["Saudi Arabia"],"title":"Medical residents' attitudes and emotions related to Middle East respiratory syndrome in Saudi Arabia A cross-sectional study"},{"arc":[[31.7554702758789,76.5339202880859],[31.7554702758789,76.5339202880859]],"countries":["India"],"title":"Medical residents' attitudes and emotions related to Middle East respiratory syndrome in Saudi Arabia A cross-sectional study"},{"arc":[[31.7554702758789,76.5339202880859],[21.4919700622559,39.2515716552734]],"countries":["Saudi Arabia","India"],"title":"Medical residents' attitudes and emotions related to Middle East respiratory syndrome in Saudi Arabia A cross-sectional study"},{"arc":[[31.7554702758789,76.5339202880859],[37.8698387145996,32.485668182373]],"countries":["India","Turkey"],"title":"Medical residents' attitudes and emotions related to Middle East respiratory syndrome in Saudi Arabia A cross-sectional study"},{"arc":[[31.7554702758789,76.5339202880859],[24.7343902587891,46.6319313049316]],"countries":["Saudi Arabia","India"],"title":"Medical residents' attitudes and emotions related to Middle East respiratory syndrome in Saudi Arabia A cross-sectional study"},{"arc":[[21.4919700622559,39.2515716552734],[37.8698387145996,32.485668182373]],"countries":["Saudi Arabia","Turkey"],"title":"Medical residents' attitudes and emotions related to Middle East respiratory syndrome in Saudi Arabia A cross-sectional study"},{"arc":[[21.4919700622559,39.2515716552734],[24.7343902587891,46.6319313049316]],"countries":["Saudi Arabia"],"title":"Medical residents' attitudes and emotions related to Middle East respiratory syndrome in Saudi Arabia A cross-sectional study"},{"arc":[[37.8698387145996,32.485668182373],[24.7343902587891,46.6319313049316]],"countries":["Saudi Arabia","Turkey"],"title":"Medical residents' attitudes and emotions related to Middle East respiratory syndrome in Saudi Arabia A cross-sectional study"},{"arc":[[39.7769203186035,-84.0670013427734],[39.7769203186035,-84.0670013427734]],"countries":["United States"],"title":"Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Colorimetric Detection of Dengue by Single Tube Reverse-Transcription-Loop-Mediated Isothermal Amplification"},{"arc":[[35.6457710266113,139.746292114258],[38.9000015258789,140.682998657227]],"countries":["Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[35.6457710266113,139.746292114258],[35.7130813598633,139.445846557617]],"countries":["Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[35.6457710266113,139.746292114258],[34.3790397644043,132.469787597656]],"countries":["Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[35.6457710266113,139.746292114258],[36.6533355712891,137.981689453125]],"countries":["Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[35.6457710266113,139.746292114258],[34.5720100402832,135.480224609375]],"countries":["Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[35.6457710266113,139.746292114258],[29.7095108032227,-95.3981781005859]],"countries":["United States","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[35.6457710266113,139.746292114258],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[35.6457710266113,139.746292114258],[35.7868995666504,-93.9436416625977]],"countries":["United States","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[38.9000015258789,140.682998657227],[35.7130813598633,139.445846557617]],"countries":["Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[38.9000015258789,140.682998657227],[34.3790397644043,132.469787597656]],"countries":["Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[38.9000015258789,140.682998657227],[36.6533355712891,137.981689453125]],"countries":["Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[38.9000015258789,140.682998657227],[34.5720100402832,135.480224609375]],"countries":["Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[38.9000015258789,140.682998657227],[29.7095108032227,-95.3981781005859]],"countries":["United States","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[38.9000015258789,140.682998657227],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[38.9000015258789,140.682998657227],[35.7868995666504,-93.9436416625977]],"countries":["United States","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[35.7130813598633,139.445846557617],[34.3790397644043,132.469787597656]],"countries":["Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[35.7130813598633,139.445846557617],[36.6533355712891,137.981689453125]],"countries":["Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[35.7130813598633,139.445846557617],[34.5720100402832,135.480224609375]],"countries":["Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[35.7130813598633,139.445846557617],[29.7095108032227,-95.3981781005859]],"countries":["United States","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[35.7130813598633,139.445846557617],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[35.7130813598633,139.445846557617],[35.7868995666504,-93.9436416625977]],"countries":["United States","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[34.3790397644043,132.469787597656],[34.3790397644043,132.469787597656]],"countries":["Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[34.3790397644043,132.469787597656],[36.6533355712891,137.981689453125]],"countries":["Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[34.3790397644043,132.469787597656],[34.5720100402832,135.480224609375]],"countries":["Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[34.3790397644043,132.469787597656],[29.7095108032227,-95.3981781005859]],"countries":["United States","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[34.3790397644043,132.469787597656],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[34.3790397644043,132.469787597656],[35.7868995666504,-93.9436416625977]],"countries":["United States","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[36.6533355712891,137.981689453125],[34.5720100402832,135.480224609375]],"countries":["Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[36.6533355712891,137.981689453125],[29.7095108032227,-95.3981781005859]],"countries":["United States","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[36.6533355712891,137.981689453125],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[36.6533355712891,137.981689453125],[36.6533355712891,137.981689453125]],"countries":["Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[36.6533355712891,137.981689453125],[35.7868995666504,-93.9436416625977]],"countries":["United States","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[34.5720100402832,135.480224609375],[29.7095108032227,-95.3981781005859]],"countries":["United States","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[34.5720100402832,135.480224609375],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[34.5720100402832,135.480224609375],[36.6533355712891,137.981689453125]],"countries":["Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[34.5720100402832,135.480224609375],[35.7868995666504,-93.9436416625977]],"countries":["United States","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[29.7095108032227,-95.3981781005859],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[29.7095108032227,-95.3981781005859],[36.6533355712891,137.981689453125]],"countries":["United States","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[29.7095108032227,-95.3981781005859],[35.7868995666504,-93.9436416625977]],"countries":["United States"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[40.9437103271484,40.2619209289551],[36.6533355712891,137.981689453125]],"countries":["Turkey","Japan"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[40.9437103271484,40.2619209289551],[35.7868995666504,-93.9436416625977]],"countries":["Turkey","United States"],"title":"A survey on infection control in emergency departments in Japan Committee for Infection Control for the Emergency Department, the Japanese Association for Acute Medicine, and the joint working group"},{"arc":[[41.7278709411621,44.764778137207],[40.1861572265625,116.418983459473]],"countries":["China","Georgia"],"title":"Thin-Section Computed Tomography Manifestations During Convalescence and Long- Term Follow-Up of Patients with Severe Acute Respiratory Syndrome (SARS) This work is licensed under Creative Common Attribution- NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)"},{"arc":[[41.7278709411621,44.764778137207],[41.7278709411621,44.764778137207]],"countries":["Georgia"],"title":"Thin-Section Computed Tomography Manifestations During Convalescence and Long- Term Follow-Up of Patients with Severe Acute Respiratory Syndrome (SARS) This work is licensed under Creative Common Attribution- NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)"},{"arc":[[40.1861572265625,116.418983459473],[41.7278709411621,44.764778137207]],"countries":["China","Georgia"],"title":"Thin-Section Computed Tomography Manifestations During Convalescence and Long- Term Follow-Up of Patients with Severe Acute Respiratory Syndrome (SARS) This work is licensed under Creative Common Attribution- NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)"},{"arc":[[47.5488014221191,7.58781003952026],[47.5488014221191,7.58781003952026]],"countries":["Switzerland"],"title":"Pelargonium sidoides radix extract EPs 7630 reduces rhinovirus infection through modulation of viral binding proteins on human bronchial epithelial cells"},{"arc":[[43.5278816223145,-80.2231063842773],[43.5278816223145,-80.2231063842773]],"countries":["Canada"],"title":"Recent Advances in Biosensor Development for Foodborne Virus Detection"},{"arc":[[13.8121700286865,-88.4092025756836],[13.8121700286865,-88.4092025756836]],"countries":["El Salvador"],"title":"Mobile ECMO team for inter-hospital transportation of patients with ARDS: a retrospective case series"},{"arc":[[54.1833305358887,13.3666696548462],[48.150390625,11.5805997848511]],"countries":["Germany"],"title":"NA"},{"arc":[[54.1833305358887,13.3666696548462],[54.1833305358887,13.3666696548462]],"countries":["Germany"],"title":"NA"},{"arc":[[54.1833305358887,13.3666696548462],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","Germany"],"title":"NA"},{"arc":[[48.150390625,11.5805997848511],[54.1833305358887,13.3666696548462]],"countries":["Germany"],"title":"NA"},{"arc":[[48.150390625,11.5805997848511],[48.150390625,11.5805997848511]],"countries":["Germany"],"title":"NA"},{"arc":[[48.150390625,11.5805997848511],[40.7182693481445,46.4133987426758]],"countries":["Germany","Azerbaijan"],"title":"NA"},{"arc":[[40.7182693481445,46.4133987426758],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan"],"title":"NA"},{"arc":[[47.3191909790039,5.06463003158569],[45.7491493225098,4.83716011047363]],"countries":["France"],"title":"Using Dynamic Stochastic Modelling to Estimate Population Risk Factors in Infectious Disease: The Example of FIV in 15 Cat Populations"},{"arc":[[47.3191909790039,5.06463003158569],[47.3191909790039,5.06463003158569]],"countries":["France"],"title":"Using Dynamic Stochastic Modelling to Estimate Population Risk Factors in Infectious Disease: The Example of FIV in 15 Cat Populations"},{"arc":[[45.7491493225098,4.83716011047363],[45.7491493225098,4.83716011047363]],"countries":["France"],"title":"Using Dynamic Stochastic Modelling to Estimate Population Risk Factors in Infectious Disease: The Example of FIV in 15 Cat Populations"},{"arc":[[45.7491493225098,4.83716011047363],[47.3191909790039,5.06463003158569]],"countries":["France"],"title":"Using Dynamic Stochastic Modelling to Estimate Population Risk Factors in Infectious Disease: The Example of FIV in 15 Cat Populations"},{"arc":[[23.9088153839111,54.3383674621582],[23.9088153839111,54.3383674621582]],"countries":["United Arab Emirates"],"title":"An analysis of the health status of the United Arab Emirates: the 'Big 4' public health issues"},{"arc":[[31.2988891601562,121.499168395996],[37.7697296142578,-122.466094970703]],"countries":["United States","China"],"title":"A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses"},{"arc":[[31.2988891601562,121.499168395996],[40.7145500183105,-74.0071411132812]],"countries":["China","United States"],"title":"A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses"},{"arc":[[31.2988891601562,121.499168395996],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","China"],"title":"A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses"},{"arc":[[31.2988891601562,121.499168395996],[28.261251449585,-82.7311248779297]],"countries":["China","United States"],"title":"A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses"},{"arc":[[37.7697296142578,-122.466094970703],[40.7145500183105,-74.0071411132812]],"countries":["United States"],"title":"A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses"},{"arc":[[37.7697296142578,-122.466094970703],[22.2802925109863,114.142951965332]],"countries":["United States","Hong Kong SAR"],"title":"A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses"},{"arc":[[37.7697296142578,-122.466094970703],[28.261251449585,-82.7311248779297]],"countries":["United States"],"title":"A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses"},{"arc":[[40.7145500183105,-74.0071411132812],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United States"],"title":"A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses"},{"arc":[[40.7145500183105,-74.0071411132812],[28.261251449585,-82.7311248779297]],"countries":["United States"],"title":"A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses"},{"arc":[[40.7145500183105,-74.0071411132812],[40.7145500183105,-74.0071411132812]],"countries":["United States"],"title":"A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses"},{"arc":[[22.2802925109863,114.142951965332],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses"},{"arc":[[22.2802925109863,114.142951965332],[28.261251449585,-82.7311248779297]],"countries":["Hong Kong SAR","United States"],"title":"A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses"},{"arc":[[22.2802925109863,114.142951965332],[40.7145500183105,-74.0071411132812]],"countries":["Hong Kong SAR","United States"],"title":"A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses"},{"arc":[[28.261251449585,-82.7311248779297],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United States"],"title":"A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses"},{"arc":[[28.261251449585,-82.7311248779297],[40.7145500183105,-74.0071411132812]],"countries":["United States"],"title":"A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses"},{"arc":[[43.9649963378906,-112.343688964844],[43.9649963378906,-112.343688964844]],"countries":["NOCOUNTRY"],"title":"A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters"},{"arc":[[43.9649963378906,-112.343688964844],[51.7589988708496,-1.26400005817413]],"countries":["NOCOUNTRY","United Kingdom"],"title":"A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters"},{"arc":[[43.9649963378906,-112.343688964844],[39.0048141479492,-77.0975341796875]],"countries":["United States","NOCOUNTRY"],"title":"A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters"},{"arc":[[51.7589988708496,-1.26400005817413],[39.0048141479492,-77.0975341796875]],"countries":["United States","United Kingdom"],"title":"A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters"},{"arc":[[51.7589988708496,-1.26400005817413],[43.9649963378906,-112.343688964844]],"countries":["NOCOUNTRY","United Kingdom"],"title":"A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters"},{"arc":[[51.7589988708496,-1.26400005817413],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom"],"title":"A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters"},{"arc":[[39.0048141479492,-77.0975341796875],[43.9649963378906,-112.343688964844]],"countries":["United States","NOCOUNTRY"],"title":"A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters"},{"arc":[[39.0048141479492,-77.0975341796875],[51.7589988708496,-1.26400005817413]],"countries":["United States","United Kingdom"],"title":"A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters"},{"arc":[[39.0048141479492,-77.0975341796875],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters"},{"arc":[[23.7489929199219,120.971282958984],[23.7489929199219,120.971282958984]],"countries":["Taiwan"],"title":"Infection Control and SARS Transmission among Healthcare Workers, Taiwan"},{"arc":[[23.7489929199219,120.971282958984],[25.033332824707,121.516670227051]],"countries":["Taiwan"],"title":"Infection Control and SARS Transmission among Healthcare Workers, Taiwan"},{"arc":[[25.033332824707,121.516670227051],[23.7489929199219,120.971282958984]],"countries":["Taiwan"],"title":"Infection Control and SARS Transmission among Healthcare Workers, Taiwan"},{"arc":[[52.2025413513184,0.119549997150898],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"Contacts in context: large-scale setting-specific social mixing matrices from the BBC Pandemic project"},{"arc":[[51.9735984802246,5.66384315490723],[52.08896,5.1784]],"countries":["Netherlands"],"title":"A Single Immunization with Soluble Recombinant Trimeric Hemagglutinin Protects Chickens against Highly Pathogenic Avian Influenza Virus H5N1"},{"arc":[[51.9735984802246,5.66384315490723],[51.9735984802246,5.66384315490723]],"countries":["Netherlands"],"title":"A Single Immunization with Soluble Recombinant Trimeric Hemagglutinin Protects Chickens against Highly Pathogenic Avian Influenza Virus H5N1"},{"arc":[[52.08896,5.1784],[52.08896,5.1784]],"countries":["Netherlands"],"title":"A Single Immunization with Soluble Recombinant Trimeric Hemagglutinin Protects Chickens against Highly Pathogenic Avian Influenza Virus H5N1"},{"arc":[[52.08896,5.1784],[51.9735984802246,5.66384315490723]],"countries":["Netherlands"],"title":"A Single Immunization with Soluble Recombinant Trimeric Hemagglutinin Protects Chickens against Highly Pathogenic Avian Influenza Virus H5N1"},{"arc":[[51.1082496643066,17.0269107818604],[51.1082496643066,17.0269107818604]],"countries":["Poland"],"title":"materials Tuning Optical and Granulometric Properties of Gold Nanostructures Synthesized with the Aid of Different Types of Honeys for Microwave-Induced Hyperthermia"},{"arc":[[38.944408416748,-92.3292999267578],[30.6127891540527,-96.339599609375]],"countries":["United States"],"title":"Evolution of the Bovine TLR Gene Family and Member Associations with Mycobacterium avium Subspecies Infection"},{"arc":[[38.944408416748,-92.3292999267578],[42.4463500976562,-76.4826889038086]],"countries":["United States"],"title":"Evolution of the Bovine TLR Gene Family and Member Associations with Mycobacterium avium Subspecies Infection"},{"arc":[[38.944408416748,-92.3292999267578],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"Evolution of the Bovine TLR Gene Family and Member Associations with Mycobacterium avium Subspecies Infection"},{"arc":[[38.944408416748,-92.3292999267578],[27.9197807312012,78.085693359375]],"countries":["United States","India"],"title":"Evolution of the Bovine TLR Gene Family and Member Associations with Mycobacterium avium Subspecies Infection"},{"arc":[[30.6127891540527,-96.339599609375],[42.4463500976562,-76.4826889038086]],"countries":["United States"],"title":"Evolution of the Bovine TLR Gene Family and Member Associations with Mycobacterium avium Subspecies Infection"},{"arc":[[30.6127891540527,-96.339599609375],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"Evolution of the Bovine TLR Gene Family and Member Associations with Mycobacterium avium Subspecies Infection"},{"arc":[[30.6127891540527,-96.339599609375],[30.6127891540527,-96.339599609375]],"countries":["United States"],"title":"Evolution of the Bovine TLR Gene Family and Member Associations with Mycobacterium avium Subspecies Infection"},{"arc":[[30.6127891540527,-96.339599609375],[27.9197807312012,78.085693359375]],"countries":["United States","India"],"title":"Evolution of the Bovine TLR Gene Family and Member Associations with Mycobacterium avium Subspecies Infection"},{"arc":[[42.4463500976562,-76.4826889038086],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"Evolution of the Bovine TLR Gene Family and Member Associations with Mycobacterium avium Subspecies Infection"},{"arc":[[42.4463500976562,-76.4826889038086],[30.6127891540527,-96.339599609375]],"countries":["United States"],"title":"Evolution of the Bovine TLR Gene Family and Member Associations with Mycobacterium avium Subspecies Infection"},{"arc":[[42.4463500976562,-76.4826889038086],[27.9197807312012,78.085693359375]],"countries":["United States","India"],"title":"Evolution of the Bovine TLR Gene Family and Member Associations with Mycobacterium avium Subspecies Infection"},{"arc":[[39.4959106445312,-98.9899826049805],[30.6127891540527,-96.339599609375]],"countries":["United States"],"title":"Evolution of the Bovine TLR Gene Family and Member Associations with Mycobacterium avium Subspecies Infection"},{"arc":[[39.4959106445312,-98.9899826049805],[27.9197807312012,78.085693359375]],"countries":["United States","India"],"title":"Evolution of the Bovine TLR Gene Family and Member Associations with Mycobacterium avium Subspecies Infection"},{"arc":[[39.4959106445312,-98.9899826049805],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"Evolution of the Bovine TLR Gene Family and Member Associations with Mycobacterium avium Subspecies Infection"},{"arc":[[27.9197807312012,78.085693359375],[39.4959106445312,-98.9899826049805]],"countries":["United States","India"],"title":"Evolution of the Bovine TLR Gene Family and Member Associations with Mycobacterium avium Subspecies Infection"},{"arc":[[27.9197807312012,78.085693359375],[30.6127891540527,-96.339599609375]],"countries":["United States","India"],"title":"Evolution of the Bovine TLR Gene Family and Member Associations with Mycobacterium avium Subspecies Infection"},{"arc":[[46.2544784545898,20.1485595703125],[47.2626495361328,11.3849096298218]],"countries":["Hungary","Austria"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[46.2544784545898,20.1485595703125],[48.5572814941406,-1.72386002540588]],"countries":["Hungary","France"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[46.2544784545898,20.1485595703125],[51.1218070983887,10.4006948471069]],"countries":["Germany","Hungary"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[46.2544784545898,20.1485595703125],[38.9326400756836,-76.9974975585938]],"countries":["Hungary","United States"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[46.2544784545898,20.1485595703125],[47.5343894958496,21.6190795898438]],"countries":["Hungary"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[47.2626495361328,11.3849096298218],[47.2626495361328,11.3849096298218]],"countries":["Austria"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[47.2626495361328,11.3849096298218],[48.5572814941406,-1.72386002540588]],"countries":["France","Austria"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[47.2626495361328,11.3849096298218],[51.1218070983887,10.4006948471069]],"countries":["Germany","Austria"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[47.2626495361328,11.3849096298218],[38.9326400756836,-76.9974975585938]],"countries":["Austria","United States"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[47.2626495361328,11.3849096298218],[47.5343894958496,21.6190795898438]],"countries":["Hungary","Austria"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[48.5572814941406,-1.72386002540588],[51.1218070983887,10.4006948471069]],"countries":["Germany","France"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[48.5572814941406,-1.72386002540588],[38.9326400756836,-76.9974975585938]],"countries":["France","United States"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[48.5572814941406,-1.72386002540588],[47.5343894958496,21.6190795898438]],"countries":["Hungary","France"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[48.5572814941406,-1.72386002540588],[47.2626495361328,11.3849096298218]],"countries":["France","Austria"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[51.1218070983887,10.4006948471069],[38.9326400756836,-76.9974975585938]],"countries":["Germany","United States"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[51.1218070983887,10.4006948471069],[51.1218070983887,10.4006948471069]],"countries":["Germany"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[51.1218070983887,10.4006948471069],[47.5343894958496,21.6190795898438]],"countries":["Germany","Hungary"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[51.1218070983887,10.4006948471069],[47.2626495361328,11.3849096298218]],"countries":["Germany","Austria"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[38.9326400756836,-76.9974975585938],[51.1218070983887,10.4006948471069]],"countries":["Germany","United States"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[38.9326400756836,-76.9974975585938],[47.5343894958496,21.6190795898438]],"countries":["Hungary","United States"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[38.9326400756836,-76.9974975585938],[47.2626495361328,11.3849096298218]],"countries":["Austria","United States"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[47.5343894958496,21.6190795898438],[47.2626495361328,11.3849096298218]],"countries":["Hungary","Austria"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[47.5343894958496,21.6190795898438],[47.5343894958496,21.6190795898438]],"countries":["Hungary"],"title":"New Antimicrobial Potential and Structural Properties of PAFB: A Cationic, Cysteine-Rich Protein from Penicillium chrysogenum Q176"},{"arc":[[30.5927600860596,114.305252075195],[32.0561103820801,118.775001525879]],"countries":["China"],"title":"Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China"},{"arc":[[30.5927600860596,114.305252075195],[39.9925537109375,116.310485839844]],"countries":["China"],"title":"Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China"},{"arc":[[32.0561103820801,118.775001525879],[39.9925537109375,116.310485839844]],"countries":["China"],"title":"Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China"},{"arc":[[31.2988891601562,121.499168395996],[37.5721130371094,112.295066833496]],"countries":["China"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[31.2988891601562,121.499168395996],[28.261251449585,-82.7311248779297]],"countries":["China","United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[31.2988891601562,121.499168395996],[45.8021583557129,126.535797119141]],"countries":["China"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[31.2988891601562,121.499168395996],[44.9734497070312,-93.2378997802734]],"countries":["China","United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[31.2988891601562,121.499168395996],[41.235668182373,-103.662322998047]],"countries":["China","United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[31.2988891601562,121.499168395996],[40.7145500183105,-74.0071411132812]],"countries":["China","United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[31.2988891601562,121.499168395996],[41.9982795715332,-87.6571731567383]],"countries":["China","United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[37.5721130371094,112.295066833496],[37.5721130371094,112.295066833496]],"countries":["China"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[37.5721130371094,112.295066833496],[28.261251449585,-82.7311248779297]],"countries":["United States","China"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[37.5721130371094,112.295066833496],[45.8021583557129,126.535797119141]],"countries":["China"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[37.5721130371094,112.295066833496],[44.9734497070312,-93.2378997802734]],"countries":["United States","China"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[37.5721130371094,112.295066833496],[41.235668182373,-103.662322998047]],"countries":["China","United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[37.5721130371094,112.295066833496],[40.7145500183105,-74.0071411132812]],"countries":["United States","China"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[37.5721130371094,112.295066833496],[41.9982795715332,-87.6571731567383]],"countries":["United States","China"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[28.261251449585,-82.7311248779297],[45.8021583557129,126.535797119141]],"countries":["United States","China"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[28.261251449585,-82.7311248779297],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[28.261251449585,-82.7311248779297],[41.235668182373,-103.662322998047]],"countries":["United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[28.261251449585,-82.7311248779297],[40.7145500183105,-74.0071411132812]],"countries":["United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[28.261251449585,-82.7311248779297],[41.9982795715332,-87.6571731567383]],"countries":["United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[45.8021583557129,126.535797119141],[44.9734497070312,-93.2378997802734]],"countries":["United States","China"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[45.8021583557129,126.535797119141],[41.235668182373,-103.662322998047]],"countries":["China","United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[45.8021583557129,126.535797119141],[40.7145500183105,-74.0071411132812]],"countries":["China","United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[45.8021583557129,126.535797119141],[41.9982795715332,-87.6571731567383]],"countries":["China","United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[44.9734497070312,-93.2378997802734],[41.235668182373,-103.662322998047]],"countries":["United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[44.9734497070312,-93.2378997802734],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[44.9734497070312,-93.2378997802734],[40.7145500183105,-74.0071411132812]],"countries":["United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[44.9734497070312,-93.2378997802734],[41.9982795715332,-87.6571731567383]],"countries":["United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[41.235668182373,-103.662322998047],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[41.235668182373,-103.662322998047],[40.7145500183105,-74.0071411132812]],"countries":["United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[41.235668182373,-103.662322998047],[41.9982795715332,-87.6571731567383]],"countries":["United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[40.7145500183105,-74.0071411132812],[41.9982795715332,-87.6571731567383]],"countries":["United States"],"title":"A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV VACCINES AND ANTIVIRAL AGENTS crossm"},{"arc":[[33.7483100891113,-84.39111328125],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[33.7483100891113,-84.39111328125],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[33.7483100891113,-84.39111328125],[0.537028014659882,37.8567771911621]],"countries":["Kenya","United States"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[39.4959106445312,-98.9899826049805],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[39.4959106445312,-98.9899826049805],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[39.4959106445312,-98.9899826049805],[0.537028014659882,37.8567771911621]],"countries":["Kenya","United States"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[40.9437103271484,40.2619209289551],[0.537028014659882,37.8567771911621]],"countries":["Turkey","Kenya"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[35.4135284423828,136.771347045898],[20.2663593292236,85.8105697631836]],"countries":["India","Japan"],"title":"Genetic and antigenic analysis of Chlamydia pecorum strains isolated from calves with diarrhea"},{"arc":[[35.4135284423828,136.771347045898],[35.4135284423828,136.771347045898]],"countries":["Japan"],"title":"Genetic and antigenic analysis of Chlamydia pecorum strains isolated from calves with diarrhea"},{"arc":[[35.4135284423828,136.771347045898],[34.1732597351074,131.47900390625]],"countries":["Japan"],"title":"Genetic and antigenic analysis of Chlamydia pecorum strains isolated from calves with diarrhea"},{"arc":[[20.2663593292236,85.8105697631836],[35.4135284423828,136.771347045898]],"countries":["India","Japan"],"title":"Genetic and antigenic analysis of Chlamydia pecorum strains isolated from calves with diarrhea"},{"arc":[[20.2663593292236,85.8105697631836],[34.1732597351074,131.47900390625]],"countries":["India","Japan"],"title":"Genetic and antigenic analysis of Chlamydia pecorum strains isolated from calves with diarrhea"},{"arc":[[20.2663593292236,85.8105697631836],[20.2663593292236,85.8105697631836]],"countries":["India"],"title":"Genetic and antigenic analysis of Chlamydia pecorum strains isolated from calves with diarrhea"},{"arc":[[34.1732597351074,131.47900390625],[34.1732597351074,131.47900390625]],"countries":["Japan"],"title":"Genetic and antigenic analysis of Chlamydia pecorum strains isolated from calves with diarrhea"},{"arc":[[34.1732597351074,131.47900390625],[20.2663593292236,85.8105697631836]],"countries":["India","Japan"],"title":"Genetic and antigenic analysis of Chlamydia pecorum strains isolated from calves with diarrhea"},{"arc":[[-25.7523803710938,28.2516193389893],[42.9547386169434,-78.8192367553711]],"countries":["United States","South Africa"],"title":"African perspectives: modern complexities of emerging, re-emerging, and endemic zoonoses"},{"arc":[[-25.7523803710938,28.2516193389893],[-25.7523803710938,28.2516193389893]],"countries":["South Africa"],"title":"African perspectives: modern complexities of emerging, re-emerging, and endemic zoonoses"},{"arc":[[42.9547386169434,-78.8192367553711],[-25.7523803710938,28.2516193389893]],"countries":["United States","South Africa"],"title":"African perspectives: modern complexities of emerging, re-emerging, and endemic zoonoses"},{"arc":[[39.9925537109375,116.310485839844],[39.9925537109375,116.310485839844]],"countries":["China"],"title":"Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study"},{"arc":[[39.9925537109375,116.310485839844],[22.333080291748,114.191223144531]],"countries":["Hong Kong SAR","China"],"title":"Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study"},{"arc":[[22.333080291748,114.191223144531],[39.9925537109375,116.310485839844]],"countries":["Hong Kong SAR","China"],"title":"Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study"},{"arc":[[55.9452209472656,-3.18803000450134],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom"],"title":"Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks"},{"arc":[[55.9452209472656,-3.18803000450134],[51.5526809692383,-0.165900006890297]],"countries":["United Kingdom"],"title":"Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks"},{"arc":[[55.9452209472656,-3.18803000450134],[53.3086013793945,-6.22065019607544]],"countries":["United Kingdom","Ireland"],"title":"Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks"},{"arc":[[55.9452209472656,-3.18803000450134],[41.8540687561035,12.6037397384644]],"countries":["United Kingdom","Italy"],"title":"Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks"},{"arc":[[55.9452209472656,-3.18803000450134],[55.8721008300781,-4.28659009933472]],"countries":["United Kingdom"],"title":"Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks"},{"arc":[[51.5526809692383,-0.165900006890297],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom"],"title":"Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks"},{"arc":[[51.5526809692383,-0.165900006890297],[53.3086013793945,-6.22065019607544]],"countries":["Ireland","United Kingdom"],"title":"Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks"},{"arc":[[51.5526809692383,-0.165900006890297],[41.8540687561035,12.6037397384644]],"countries":["United Kingdom","Italy"],"title":"Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks"},{"arc":[[51.5526809692383,-0.165900006890297],[55.8721008300781,-4.28659009933472]],"countries":["United Kingdom"],"title":"Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks"},{"arc":[[53.3086013793945,-6.22065019607544],[41.8540687561035,12.6037397384644]],"countries":["Ireland","Italy"],"title":"Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks"},{"arc":[[53.3086013793945,-6.22065019607544],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom","Ireland"],"title":"Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks"},{"arc":[[53.3086013793945,-6.22065019607544],[55.8721008300781,-4.28659009933472]],"countries":["United Kingdom","Ireland"],"title":"Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks"},{"arc":[[41.8540687561035,12.6037397384644],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom","Italy"],"title":"Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks"},{"arc":[[41.8540687561035,12.6037397384644],[55.8721008300781,-4.28659009933472]],"countries":["United Kingdom","Italy"],"title":"Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks"},{"arc":[[41.8540687561035,12.6037397384644],[41.8540687561035,12.6037397384644]],"countries":["Italy"],"title":"Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks"},{"arc":[[55.8721008300781,-4.28659009933472],[41.8540687561035,12.6037397384644]],"countries":["United Kingdom","Italy"],"title":"Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks"},{"arc":[[55.8721008300781,-4.28659009933472],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom"],"title":"Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks"},{"arc":[[48.7307891845703,2.17218995094299],[48.7307891845703,2.17218995094299]],"countries":["France"],"title":"cells Interplay between Intrinsic and Innate Immunity during HIV Infection"},{"arc":[[51.1218070983887,10.4006948471069],[51.1218070983887,10.4006948471069]],"countries":["Germany"],"title":"Detection of alpha and betacoronaviruses in multiple Iberian bat species"},{"arc":[[51.1218070983887,10.4006948471069],[43.0435333251953,-2.61686491966248]],"countries":["Germany","Spain"],"title":"Detection of alpha and betacoronaviruses in multiple Iberian bat species"},{"arc":[[43.0435333251953,-2.61686491966248],[43.0435333251953,-2.61686491966248]],"countries":["Spain"],"title":"Detection of alpha and betacoronaviruses in multiple Iberian bat species"},{"arc":[[42.4881896972656,-83.1424331665039],[42.672420501709,-83.21826171875]],"countries":["United States"],"title":"Rapid Detection of Novel Coronavirus (COVID-19) by Reverse Transcription- Loop-Mediated Isothermal Amplification"},{"arc":[[42.4881896972656,-83.1424331665039],[42.4881896972656,-83.1424331665039]],"countries":["United States"],"title":"Rapid Detection of Novel Coronavirus (COVID-19) by Reverse Transcription- Loop-Mediated Isothermal Amplification"},{"arc":[[42.672420501709,-83.21826171875],[42.4881896972656,-83.1424331665039]],"countries":["United States"],"title":"Rapid Detection of Novel Coronavirus (COVID-19) by Reverse Transcription- Loop-Mediated Isothermal Amplification"},{"arc":[[37.7697296142578,-122.466094970703],[40.9437103271484,40.2619209289551]],"countries":["United States","Turkey"],"title":"GI-type T4SS-mediated horizontal transfer of the 89K pathogenicity island in epidemic Streptococcus suis serotype 2m mi_7553 1670..1683"},{"arc":[[37.7697296142578,-122.466094970703],[39.0010192365134,-77.0841755726199]],"countries":["United States"],"title":"GI-type T4SS-mediated horizontal transfer of the 89K pathogenicity island in epidemic Streptococcus suis serotype 2m mi_7553 1670..1683"},{"arc":[[37.7697296142578,-122.466094970703],[37.7697296142578,-122.466094970703]],"countries":["United States"],"title":"GI-type T4SS-mediated horizontal transfer of the 89K pathogenicity island in epidemic Streptococcus suis serotype 2m mi_7553 1670..1683"},{"arc":[[37.7697296142578,-122.466094970703],[32.0583801269531,118.79647064209]],"countries":["United States","China"],"title":"GI-type T4SS-mediated horizontal transfer of the 89K pathogenicity island in epidemic Streptococcus suis serotype 2m mi_7553 1670..1683"},{"arc":[[40.9437103271484,40.2619209289551],[39.0010192365134,-77.0841755726199]],"countries":["Turkey","United States"],"title":"GI-type T4SS-mediated horizontal transfer of the 89K pathogenicity island in epidemic Streptococcus suis serotype 2m mi_7553 1670..1683"},{"arc":[[40.9437103271484,40.2619209289551],[37.7697296142578,-122.466094970703]],"countries":["United States","Turkey"],"title":"GI-type T4SS-mediated horizontal transfer of the 89K pathogenicity island in epidemic Streptococcus suis serotype 2m mi_7553 1670..1683"},{"arc":[[40.9437103271484,40.2619209289551],[32.0583801269531,118.79647064209]],"countries":["Turkey","China"],"title":"GI-type T4SS-mediated horizontal transfer of the 89K pathogenicity island in epidemic Streptococcus suis serotype 2m mi_7553 1670..1683"},{"arc":[[39.0010192365134,-77.0841755726199],[37.7697296142578,-122.466094970703]],"countries":["United States"],"title":"GI-type T4SS-mediated horizontal transfer of the 89K pathogenicity island in epidemic Streptococcus suis serotype 2m mi_7553 1670..1683"},{"arc":[[39.0010192365134,-77.0841755726199],[32.0583801269531,118.79647064209]],"countries":["China","United States"],"title":"GI-type T4SS-mediated horizontal transfer of the 89K pathogenicity island in epidemic Streptococcus suis serotype 2m mi_7553 1670..1683"},{"arc":[[39.0010192365134,-77.0841755726199],[39.0010192365134,-77.0841755726199]],"countries":["United States"],"title":"GI-type T4SS-mediated horizontal transfer of the 89K pathogenicity island in epidemic Streptococcus suis serotype 2m mi_7553 1670..1683"},{"arc":[[32.0583801269531,118.79647064209],[39.0010192365134,-77.0841755726199]],"countries":["China","United States"],"title":"GI-type T4SS-mediated horizontal transfer of the 89K pathogenicity island in epidemic Streptococcus suis serotype 2m mi_7553 1670..1683"},{"arc":[[32.0583801269531,118.79647064209],[37.7697296142578,-122.466094970703]],"countries":["United States","China"],"title":"GI-type T4SS-mediated horizontal transfer of the 89K pathogenicity island in epidemic Streptococcus suis serotype 2m mi_7553 1670..1683"},{"arc":[[42.9547386169434,-78.8192367553711],[5.35387992858887,100.30248260498]],"countries":["United States","Malaysia"],"title":"Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling"},{"arc":[[42.9547386169434,-78.8192367553711],[3.12263989448547,101.651702880859]],"countries":["United States","Malaysia"],"title":"Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling"},{"arc":[[42.9547386169434,-78.8192367553711],[3.60545492172241,114.710678100586]],"countries":["United States","Malaysia"],"title":"Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling"},{"arc":[[5.35387992858887,100.30248260498],[5.35387992858887,100.30248260498]],"countries":["Malaysia"],"title":"Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling"},{"arc":[[5.35387992858887,100.30248260498],[3.12263989448547,101.651702880859]],"countries":["Malaysia"],"title":"Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling"},{"arc":[[5.35387992858887,100.30248260498],[3.60545492172241,114.710678100586]],"countries":["Malaysia"],"title":"Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling"},{"arc":[[3.12263989448547,101.651702880859],[3.12263989448547,101.651702880859]],"countries":["Malaysia"],"title":"Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling"},{"arc":[[3.12263989448547,101.651702880859],[5.35387992858887,100.30248260498]],"countries":["Malaysia"],"title":"Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling"},{"arc":[[3.12263989448547,101.651702880859],[3.60545492172241,114.710678100586]],"countries":["Malaysia"],"title":"Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling"},{"arc":[[3.60545492172241,114.710678100586],[3.12263989448547,101.651702880859]],"countries":["Malaysia"],"title":"Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling"},{"arc":[[3.60545492172241,114.710678100586],[5.35387992858887,100.30248260498]],"countries":["Malaysia"],"title":"Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling"},{"arc":[[40.0063018798828,-83.0163803100586],[40.0063018798828,-83.0163803100586]],"countries":["United States"],"title":"The Inhibition of HIV-1 Entry Imposed by Interferon Inducible Transmembrane Proteins Is Independent of Co-Receptor Usage"},{"arc":[[37.498367,126.675769],[37.498367,126.675769]],"countries":["South Korea"],"title":"Procalcitonin as a prognostic marker for sepsis based on SEPSIS-3"},{"arc":[[37.498367,126.675769],[37.566535949707,126.977966308594]],"countries":["South Korea"],"title":"Procalcitonin as a prognostic marker for sepsis based on SEPSIS-3"},{"arc":[[37.566535949707,126.977966308594],[37.498367,126.675769]],"countries":["South Korea"],"title":"Procalcitonin as a prognostic marker for sepsis based on SEPSIS-3"},{"arc":[[37.566535949707,126.977966308594],[37.566535949707,126.977966308594]],"countries":["South Korea"],"title":"Procalcitonin as a prognostic marker for sepsis based on SEPSIS-3"},{"arc":[[51.300220489502,-0.645680010318756],[7.9606761932373,-1.20756804943085]],"countries":["United Kingdom","Ghana"],"title":"Current and Novel Approaches in Influenza Management"},{"arc":[[7.9606761932373,-1.20756804943085],[7.9606761932373,-1.20756804943085]],"countries":["Ghana"],"title":"Current and Novel Approaches in Influenza Management"},{"arc":[[50.7338905334473,7.10222196578979],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"Early Introduction and Delayed Dissemination of Pandemic Influenza, Gabon"},{"arc":[[37.7697296142578,-122.466094970703],[40.4406089782715,-79.953971862793]],"countries":["United States"],"title":"Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China"},{"arc":[[37.7697296142578,-122.466094970703],[40.9437103271484,40.2619209289551]],"countries":["United States","Turkey"],"title":"Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China"},{"arc":[[37.7697296142578,-122.466094970703],[37.7697296142578,-122.466094970703]],"countries":["United States"],"title":"Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China"},{"arc":[[40.4406089782715,-79.953971862793],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China"},{"arc":[[40.4406089782715,-79.953971862793],[37.7697296142578,-122.466094970703]],"countries":["United States"],"title":"Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China"},{"arc":[[40.9437103271484,40.2619209289551],[37.7697296142578,-122.466094970703]],"countries":["United States","Turkey"],"title":"Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China"},{"arc":[[23.1290798187256,113.264358520508],[41.6625213623047,-91.536506652832]],"countries":["China","United States"],"title":"The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection"},{"arc":[[23.1290798187256,113.264358520508],[23.1290798187256,113.264358520508]],"countries":["China"],"title":"The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection"},{"arc":[[41.6625213623047,-91.536506652832],[41.6625213623047,-91.536506652832]],"countries":["United States"],"title":"The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection"},{"arc":[[41.6625213623047,-91.536506652832],[23.1290798187256,113.264358520508]],"countries":["China","United States"],"title":"The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection"},{"arc":[[47.3764152526855,8.54810237884521],[47.3764152526855,8.54810237884521]],"countries":["Switzerland"],"title":"Gene Expression Profiling in Cells with Enhanced c-Secretase Activity"},{"arc":[[51.0766296386719,-114.13208770752],[51.0766296386719,-114.13208770752]],"countries":["Canada"],"title":"Delmarva (DMV/1639) Infectious Bronchitis Virus (IBV) Variants Isolated in Eastern Canada Show Evidence of Recombination"},{"arc":[[51.0766296386719,-114.13208770752],[43.5278816223145,-80.2231063842773]],"countries":["Canada"],"title":"Delmarva (DMV/1639) Infectious Bronchitis Virus (IBV) Variants Isolated in Eastern Canada Show Evidence of Recombination"},{"arc":[[43.5278816223145,-80.2231063842773],[51.0766296386719,-114.13208770752]],"countries":["Canada"],"title":"Delmarva (DMV/1639) Infectious Bronchitis Virus (IBV) Variants Isolated in Eastern Canada Show Evidence of Recombination"},{"arc":[[32.7603302001953,129.866546630859],[32.7603302001953,129.866546630859]],"countries":["Japan"],"title":"Protein Reporter Bioassay Systems for the Phenotypic Screening of Candidate Drugs: A Mouse Platform for Anti-Aging Drug Screening"},{"arc":[[0.335489988327026,32.5687217712402],[0.335489988327026,32.5687217712402]],"countries":["Uganda"],"title":"Viral causes of Influenza Like Illness in Uganda, 2008 to 2017"},{"arc":[[27.6111698150635,115.727165222168],[27.6111698150635,115.727165222168]],"countries":["China"],"title":"Molecular Characterization and Phylogenetic Analysis of Porcine Epidemic Diarrhea Viruses Associated with Outbreaks of Severe Diarrhea in Piglets in Jiangxi"},{"arc":[[27.6111698150635,115.727165222168],[37.7697296142578,-122.466094970703]],"countries":["United States","China"],"title":"Molecular Characterization and Phylogenetic Analysis of Porcine Epidemic Diarrhea Viruses Associated with Outbreaks of Severe Diarrhea in Piglets in Jiangxi"},{"arc":[[35.7442817687988,127.166305541992],[35.7442817687988,127.166305541992]],"countries":["South Korea"],"title":"Annals of Rehabilitation Medicine Effects of 3-Dimensional Lumbar Stabilization Training for Balance in Chronic Hemiplegic Stroke Patients: A Randomized Controlled Trial Improvement of Gait and Balance by Spine Balance 3 D System 973 www.e-arm.org"},{"arc":[[51.5235214233398,-0.132312998175621],[41.3633193969727,2.1051299571991]],"countries":["United Kingdom","Spain"],"title":"Prevention of influenza among travellers attending at a UK travel clinic: beliefs and perceptions. A cross-sectional study"},{"arc":[[51.5235214233398,-0.132312998175621],[51.5235214233398,-0.132312998175621]],"countries":["United Kingdom"],"title":"Prevention of influenza among travellers attending at a UK travel clinic: beliefs and perceptions. A cross-sectional study"},{"arc":[[41.3633193969727,2.1051299571991],[51.5235214233398,-0.132312998175621]],"countries":["United Kingdom","Spain"],"title":"Prevention of influenza among travellers attending at a UK travel clinic: beliefs and perceptions. A cross-sectional study"},{"arc":[[22.333080291748,114.191223144531],[22.333080291748,114.191223144531]],"countries":["Hong Kong SAR"],"title":"Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020"},{"arc":[[22.333080291748,114.191223144531],[30.5701999664307,104.064758300781]],"countries":["Hong Kong SAR","China"],"title":"Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020"},{"arc":[[22.333080291748,114.191223144531],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020"},{"arc":[[22.333080291748,114.191223144531],[40.6942749023438,-73.9868011474609]],"countries":["Hong Kong SAR","United States"],"title":"Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020"},{"arc":[[22.333080291748,114.191223144531],[42.2762107849121,-83.7407531738281]],"countries":["Hong Kong SAR","United States"],"title":"Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020"},{"arc":[[30.5701999664307,104.064758300781],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","China"],"title":"Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020"},{"arc":[[30.5701999664307,104.064758300781],[40.6942749023438,-73.9868011474609]],"countries":["United States","China"],"title":"Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020"},{"arc":[[30.5701999664307,104.064758300781],[42.2762107849121,-83.7407531738281]],"countries":["United States","China"],"title":"Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020"},{"arc":[[30.5701999664307,104.064758300781],[22.333080291748,114.191223144531]],"countries":["Hong Kong SAR","China"],"title":"Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020"},{"arc":[[22.2802925109863,114.142951965332],[40.6942749023438,-73.9868011474609]],"countries":["Hong Kong SAR","United States"],"title":"Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020"},{"arc":[[22.2802925109863,114.142951965332],[42.2762107849121,-83.7407531738281]],"countries":["Hong Kong SAR","United States"],"title":"Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020"},{"arc":[[22.2802925109863,114.142951965332],[22.333080291748,114.191223144531]],"countries":["Hong Kong SAR"],"title":"Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020"},{"arc":[[40.6942749023438,-73.9868011474609],[40.6942749023438,-73.9868011474609]],"countries":["United States"],"title":"Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020"},{"arc":[[40.6942749023438,-73.9868011474609],[42.2762107849121,-83.7407531738281]],"countries":["United States"],"title":"Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020"},{"arc":[[40.6942749023438,-73.9868011474609],[22.333080291748,114.191223144531]],"countries":["Hong Kong SAR","United States"],"title":"Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020"},{"arc":[[42.2762107849121,-83.7407531738281],[22.333080291748,114.191223144531]],"countries":["Hong Kong SAR","United States"],"title":"Preliminary estimating the reproduction number of the coronavirus disease (COVID-19) outbreak in Republic of Korea and Italy by 5 March 2020"},{"arc":[[33.7531509399414,-84.384880065918],[33.4219207763672,-111.934936523438]],"countries":["United States"],"title":"NA"},{"arc":[[33.7531509399414,-84.384880065918],[33.7531509399414,-84.384880065918]],"countries":["United States"],"title":"NA"},{"arc":[[33.7531509399414,-84.384880065918],[29.9353504180908,-90.123176574707]],"countries":["United States"],"title":"NA"},{"arc":[[33.4219207763672,-111.934936523438],[33.7531509399414,-84.384880065918]],"countries":["United States"],"title":"NA"},{"arc":[[33.4219207763672,-111.934936523438],[29.9353504180908,-90.123176574707]],"countries":["United States"],"title":"NA"},{"arc":[[29.9353504180908,-90.123176574707],[33.7531509399414,-84.384880065918]],"countries":["United States"],"title":"NA"},{"arc":[[23.7489929199219,120.971282958984],[23.7489929199219,120.971282958984]],"countries":["Taiwan"],"title":"Coordination among tertiary base pairs results in an efficient frameshift-stimulating RNA pseudoknot"},{"arc":[[23.7489929199219,120.971282958984],[30.3002605438232,108.037666320801]],"countries":["Taiwan","China"],"title":"Coordination among tertiary base pairs results in an efficient frameshift-stimulating RNA pseudoknot"},{"arc":[[30.3002605438232,108.037666320801],[23.7489929199219,120.971282958984]],"countries":["Taiwan","China"],"title":"Coordination among tertiary base pairs results in an efficient frameshift-stimulating RNA pseudoknot"},{"arc":[[30.3002605438232,108.037666320801],[30.3002605438232,108.037666320801]],"countries":["China"],"title":"Coordination among tertiary base pairs results in an efficient frameshift-stimulating RNA pseudoknot"},{"arc":[[-37.7949981689453,144.949722290039],[-37.7949981689453,144.949722290039]],"countries":["Australia"],"title":"Viruses causing lower respiratory symptoms in young children: findings from the ORChID birth cohort Respiratory infection"},{"arc":[[-37.7949981689453,144.949722290039],[38.6370010375977,-90.2646026611328]],"countries":["Australia","United States"],"title":"Viruses causing lower respiratory symptoms in young children: findings from the ORChID birth cohort Respiratory infection"},{"arc":[[-37.7949981689453,144.949722290039],[24.7343902587891,46.6319313049316]],"countries":["Australia","Saudi Arabia"],"title":"Viruses causing lower respiratory symptoms in young children: findings from the ORChID birth cohort Respiratory infection"},{"arc":[[-37.7949981689453,144.949722290039],[-27.4939594268799,153.00617980957]],"countries":["Australia"],"title":"Viruses causing lower respiratory symptoms in young children: findings from the ORChID birth cohort Respiratory infection"},{"arc":[[-37.7949981689453,144.949722290039],[-27.4479598999023,153.016067504883]],"countries":["Australia"],"title":"Viruses causing lower respiratory symptoms in young children: findings from the ORChID birth cohort Respiratory infection"},{"arc":[[38.6370010375977,-90.2646026611328],[24.7343902587891,46.6319313049316]],"countries":["United States","Saudi Arabia"],"title":"Viruses causing lower respiratory symptoms in young children: findings from the ORChID birth cohort Respiratory infection"},{"arc":[[38.6370010375977,-90.2646026611328],[-27.4939594268799,153.00617980957]],"countries":["United States","Australia"],"title":"Viruses causing lower respiratory symptoms in young children: findings from the ORChID birth cohort Respiratory infection"},{"arc":[[38.6370010375977,-90.2646026611328],[-37.7949981689453,144.949722290039]],"countries":["Australia","United States"],"title":"Viruses causing lower respiratory symptoms in young children: findings from the ORChID birth cohort Respiratory infection"},{"arc":[[38.6370010375977,-90.2646026611328],[-27.4479598999023,153.016067504883]],"countries":["United States","Australia"],"title":"Viruses causing lower respiratory symptoms in young children: findings from the ORChID birth cohort Respiratory infection"},{"arc":[[24.7343902587891,46.6319313049316],[-27.4939594268799,153.00617980957]],"countries":["Saudi Arabia","Australia"],"title":"Viruses causing lower respiratory symptoms in young children: findings from the ORChID birth cohort Respiratory infection"},{"arc":[[24.7343902587891,46.6319313049316],[-37.7949981689453,144.949722290039]],"countries":["Australia","Saudi Arabia"],"title":"Viruses causing lower respiratory symptoms in young children: findings from the ORChID birth cohort Respiratory infection"},{"arc":[[24.7343902587891,46.6319313049316],[-27.4479598999023,153.016067504883]],"countries":["Saudi Arabia","Australia"],"title":"Viruses causing lower respiratory symptoms in young children: findings from the ORChID birth cohort Respiratory infection"},{"arc":[[-27.4939594268799,153.00617980957],[-37.7949981689453,144.949722290039]],"countries":["Australia"],"title":"Viruses causing lower respiratory symptoms in young children: findings from the ORChID birth cohort Respiratory infection"},{"arc":[[-27.4939594268799,153.00617980957],[-27.4479598999023,153.016067504883]],"countries":["Australia"],"title":"Viruses causing lower respiratory symptoms in young children: findings from the ORChID birth cohort Respiratory infection"},{"arc":[[51.1242790222168,-1.71630001068115],[51.1242790222168,-1.71630001068115]],"countries":["United Kingdom"],"title":"A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease"},{"arc":[[51.5235214233398,-0.132312998175621],[51.5235214233398,-0.132312998175621]],"countries":["United Kingdom"],"title":"Bayesian mixture analysis for metagenomic community profiling"},{"arc":[[-37.7035598754883,145.180358886719],[-37.7035598754883,145.180358886719]],"countries":["Australia"],"title":"Nearly full-length genome sequence of a novel astrovirus isolated from chickens with 'white chicks' condition"},{"arc":[[52.4488296508789,-1.93190002441406],[52.4488296508789,-1.93190002441406]],"countries":["United Kingdom"],"title":"BMC Public Health Healthcare workers' attitudes towards working during pandemic influenza: A multi method study"},{"arc":[[55.7110481262207,37.5794792175293],[15.1653995513916,120.608467102051]],"countries":["Russia","Philippines"],"title":"Supplementary Data Genetic dissection of host immune response in pneumonia development and progression"},{"arc":[[55.7110481262207,37.5794792175293],[55.7110481262207,37.5794792175293]],"countries":["Russia"],"title":"Supplementary Data Genetic dissection of host immune response in pneumonia development and progression"},{"arc":[[15.1653995513916,120.608467102051],[55.7110481262207,37.5794792175293]],"countries":["Russia","Philippines"],"title":"Supplementary Data Genetic dissection of host immune response in pneumonia development and progression"},{"arc":[[30.6250877380371,102.697288513184],[39.9046897888184,116.407173156738]],"countries":["China"],"title":"Influenza A(H1N1) pdm09 Virus Infection in Giant Pandas, China"},{"arc":[[30.6250877380371,102.697288513184],[30.6250877380371,102.697288513184]],"countries":["China"],"title":"Influenza A(H1N1) pdm09 Virus Infection in Giant Pandas, China"},{"arc":[[30.6250877380371,102.697288513184],[40.9437103271484,40.2619209289551]],"countries":["Turkey","China"],"title":"Influenza A(H1N1) pdm09 Virus Infection in Giant Pandas, China"},{"arc":[[39.9046897888184,116.407173156738],[30.6250877380371,102.697288513184]],"countries":["China"],"title":"Influenza A(H1N1) pdm09 Virus Infection in Giant Pandas, China"},{"arc":[[39.9046897888184,116.407173156738],[40.9437103271484,40.2619209289551]],"countries":["Turkey","China"],"title":"Influenza A(H1N1) pdm09 Virus Infection in Giant Pandas, China"},{"arc":[[39.9046897888184,116.407173156738],[39.9046897888184,116.407173156738]],"countries":["China"],"title":"Influenza A(H1N1) pdm09 Virus Infection in Giant Pandas, China"},{"arc":[[40.9437103271484,40.2619209289551],[30.6250877380371,102.697288513184]],"countries":["Turkey","China"],"title":"Influenza A(H1N1) pdm09 Virus Infection in Giant Pandas, China"},{"arc":[[40.9437103271484,40.2619209289551],[39.9046897888184,116.407173156738]],"countries":["Turkey","China"],"title":"Influenza A(H1N1) pdm09 Virus Infection in Giant Pandas, China"},{"arc":[[21.0288791656494,105.854637145996],[18.495677947998,103.767715454102]],"countries":["Vietnam","Laos"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[21.0288791656494,105.854637145996],[63.8252906799316,20.2605895996094]],"countries":["Sweden","Vietnam"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[21.0288791656494,105.854637145996],[42.9547386169434,-78.8192367553711]],"countries":["United States","Vietnam"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[21.0288791656494,105.854637145996],[3.60545492172241,114.710678100586]],"countries":["Vietnam","Malaysia"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[21.0288791656494,105.854637145996],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Vietnam"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[21.0288791656494,105.854637145996],[26.7811698913574,75.81005859375]],"countries":["Vietnam","India"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[21.0288791656494,105.854637145996],[34.3412704467773,108.939842224121]],"countries":["China","Vietnam"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[18.495677947998,103.767715454102],[63.8252906799316,20.2605895996094]],"countries":["Sweden","Laos"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[18.495677947998,103.767715454102],[42.9547386169434,-78.8192367553711]],"countries":["United States","Laos"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[18.495677947998,103.767715454102],[3.60545492172241,114.710678100586]],"countries":["Malaysia","Laos"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[18.495677947998,103.767715454102],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Laos"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[18.495677947998,103.767715454102],[26.7811698913574,75.81005859375]],"countries":["Laos","India"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[18.495677947998,103.767715454102],[34.3412704467773,108.939842224121]],"countries":["China","Laos"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[63.8252906799316,20.2605895996094],[42.9547386169434,-78.8192367553711]],"countries":["United States","Sweden"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[63.8252906799316,20.2605895996094],[3.60545492172241,114.710678100586]],"countries":["Sweden","Malaysia"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[63.8252906799316,20.2605895996094],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Sweden"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[63.8252906799316,20.2605895996094],[26.7811698913574,75.81005859375]],"countries":["Sweden","India"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[63.8252906799316,20.2605895996094],[34.3412704467773,108.939842224121]],"countries":["Sweden","China"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[42.9547386169434,-78.8192367553711],[3.60545492172241,114.710678100586]],"countries":["United States","Malaysia"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[42.9547386169434,-78.8192367553711],[42.9547386169434,-78.8192367553711]],"countries":["United States"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[42.9547386169434,-78.8192367553711],[40.9437103271484,40.2619209289551]],"countries":["United States","Turkey"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[42.9547386169434,-78.8192367553711],[26.7811698913574,75.81005859375]],"countries":["United States","India"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[42.9547386169434,-78.8192367553711],[34.3412704467773,108.939842224121]],"countries":["United States","China"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[3.60545492172241,114.710678100586],[42.9547386169434,-78.8192367553711]],"countries":["United States","Malaysia"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[3.60545492172241,114.710678100586],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Malaysia"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[3.60545492172241,114.710678100586],[26.7811698913574,75.81005859375]],"countries":["Malaysia","India"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[3.60545492172241,114.710678100586],[34.3412704467773,108.939842224121]],"countries":["China","Malaysia"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[40.9437103271484,40.2619209289551],[26.7811698913574,75.81005859375]],"countries":["Turkey","India"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[40.9437103271484,40.2619209289551],[34.3412704467773,108.939842224121]],"countries":["Turkey","China"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[26.7811698913574,75.81005859375],[40.9437103271484,40.2619209289551]],"countries":["Turkey","India"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[26.7811698913574,75.81005859375],[34.3412704467773,108.939842224121]],"countries":["China","India"],"title":"Progress toward universal health coverage in ASEAN"},{"arc":[[52.421459197998,-1.43792998790741],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom"],"title":"Open Access Epidemiology and clinical outcome of virus-positive respiratory samples in ventilated patients: a prospective cohort study"},{"arc":[[37.8056831359863,-122.268104553223],[9.0671501159668,-79.387336730957]],"countries":["United States","Panama"],"title":"Alzheimer's disease Advax CpG - adjuvanted MultiTEP-based dual and single vaccines induce high- titer antibodies against various forms of tau and Aβ pathological molecules"},{"arc":[[37.8056831359863,-122.268104553223],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Alzheimer's disease Advax CpG - adjuvanted MultiTEP-based dual and single vaccines induce high- titer antibodies against various forms of tau and Aβ pathological molecules"},{"arc":[[37.8056831359863,-122.268104553223],[-35.0198211669922,138.568862915039]],"countries":["United States","Australia"],"title":"Alzheimer's disease Advax CpG - adjuvanted MultiTEP-based dual and single vaccines induce high- titer antibodies against various forms of tau and Aβ pathological molecules"},{"arc":[[9.0671501159668,-79.387336730957],[37.8056831359863,-122.268104553223]],"countries":["United States","Panama"],"title":"Alzheimer's disease Advax CpG - adjuvanted MultiTEP-based dual and single vaccines induce high- titer antibodies against various forms of tau and Aβ pathological molecules"},{"arc":[[9.0671501159668,-79.387336730957],[-35.0198211669922,138.568862915039]],"countries":["Australia","Panama"],"title":"Alzheimer's disease Advax CpG - adjuvanted MultiTEP-based dual and single vaccines induce high- titer antibodies against various forms of tau and Aβ pathological molecules"},{"arc":[[23.8029747009277,108.794311523438],[22.3337936154897,114.179224932647]],"countries":["Hong Kong-China","China"],"title":"Detection and genetic characterization of canine astroviruses in pet dogs in Guangxi, China"},{"arc":[[23.8029747009277,108.794311523438],[35.2153701782227,-97.447998046875]],"countries":["China","United States"],"title":"Detection and genetic characterization of canine astroviruses in pet dogs in Guangxi, China"},{"arc":[[23.8029747009277,108.794311523438],[39.9530487060547,-75.1940231323242]],"countries":["United States","China"],"title":"Detection and genetic characterization of canine astroviruses in pet dogs in Guangxi, China"},{"arc":[[23.8029747009277,108.794311523438],[23.8029747009277,108.794311523438]],"countries":["China"],"title":"Detection and genetic characterization of canine astroviruses in pet dogs in Guangxi, China"},{"arc":[[22.3337936154897,114.179224932647],[35.2153701782227,-97.447998046875]],"countries":["Hong Kong-China","United States"],"title":"Detection and genetic characterization of canine astroviruses in pet dogs in Guangxi, China"},{"arc":[[22.3337936154897,114.179224932647],[39.9530487060547,-75.1940231323242]],"countries":["Hong Kong-China","United States"],"title":"Detection and genetic characterization of canine astroviruses in pet dogs in Guangxi, China"},{"arc":[[22.3337936154897,114.179224932647],[23.8029747009277,108.794311523438]],"countries":["Hong Kong-China","China"],"title":"Detection and genetic characterization of canine astroviruses in pet dogs in Guangxi, China"},{"arc":[[35.2153701782227,-97.447998046875],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Detection and genetic characterization of canine astroviruses in pet dogs in Guangxi, China"},{"arc":[[35.2153701782227,-97.447998046875],[23.8029747009277,108.794311523438]],"countries":["China","United States"],"title":"Detection and genetic characterization of canine astroviruses in pet dogs in Guangxi, China"},{"arc":[[39.9530487060547,-75.1940231323242],[23.8029747009277,108.794311523438]],"countries":["United States","China"],"title":"Detection and genetic characterization of canine astroviruses in pet dogs in Guangxi, China"},{"arc":[[42.7586784362793,-82.483512878418],[38.9140090942383,121.614700317383]],"countries":["China","United States"],"title":"BMC Bioinformatics An effective docking strategy for virtual screening based on multi-objective optimization algorithm"},{"arc":[[42.7586784362793,-82.483512878418],[37.7697296142578,-122.466094970703]],"countries":["United States"],"title":"BMC Bioinformatics An effective docking strategy for virtual screening based on multi-objective optimization algorithm"},{"arc":[[42.7586784362793,-82.483512878418],[42.7586784362793,-82.483512878418]],"countries":["United States"],"title":"BMC Bioinformatics An effective docking strategy for virtual screening based on multi-objective optimization algorithm"},{"arc":[[38.9140090942383,121.614700317383],[37.7697296142578,-122.466094970703]],"countries":["United States","China"],"title":"BMC Bioinformatics An effective docking strategy for virtual screening based on multi-objective optimization algorithm"},{"arc":[[38.9140090942383,121.614700317383],[42.7586784362793,-82.483512878418]],"countries":["China","United States"],"title":"BMC Bioinformatics An effective docking strategy for virtual screening based on multi-objective optimization algorithm"},{"arc":[[38.9140090942383,121.614700317383],[38.9140090942383,121.614700317383]],"countries":["China"],"title":"BMC Bioinformatics An effective docking strategy for virtual screening based on multi-objective optimization algorithm"},{"arc":[[37.7697296142578,-122.466094970703],[42.7586784362793,-82.483512878418]],"countries":["United States"],"title":"BMC Bioinformatics An effective docking strategy for virtual screening based on multi-objective optimization algorithm"},{"arc":[[37.7697296142578,-122.466094970703],[37.7697296142578,-122.466094970703]],"countries":["United States"],"title":"BMC Bioinformatics An effective docking strategy for virtual screening based on multi-objective optimization algorithm"},{"arc":[[37.7697296142578,-122.466094970703],[38.9140090942383,121.614700317383]],"countries":["United States","China"],"title":"BMC Bioinformatics An effective docking strategy for virtual screening based on multi-objective optimization algorithm"},{"arc":[[51.0766296386719,-114.13208770752],[51.0766296386719,-114.13208770752]],"countries":["Canada"],"title":"Immuno-modulating properties of Tulathromycin in porcine monocyte-derived macrophages infected with porcine reproductive and respiratory syndrome virus"},{"arc":[[51.1218070983887,10.4006948471069],[51.1218070983887,10.4006948471069]],"countries":["Germany"],"title":"Antiviral Role of IFITM Proteins in African Swine Fever Virus Infection"},{"arc":[[51.1218070983887,10.4006948471069],[39.4959106445312,-98.9899826049805]],"countries":["Germany","United States"],"title":"Antiviral Role of IFITM Proteins in African Swine Fever Virus Infection"},{"arc":[[39.4959106445312,-98.9899826049805],[51.1218070983887,10.4006948471069]],"countries":["Germany","United States"],"title":"Antiviral Role of IFITM Proteins in African Swine Fever Virus Infection"},{"arc":[[53.4570770263672,27.2214450836182],[53.4570770263672,27.2214450836182]],"countries":["Belarus"],"title":"Complete Genome Sequence of Bordetella bronchiseptica Strain KM22"},{"arc":[[25.7175693511963,-80.2775802612305],[-37.7035598754883,145.180358886719]],"countries":["Australia","United States"],"title":"MINI REVIEW Endocrinology of Aging, a section of the journal Frontiers in Endocrinology Influence of Obesity on Pneumococcus Infection Risk in the Elderly"},{"arc":[[44.9734497070312,-93.2378997802734],[40.0063018798828,-83.0163803100586]],"countries":["United States"],"title":"Evaluation of immune responses to porcine reproductive and respiratory syndrome virus in pigs during early stage of infection under farm conditions"},{"arc":[[50.7338905334473,7.10222196578979],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"NA"},{"arc":[[50.7338905334473,7.10222196578979],[52.5251808166504,13.3792200088501]],"countries":["Germany"],"title":"NA"},{"arc":[[52.5251808166504,13.3792200088501],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"NA"},{"arc":[[49.8096008300781,-97.1333312988281],[43.9649963378906,-112.343688964844]],"countries":["Canada","NOCOUNTRY"],"title":"Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean- Congo hemorrhagic fever virus challenge"},{"arc":[[49.8096008300781,-97.1333312988281],[39.0048141479492,-77.0975341796875]],"countries":["United States","Canada"],"title":"Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean- Congo hemorrhagic fever virus challenge"},{"arc":[[43.9649963378906,-112.343688964844],[43.9649963378906,-112.343688964844]],"countries":["NOCOUNTRY"],"title":"Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean- Congo hemorrhagic fever virus challenge"},{"arc":[[43.9649963378906,-112.343688964844],[39.0048141479492,-77.0975341796875]],"countries":["United States","NOCOUNTRY"],"title":"Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean- Congo hemorrhagic fever virus challenge"},{"arc":[[55.84738,-4.25425],[55.84738,-4.25425]],"countries":["United Kingdom"],"title":"MINI REVIEW ARTICLE Asymmetry of cell division in CFSE-based lymphocyte proliferation analysis"},{"arc":[[55.84738,-4.25425],[55.7110481262207,37.5794792175293]],"countries":["Russia","United Kingdom"],"title":"MINI REVIEW ARTICLE Asymmetry of cell division in CFSE-based lymphocyte proliferation analysis"},{"arc":[[55.7110481262207,37.5794792175293],[55.7110481262207,37.5794792175293]],"countries":["Russia"],"title":"MINI REVIEW ARTICLE Asymmetry of cell division in CFSE-based lymphocyte proliferation analysis"},{"arc":[[37.7697296142578,-122.466094970703],[37.7697296142578,-122.466094970703]],"countries":["United States"],"title":"Autographa californica Multiple Nucleopolyhedrovirus Ac34 Protein Retains Cellular Actin-Related Protein 2/3 Complex in the Nucleus by Subversion of CRM1- Dependent Nuclear Export a11111 OPEN ACCESS"},{"arc":[[39.9616241455078,116.365791320801],[39.9616241455078,116.365791320801]],"countries":["China"],"title":"ARTICLE Reconstructing propagation networks with natural diversity and identifying hidden sources"},{"arc":[[39.9616241455078,116.365791320801],[56.4566688537598,-2.97974991798401]],"countries":["China","United Kingdom"],"title":"ARTICLE Reconstructing propagation networks with natural diversity and identifying hidden sources"},{"arc":[[39.9616241455078,116.365791320801],[33.4219207763672,-111.934936523438]],"countries":["China","United States"],"title":"ARTICLE Reconstructing propagation networks with natural diversity and identifying hidden sources"},{"arc":[[56.4566688537598,-2.97974991798401],[39.9616241455078,116.365791320801]],"countries":["China","United Kingdom"],"title":"ARTICLE Reconstructing propagation networks with natural diversity and identifying hidden sources"},{"arc":[[56.4566688537598,-2.97974991798401],[33.4219207763672,-111.934936523438]],"countries":["United Kingdom","United States"],"title":"ARTICLE Reconstructing propagation networks with natural diversity and identifying hidden sources"},{"arc":[[28.7162494659424,77.2728576660156],[14.3596153259277,-14.4684610366821]],"countries":["India","Senegal"],"title":"From SARS-CoV to SARS-CoV-2 Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends"},{"arc":[[28.7162494659424,77.2728576660156],[42.3502082824707,-71.0988693237305]],"countries":["India","United States"],"title":"From SARS-CoV to SARS-CoV-2 Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends"},{"arc":[[28.7162494659424,77.2728576660156],[40.8081588745117,-73.9636535644531]],"countries":["India","United States"],"title":"From SARS-CoV to SARS-CoV-2 Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends"},{"arc":[[14.3596153259277,-14.4684610366821],[14.3596153259277,-14.4684610366821]],"countries":["Senegal"],"title":"From SARS-CoV to SARS-CoV-2 Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends"},{"arc":[[14.3596153259277,-14.4684610366821],[42.3502082824707,-71.0988693237305]],"countries":["United States","Senegal"],"title":"From SARS-CoV to SARS-CoV-2 Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends"},{"arc":[[14.3596153259277,-14.4684610366821],[40.8081588745117,-73.9636535644531]],"countries":["United States","Senegal"],"title":"From SARS-CoV to SARS-CoV-2 Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends"},{"arc":[[42.3502082824707,-71.0988693237305],[14.3596153259277,-14.4684610366821]],"countries":["United States","Senegal"],"title":"From SARS-CoV to SARS-CoV-2 Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends"},{"arc":[[42.3502082824707,-71.0988693237305],[40.8081588745117,-73.9636535644531]],"countries":["United States"],"title":"From SARS-CoV to SARS-CoV-2 Outbreak: Similarities in the Early Epidemics and Prediction of Future Trends"},{"arc":[[53.5207481384277,-113.523216247559],[53.5207481384277,-113.523216247559]],"countries":["Canada"],"title":"Is there a Role for Cyclophilin Inhibitors in the Management of Primary Biliary Cirrhosis?"},{"arc":[[32.3935813903809,119.412689208984],[-25.1099891662598,30.7521800994873]],"countries":["South Africa","China"],"title":"single Dose of consensus hemagglutinin-Based Virus-like Particles Vaccine Protects chickens against Divergent h5 subtype influenza Viruses"},{"arc":[[32.3935813903809,119.412689208984],[32.3935813903809,119.412689208984]],"countries":["China"],"title":"single Dose of consensus hemagglutinin-Based Virus-like Particles Vaccine Protects chickens against Divergent h5 subtype influenza Viruses"},{"arc":[[32.3935813903809,119.412689208984],[33.7531509399414,-84.384880065918]],"countries":["China","United States"],"title":"single Dose of consensus hemagglutinin-Based Virus-like Particles Vaccine Protects chickens against Divergent h5 subtype influenza Viruses"},{"arc":[[32.3935813903809,119.412689208984],[51.5235214233398,-0.132312998175621]],"countries":["United Kingdom","China"],"title":"single Dose of consensus hemagglutinin-Based Virus-like Particles Vaccine Protects chickens against Divergent h5 subtype influenza Viruses"},{"arc":[[-25.1099891662598,30.7521800994873],[32.3935813903809,119.412689208984]],"countries":["South Africa","China"],"title":"single Dose of consensus hemagglutinin-Based Virus-like Particles Vaccine Protects chickens against Divergent h5 subtype influenza Viruses"},{"arc":[[-25.1099891662598,30.7521800994873],[33.7531509399414,-84.384880065918]],"countries":["South Africa","United States"],"title":"single Dose of consensus hemagglutinin-Based Virus-like Particles Vaccine Protects chickens against Divergent h5 subtype influenza Viruses"},{"arc":[[-25.1099891662598,30.7521800994873],[51.5235214233398,-0.132312998175621]],"countries":["South Africa","United Kingdom"],"title":"single Dose of consensus hemagglutinin-Based Virus-like Particles Vaccine Protects chickens against Divergent h5 subtype influenza Viruses"},{"arc":[[33.7531509399414,-84.384880065918],[51.5235214233398,-0.132312998175621]],"countries":["United Kingdom","United States"],"title":"single Dose of consensus hemagglutinin-Based Virus-like Particles Vaccine Protects chickens against Divergent h5 subtype influenza Viruses"},{"arc":[[51.1218070983887,10.4006948471069],[51.1218070983887,10.4006948471069]],"countries":["Germany"],"title":"Global Influenza Hospital-based Surveillance Network (GIHSN): results of surveillance of influenza and other respiratory viruses in hospitalised patients in Brazil, 2015"},{"arc":[[51.1218070983887,10.4006948471069],[-22.881010055542,-43.352668762207]],"countries":["Germany","Brazil"],"title":"Global Influenza Hospital-based Surveillance Network (GIHSN): results of surveillance of influenza and other respiratory viruses in hospitalised patients in Brazil, 2015"},{"arc":[[51.1218070983887,10.4006948471069],[42.385311126709,-72.5253524780273]],"countries":["United States","Germany"],"title":"Global Influenza Hospital-based Surveillance Network (GIHSN): results of surveillance of influenza and other respiratory viruses in hospitalised patients in Brazil, 2015"},{"arc":[[-22.881010055542,-43.352668762207],[42.385311126709,-72.5253524780273]],"countries":["United States","Brazil"],"title":"Global Influenza Hospital-based Surveillance Network (GIHSN): results of surveillance of influenza and other respiratory viruses in hospitalised patients in Brazil, 2015"},{"arc":[[52.2027015686035,0.119883999228477],[52.2027015686035,0.119883999228477]],"countries":["United Kingdom"],"title":"Photodynamic Antimicrobial Polymers for Infection Control"},{"arc":[[52.2027015686035,0.119883999228477],[43.0402717590332,-76.1366424560547]],"countries":["United Kingdom","United States"],"title":"Photodynamic Antimicrobial Polymers for Infection Control"},{"arc":[[43.0402717590332,-76.1366424560547],[52.2027015686035,0.119883999228477]],"countries":["United Kingdom","United States"],"title":"Photodynamic Antimicrobial Polymers for Infection Control"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"viruses Isolation of a Divergent Strain of Bovine Parainfluenza Virus Type 3 (BPIV3) Infecting Cattle in China"},{"arc":[[40.9437103271484,40.2619209289551],[-1.43936002254486,-48.497688293457]],"countries":["Turkey","Brazil"],"title":"viruses Isolation of a Divergent Strain of Bovine Parainfluenza Virus Type 3 (BPIV3) Infecting Cattle in China"},{"arc":[[-1.43936002254486,-48.497688293457],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Brazil"],"title":"viruses Isolation of a Divergent Strain of Bovine Parainfluenza Virus Type 3 (BPIV3) Infecting Cattle in China"},{"arc":[[47.8637313842773,127.773658752441],[47.8637313842773,127.773658752441]],"countries":["China"],"title":"Prevalence and phylogenetic analysis of canine kobuviruses in diarrhoetic dogs in northeast China"},{"arc":[[42.373161315918,-71.1181182861328],[35.9524993896484,-83.9270706176758]],"countries":["United States"],"title":"Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification"},{"arc":[[42.373161315918,-71.1181182861328],[42.373161315918,-71.1181182861328]],"countries":["United States"],"title":"Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification"},{"arc":[[42.373161315918,-71.1181182861328],[35.1019592285156,-106.591567993164]],"countries":["United States"],"title":"Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification"},{"arc":[[42.373161315918,-71.1181182861328],[39.6785011291504,-104.966621398926]],"countries":["United States"],"title":"Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification"},{"arc":[[35.9524993896484,-83.9270706176758],[42.373161315918,-71.1181182861328]],"countries":["United States"],"title":"Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification"},{"arc":[[35.9524993896484,-83.9270706176758],[35.1019592285156,-106.591567993164]],"countries":["United States"],"title":"Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification"},{"arc":[[35.9524993896484,-83.9270706176758],[39.6785011291504,-104.966621398926]],"countries":["United States"],"title":"Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification"},{"arc":[[35.1019592285156,-106.591567993164],[42.373161315918,-71.1181182861328]],"countries":["United States"],"title":"Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification"},{"arc":[[35.1019592285156,-106.591567993164],[39.6785011291504,-104.966621398926]],"countries":["United States"],"title":"Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification"},{"arc":[[39.6785011291504,-104.966621398926],[42.373161315918,-71.1181182861328]],"countries":["United States"],"title":"Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplification"},{"arc":[[51.7723388671875,19.4748992919922],[50.877628326416,4.70719003677368]],"countries":["Belgium","Poland"],"title":"Design, synthesis, antiviral and cytotoxic evaluation of novel acyclic phosphonate nucleotide analogues with a 5,6-dihydro- 1H-[1,2,3]triazolo[4,5-d]pyridazine-4,7-dione system"},{"arc":[[22.2802925109863,114.142951965332],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Cytokine Profiles in Human Immunodeficiency Virus-Infected Children Treated With Highly Active Antiretroviral Therapy"},{"arc":[[40.7182693481445,46.4133987426758],[39.0048141479492,-77.0975341796875]],"countries":["United States","Azerbaijan"],"title":"The Ebola Virus Nucleoprotein Recruits the Nuclear RNA Export Factor NXF1 into Inclusion Bodies to Facilitate Viral Protein Expression"},{"arc":[[40.7182693481445,46.4133987426758],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan"],"title":"The Ebola Virus Nucleoprotein Recruits the Nuclear RNA Export Factor NXF1 into Inclusion Bodies to Facilitate Viral Protein Expression"},{"arc":[[39.0048141479492,-77.0975341796875],[40.7182693481445,46.4133987426758]],"countries":["United States","Azerbaijan"],"title":"The Ebola Virus Nucleoprotein Recruits the Nuclear RNA Export Factor NXF1 into Inclusion Bodies to Facilitate Viral Protein Expression"},{"arc":[[41.9982795715332,-87.6571731567383],[41.9982795715332,-87.6571731567383]],"countries":["United States"],"title":"Ready, Set, Fuse! The Coronavirus Spike Protein and Acquisition of Fusion Competence"},{"arc":[[40.9437103271484,40.2619209289551],[22.333080291748,114.191223144531]],"countries":["Turkey","Hong Kong SAR"],"title":"The Journal of Experimental Medicine A novel subset of putative stem/progenitor CD34 ؉ Oct-4 ؉ cells is the major target for SARS coronavirus in human lung"},{"arc":[[40.9437103271484,40.2619209289551],[51.5172462463379,-0.236009001731873]],"countries":["Turkey","United Kingdom"],"title":"The Journal of Experimental Medicine A novel subset of putative stem/progenitor CD34 ؉ Oct-4 ؉ cells is the major target for SARS coronavirus in human lung"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"The Journal of Experimental Medicine A novel subset of putative stem/progenitor CD34 ؉ Oct-4 ؉ cells is the major target for SARS coronavirus in human lung"},{"arc":[[22.333080291748,114.191223144531],[51.5172462463379,-0.236009001731873]],"countries":["Hong Kong SAR","United Kingdom"],"title":"The Journal of Experimental Medicine A novel subset of putative stem/progenitor CD34 ؉ Oct-4 ؉ cells is the major target for SARS coronavirus in human lung"},{"arc":[[22.333080291748,114.191223144531],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Hong Kong SAR"],"title":"The Journal of Experimental Medicine A novel subset of putative stem/progenitor CD34 ؉ Oct-4 ؉ cells is the major target for SARS coronavirus in human lung"},{"arc":[[51.5172462463379,-0.236009001731873],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United Kingdom"],"title":"The Journal of Experimental Medicine A novel subset of putative stem/progenitor CD34 ؉ Oct-4 ؉ cells is the major target for SARS coronavirus in human lung"},{"arc":[[5.010666847229,-9.03868961334229],[26.7023582458496,-80.0865325927734]],"countries":["United States","Liberia"],"title":"SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison and Potential Implications on Neutralizing Antibody and Vaccine Development"},{"arc":[[40.7182693481445,46.4133987426758],[40.0873985290527,-8.70540046691895]],"countries":["Azerbaijan","Portugal"],"title":"Contribution of Host Intracellular Transport Machineries to Intercellular Movement of Turnip Mosaic Virus"},{"arc":[[40.7182693481445,46.4133987426758],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan"],"title":"Contribution of Host Intracellular Transport Machineries to Intercellular Movement of Turnip Mosaic Virus"},{"arc":[[40.7182693481445,46.4133987426758],[36.5631141662598,103.735809326172]],"countries":["China","Azerbaijan"],"title":"Contribution of Host Intracellular Transport Machineries to Intercellular Movement of Turnip Mosaic Virus"},{"arc":[[40.7182693481445,46.4133987426758],[45.5065994262695,-73.5779571533203]],"countries":["Azerbaijan","Canada"],"title":"Contribution of Host Intracellular Transport Machineries to Intercellular Movement of Turnip Mosaic Virus"},{"arc":[[40.0873985290527,-8.70540046691895],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","Portugal"],"title":"Contribution of Host Intracellular Transport Machineries to Intercellular Movement of Turnip Mosaic Virus"},{"arc":[[40.0873985290527,-8.70540046691895],[36.5631141662598,103.735809326172]],"countries":["China","Portugal"],"title":"Contribution of Host Intracellular Transport Machineries to Intercellular Movement of Turnip Mosaic Virus"},{"arc":[[40.0873985290527,-8.70540046691895],[45.5065994262695,-73.5779571533203]],"countries":["Canada","Portugal"],"title":"Contribution of Host Intracellular Transport Machineries to Intercellular Movement of Turnip Mosaic Virus"},{"arc":[[36.5631141662598,103.735809326172],[45.5065994262695,-73.5779571533203]],"countries":["China","Canada"],"title":"Contribution of Host Intracellular Transport Machineries to Intercellular Movement of Turnip Mosaic Virus"},{"arc":[[35.876606,126.8157],[35.876606,126.8157]],"countries":["South Korea"],"title":"Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated Area OPEN"},{"arc":[[31.3202800750732,48.6691703796387],[31.3202800750732,48.6691703796387]],"countries":["Iran"],"title":"In Vitro Anti-rotaviral Activity of Achillea kellalensis"},{"arc":[[47.6565093994141,-122.312088012695],[47.6565093994141,-122.312088012695]],"countries":["United States"],"title":"Oas1b-dependent Immune Transcriptional Profiles of West Nile Virus Infection in the Collaborative Cross"},{"arc":[[47.6565093994141,-122.312088012695],[14.477560043335,120.89826965332]],"countries":["United States","Philippines"],"title":"Oas1b-dependent Immune Transcriptional Profiles of West Nile Virus Infection in the Collaborative Cross"},{"arc":[[47.6565093994141,-122.312088012695],[45.5003509521484,-122.686950683594]],"countries":["United States"],"title":"Oas1b-dependent Immune Transcriptional Profiles of West Nile Virus Infection in the Collaborative Cross"},{"arc":[[47.6565093994141,-122.312088012695],[34.39375,-87.11915]],"countries":["United States"],"title":"Oas1b-dependent Immune Transcriptional Profiles of West Nile Virus Infection in the Collaborative Cross"},{"arc":[[14.477560043335,120.89826965332],[47.6565093994141,-122.312088012695]],"countries":["United States","Philippines"],"title":"Oas1b-dependent Immune Transcriptional Profiles of West Nile Virus Infection in the Collaborative Cross"},{"arc":[[14.477560043335,120.89826965332],[14.477560043335,120.89826965332]],"countries":["Philippines"],"title":"Oas1b-dependent Immune Transcriptional Profiles of West Nile Virus Infection in the Collaborative Cross"},{"arc":[[14.477560043335,120.89826965332],[45.5003509521484,-122.686950683594]],"countries":["United States","Philippines"],"title":"Oas1b-dependent Immune Transcriptional Profiles of West Nile Virus Infection in the Collaborative Cross"},{"arc":[[14.477560043335,120.89826965332],[34.39375,-87.11915]],"countries":["United States","Philippines"],"title":"Oas1b-dependent Immune Transcriptional Profiles of West Nile Virus Infection in the Collaborative Cross"},{"arc":[[45.5003509521484,-122.686950683594],[34.39375,-87.11915]],"countries":["United States"],"title":"Oas1b-dependent Immune Transcriptional Profiles of West Nile Virus Infection in the Collaborative Cross"},{"arc":[[45.5003509521484,-122.686950683594],[47.6565093994141,-122.312088012695]],"countries":["United States"],"title":"Oas1b-dependent Immune Transcriptional Profiles of West Nile Virus Infection in the Collaborative Cross"},{"arc":[[34.39375,-87.11915],[47.6565093994141,-122.312088012695]],"countries":["United States"],"title":"Oas1b-dependent Immune Transcriptional Profiles of West Nile Virus Infection in the Collaborative Cross"},{"arc":[[37.7697296142578,-122.466094970703],[30.2633018493652,120.122261047363]],"countries":["United States","China"],"title":"Appealing for Efficient, Well Organized Clinical Trials on COVID-19"},{"arc":[[37.7697296142578,-122.466094970703],[40.1861572265625,116.418983459473]],"countries":["United States","China"],"title":"Appealing for Efficient, Well Organized Clinical Trials on COVID-19"},{"arc":[[37.7697296142578,-122.466094970703],[22.3337936154897,114.179224932647]],"countries":["Hong Kong-China","United States"],"title":"Appealing for Efficient, Well Organized Clinical Trials on COVID-19"},{"arc":[[30.2633018493652,120.122261047363],[40.1861572265625,116.418983459473]],"countries":["China"],"title":"Appealing for Efficient, Well Organized Clinical Trials on COVID-19"},{"arc":[[30.2633018493652,120.122261047363],[22.3337936154897,114.179224932647]],"countries":["Hong Kong-China","China"],"title":"Appealing for Efficient, Well Organized Clinical Trials on COVID-19"},{"arc":[[40.1861572265625,116.418983459473],[22.3337936154897,114.179224932647]],"countries":["Hong Kong-China","China"],"title":"Appealing for Efficient, Well Organized Clinical Trials on COVID-19"},{"arc":[[41.7278709411621,44.764778137207],[41.7278709411621,44.764778137207]],"countries":["Georgia"],"title":"Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig"},{"arc":[[41.7278709411621,44.764778137207],[31.0254402160645,121.436302185059]],"countries":["China","Georgia"],"title":"Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig"},{"arc":[[51.5002288818359,-0.178939998149872],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom"],"title":"SARS-CoV Antibody Prevalence in All Hong Kong Patient Contacts"},{"arc":[[51.5002288818359,-0.178939998149872],[22.333080291748,114.191223144531]],"countries":["Hong Kong SAR","United Kingdom"],"title":"SARS-CoV Antibody Prevalence in All Hong Kong Patient Contacts"},{"arc":[[51.5002288818359,-0.178939998149872],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United Kingdom"],"title":"SARS-CoV Antibody Prevalence in All Hong Kong Patient Contacts"},{"arc":[[22.333080291748,114.191223144531],[51.5002288818359,-0.178939998149872]],"countries":["Hong Kong SAR","United Kingdom"],"title":"SARS-CoV Antibody Prevalence in All Hong Kong Patient Contacts"},{"arc":[[22.333080291748,114.191223144531],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"SARS-CoV Antibody Prevalence in All Hong Kong Patient Contacts"},{"arc":[[40.9437103271484,40.2619209289551],[40.152660369873,-80.2116928100586]],"countries":["Turkey","United States"],"title":"Reproductive Number and Serial Interval of the First Wave of Influenza A(H1N1)pdm09 Virus in South Africa"},{"arc":[[34.8679008483887,126.990997314453],[40.9469909667969,-81.4652099609375]],"countries":["South Korea","United States"],"title":"CLINICAL EXPERIMENTAL VACCINE RESEARCH K O R E A N V A C C I N E S O C I E T Y K O R E A N A C C I N E O C I E T Y V S Animal models for dengue vaccine development and testing"},{"arc":[[52.1751708984375,0.140450000762939],[52.1751708984375,0.140450000762939]],"countries":["United Kingdom"],"title":"Subgenomic promoter recognition by the norovirus RNA-dependent RNA polymerases"},{"arc":[[52.1751708984375,0.140450000762939],[46.0363998413086,21.4962005615234]],"countries":["United Kingdom","Romania"],"title":"Subgenomic promoter recognition by the norovirus RNA-dependent RNA polymerases"},{"arc":[[52.1751708984375,0.140450000762939],[39.173511505127,-86.5160522460938]],"countries":["United Kingdom","United States"],"title":"Subgenomic promoter recognition by the norovirus RNA-dependent RNA polymerases"},{"arc":[[46.0363998413086,21.4962005615234],[39.173511505127,-86.5160522460938]],"countries":["United States","Romania"],"title":"Subgenomic promoter recognition by the norovirus RNA-dependent RNA polymerases"},{"arc":[[46.0363998413086,21.4962005615234],[46.0363998413086,21.4962005615234]],"countries":["Romania"],"title":"Subgenomic promoter recognition by the norovirus RNA-dependent RNA polymerases"},{"arc":[[39.173511505127,-86.5160522460938],[39.173511505127,-86.5160522460938]],"countries":["United States"],"title":"Subgenomic promoter recognition by the norovirus RNA-dependent RNA polymerases"},{"arc":[[39.173511505127,-86.5160522460938],[46.0363998413086,21.4962005615234]],"countries":["United States","Romania"],"title":"Subgenomic promoter recognition by the norovirus RNA-dependent RNA polymerases"},{"arc":[[37.7697296142578,-122.466094970703],[40.9437103271484,40.2619209289551]],"countries":["United States","Turkey"],"title":"Comprehensive viral oligonucleotide probe design using conserved protein regions"},{"arc":[[37.7697296142578,-122.466094970703],[40.8081588745117,-73.9636535644531]],"countries":["United States"],"title":"Comprehensive viral oligonucleotide probe design using conserved protein regions"},{"arc":[[37.7697296142578,-122.466094970703],[37.7697296142578,-122.466094970703]],"countries":["United States"],"title":"Comprehensive viral oligonucleotide probe design using conserved protein regions"},{"arc":[[37.7697296142578,-122.466094970703],[41.7922172546387,-87.6018371582031]],"countries":["United States"],"title":"Comprehensive viral oligonucleotide probe design using conserved protein regions"},{"arc":[[40.9437103271484,40.2619209289551],[40.8081588745117,-73.9636535644531]],"countries":["Turkey","United States"],"title":"Comprehensive viral oligonucleotide probe design using conserved protein regions"},{"arc":[[40.9437103271484,40.2619209289551],[37.7697296142578,-122.466094970703]],"countries":["United States","Turkey"],"title":"Comprehensive viral oligonucleotide probe design using conserved protein regions"},{"arc":[[40.9437103271484,40.2619209289551],[41.7922172546387,-87.6018371582031]],"countries":["Turkey","United States"],"title":"Comprehensive viral oligonucleotide probe design using conserved protein regions"},{"arc":[[40.8081588745117,-73.9636535644531],[40.8081588745117,-73.9636535644531]],"countries":["United States"],"title":"Comprehensive viral oligonucleotide probe design using conserved protein regions"},{"arc":[[40.8081588745117,-73.9636535644531],[37.7697296142578,-122.466094970703]],"countries":["United States"],"title":"Comprehensive viral oligonucleotide probe design using conserved protein regions"},{"arc":[[40.8081588745117,-73.9636535644531],[41.7922172546387,-87.6018371582031]],"countries":["United States"],"title":"Comprehensive viral oligonucleotide probe design using conserved protein regions"},{"arc":[[41.4491691589355,2.24833011627197],[41.4491691589355,2.24833011627197]],"countries":["Spain"],"title":"Lack of detection of Middle East respiratory syndrome coronavirus in mild and severe respiratory infections in Catalonia, northeastern Spain"},{"arc":[[41.4491691589355,2.24833011627197],[41.796745300293,1.53171694278717]],"countries":["Spain"],"title":"Lack of detection of Middle East respiratory syndrome coronavirus in mild and severe respiratory infections in Catalonia, northeastern Spain"},{"arc":[[41.796745300293,1.53171694278717],[41.796745300293,1.53171694278717]],"countries":["Spain"],"title":"Lack of detection of Middle East respiratory syndrome coronavirus in mild and severe respiratory infections in Catalonia, northeastern Spain"},{"arc":[[41.796745300293,1.53171694278717],[41.4491691589355,2.24833011627197]],"countries":["Spain"],"title":"Lack of detection of Middle East respiratory syndrome coronavirus in mild and severe respiratory infections in Catalonia, northeastern Spain"},{"arc":[[50.93091,5.36806],[50.93091,5.36806]],"countries":["Belgium"],"title":"Estimating the generation interval for COVID-19 based on symptom onset data"},{"arc":[[50.93091,5.36806],[28.7162494659424,77.2728576660156]],"countries":["India","Belgium"],"title":"Estimating the generation interval for COVID-19 based on symptom onset data"},{"arc":[[28.7162494659424,77.2728576660156],[50.93091,5.36806]],"countries":["India","Belgium"],"title":"Estimating the generation interval for COVID-19 based on symptom onset data"},{"arc":[[28.7162494659424,77.2728576660156],[28.7162494659424,77.2728576660156]],"countries":["India"],"title":"Estimating the generation interval for COVID-19 based on symptom onset data"},{"arc":[[35.9900016784668,139.800003051758],[35.9900016784668,139.800003051758]],"countries":["Japan"],"title":"Estimation of the effective reproduction number of influenza based on weekly reports in Miyazaki Prefecture"},{"arc":[[35.9900016784668,139.800003051758],[32.7603302001953,129.866546630859]],"countries":["Japan"],"title":"Estimation of the effective reproduction number of influenza based on weekly reports in Miyazaki Prefecture"},{"arc":[[35.9900016784668,139.800003051758],[31.9124298095703,131.421112060547]],"countries":["Japan"],"title":"Estimation of the effective reproduction number of influenza based on weekly reports in Miyazaki Prefecture"},{"arc":[[32.7603302001953,129.866546630859],[31.9124298095703,131.421112060547]],"countries":["Japan"],"title":"Estimation of the effective reproduction number of influenza based on weekly reports in Miyazaki Prefecture"},{"arc":[[31.0254402160645,121.436302185059],[31.0254402160645,121.436302185059]],"countries":["China"],"title":"A Rationally Designed TNF-α Epitope- Scaffold Immunogen Induces Sustained Antibody Response and Alleviates Collagen- Induced Arthritis in Mice"},{"arc":[[31.0254402160645,121.436302185059],[44.3065299987793,86.0789337158203]],"countries":["China"],"title":"A Rationally Designed TNF-α Epitope- Scaffold Immunogen Induces Sustained Antibody Response and Alleviates Collagen- Induced Arthritis in Mice"},{"arc":[[44.3065299987793,86.0789337158203],[31.0254402160645,121.436302185059]],"countries":["China"],"title":"A Rationally Designed TNF-α Epitope- Scaffold Immunogen Induces Sustained Antibody Response and Alleviates Collagen- Induced Arthritis in Mice"},{"arc":[[36.4511566162109,127.861145019531],[36.4511566162109,127.861145019531]],"countries":["South Korea"],"title":"NA"},{"arc":[[26.029390335083,118.138877868652],[26.029390335083,118.138877868652]],"countries":["China"],"title":"Functional Involvement of Interferon-Inducible Transmembrane Proteins in Antiviral Immunity"},{"arc":[[26.029390335083,118.138877868652],[37.7697296142578,-122.466094970703]],"countries":["United States","China"],"title":"Functional Involvement of Interferon-Inducible Transmembrane Proteins in Antiviral Immunity"},{"arc":[[26.029390335083,118.138877868652],[9.36855030059814,-83.6394882202148]],"countries":["Costa Rica","China"],"title":"Functional Involvement of Interferon-Inducible Transmembrane Proteins in Antiviral Immunity"},{"arc":[[37.7697296142578,-122.466094970703],[9.36855030059814,-83.6394882202148]],"countries":["United States","Costa Rica"],"title":"Functional Involvement of Interferon-Inducible Transmembrane Proteins in Antiviral Immunity"},{"arc":[[37.7697296142578,-122.466094970703],[26.029390335083,118.138877868652]],"countries":["United States","China"],"title":"Functional Involvement of Interferon-Inducible Transmembrane Proteins in Antiviral Immunity"},{"arc":[[9.36855030059814,-83.6394882202148],[26.029390335083,118.138877868652]],"countries":["Costa Rica","China"],"title":"Functional Involvement of Interferon-Inducible Transmembrane Proteins in Antiviral Immunity"},{"arc":[[30.787769317627,74.4202423095703],[30.787769317627,74.4202423095703]],"countries":["India"],"title":"4th Annual ELSO-SWAC Conference Proceedings Qatar ECMO program: Past, present, and future"},{"arc":[[22.2802925109863,114.142951965332],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Evaluation of NxTAG Respiratory Pathogen Panel and Comparison with xTAG Respiratory Viral Panel Fast v2 and Film Array Respiratory Panel for Detecting Respiratory Pathogens in Nasopharyngeal Aspirates and Swine/Avian-Origin Influenza A Subtypes in Culture Isolates"},{"arc":[[41.9015502929688,12.5122203826904],[41.9015502929688,12.5122203826904]],"countries":["Italy"],"title":"Role of Lactobacilli and Lactoferrin in the Mucosal Cervicovaginal Defense"},{"arc":[[46.7798385620117,-71.2695007324219],[46.7798385620117,-71.2695007324219]],"countries":["Canada"],"title":"Dendritic Cell Immunoreceptor Is a New Target for Anti- AIDS Drug Development: Identification of DCIR/HIV-1 Inhibitors"},{"arc":[[14.3596153259277,-14.4684610366821],[14.3596153259277,-14.4684610366821]],"countries":["Senegal"],"title":"GenomeLandscaper: Landscape analysis of genome-fingerprints maps assessing chromosome architecture OPEN"},{"arc":[[42.3402290344238,-71.0890197753906],[23.2024116516113,113.38606262207]],"countries":["China","United States"],"title":"Homologous recombination is a force in the evolution of canine distemper virus"},{"arc":[[42.3402290344238,-71.0890197753906],[42.3402290344238,-71.0890197753906]],"countries":["United States"],"title":"Homologous recombination is a force in the evolution of canine distemper virus"},{"arc":[[23.2024116516113,113.38606262207],[42.3402290344238,-71.0890197753906]],"countries":["China","United States"],"title":"Homologous recombination is a force in the evolution of canine distemper virus"},{"arc":[[40.9437103271484,40.2619209289551],[34.0983047485352,-117.269203186035]],"countries":["Turkey","United States"],"title":"Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein"},{"arc":[[34.0983047485352,-117.269203186035],[34.0983047485352,-117.269203186035]],"countries":["United States"],"title":"Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein"},{"arc":[[19.4971599578857,-99.1421585083008],[22.3358345031738,-102.292419433594]],"countries":["Mexico"],"title":"Virome and bacteriome characterization of children with pneumonia and asthma in Mexico City during winter seasons 2014 and 2015"},{"arc":[[19.4971599578857,-99.1421585083008],[41.7278709411621,44.764778137207]],"countries":["Georgia","Mexico"],"title":"Virome and bacteriome characterization of children with pneumonia and asthma in Mexico City during winter seasons 2014 and 2015"},{"arc":[[19.4971599578857,-99.1421585083008],[19.4971599578857,-99.1421585083008]],"countries":["Mexico"],"title":"Virome and bacteriome characterization of children with pneumonia and asthma in Mexico City during winter seasons 2014 and 2015"},{"arc":[[22.3358345031738,-102.292419433594],[22.3358345031738,-102.292419433594]],"countries":["Mexico"],"title":"Virome and bacteriome characterization of children with pneumonia and asthma in Mexico City during winter seasons 2014 and 2015"},{"arc":[[22.3358345031738,-102.292419433594],[41.7278709411621,44.764778137207]],"countries":["Georgia","Mexico"],"title":"Virome and bacteriome characterization of children with pneumonia and asthma in Mexico City during winter seasons 2014 and 2015"},{"arc":[[22.3358345031738,-102.292419433594],[19.4971599578857,-99.1421585083008]],"countries":["Mexico"],"title":"Virome and bacteriome characterization of children with pneumonia and asthma in Mexico City during winter seasons 2014 and 2015"},{"arc":[[41.7278709411621,44.764778137207],[22.3358345031738,-102.292419433594]],"countries":["Georgia","Mexico"],"title":"Virome and bacteriome characterization of children with pneumonia and asthma in Mexico City during winter seasons 2014 and 2015"},{"arc":[[41.7278709411621,44.764778137207],[19.4971599578857,-99.1421585083008]],"countries":["Georgia","Mexico"],"title":"Virome and bacteriome characterization of children with pneumonia and asthma in Mexico City during winter seasons 2014 and 2015"},{"arc":[[42.2077713012695,-78.1342010498047],[42.2077713012695,-78.1342010498047]],"countries":["United States"],"title":"Extracorporeal shockwave therapy in osteonecrosis of femoral head A systematic review of now available clinical evidences"},{"arc":[[37.8056831359863,-122.268104553223],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Conflicts of Interest during Contact Investigations: A Game-Theoretic Analysis"},{"arc":[[37.8056831359863,-122.268104553223],[37.7633209228516,-122.458541870117]],"countries":["United States"],"title":"Conflicts of Interest during Contact Investigations: A Game-Theoretic Analysis"},{"arc":[[36.4511566162109,127.861145019531],[34.8679008483887,126.990997314453]],"countries":["South Korea"],"title":"Activation of COX-2/PGE 2 Promotes Sapovirus Replication via the Inhibition of Nitric Oxide Production VIRUS-CELL INTERACTIONS crossm"},{"arc":[[36.4511566162109,127.861145019531],[52.2025413513184,0.119549997150898]],"countries":["South Korea","United Kingdom"],"title":"Activation of COX-2/PGE 2 Promotes Sapovirus Replication via the Inhibition of Nitric Oxide Production VIRUS-CELL INTERACTIONS crossm"},{"arc":[[36.4511566162109,127.861145019531],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom","South Korea"],"title":"Activation of COX-2/PGE 2 Promotes Sapovirus Replication via the Inhibition of Nitric Oxide Production VIRUS-CELL INTERACTIONS crossm"},{"arc":[[36.4511566162109,127.861145019531],[36.4511566162109,127.861145019531]],"countries":["South Korea"],"title":"Activation of COX-2/PGE 2 Promotes Sapovirus Replication via the Inhibition of Nitric Oxide Production VIRUS-CELL INTERACTIONS crossm"},{"arc":[[34.8679008483887,126.990997314453],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","South Korea"],"title":"Activation of COX-2/PGE 2 Promotes Sapovirus Replication via the Inhibition of Nitric Oxide Production VIRUS-CELL INTERACTIONS crossm"},{"arc":[[34.8679008483887,126.990997314453],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom","South Korea"],"title":"Activation of COX-2/PGE 2 Promotes Sapovirus Replication via the Inhibition of Nitric Oxide Production VIRUS-CELL INTERACTIONS crossm"},{"arc":[[34.8679008483887,126.990997314453],[36.4511566162109,127.861145019531]],"countries":["South Korea"],"title":"Activation of COX-2/PGE 2 Promotes Sapovirus Replication via the Inhibition of Nitric Oxide Production VIRUS-CELL INTERACTIONS crossm"},{"arc":[[34.8679008483887,126.990997314453],[34.8679008483887,126.990997314453]],"countries":["South Korea"],"title":"Activation of COX-2/PGE 2 Promotes Sapovirus Replication via the Inhibition of Nitric Oxide Production VIRUS-CELL INTERACTIONS crossm"},{"arc":[[52.2025413513184,0.119549997150898],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom"],"title":"Activation of COX-2/PGE 2 Promotes Sapovirus Replication via the Inhibition of Nitric Oxide Production VIRUS-CELL INTERACTIONS crossm"},{"arc":[[52.2025413513184,0.119549997150898],[36.4511566162109,127.861145019531]],"countries":["South Korea","United Kingdom"],"title":"Activation of COX-2/PGE 2 Promotes Sapovirus Replication via the Inhibition of Nitric Oxide Production VIRUS-CELL INTERACTIONS crossm"},{"arc":[[52.2025413513184,0.119549997150898],[34.8679008483887,126.990997314453]],"countries":["United Kingdom","South Korea"],"title":"Activation of COX-2/PGE 2 Promotes Sapovirus Replication via the Inhibition of Nitric Oxide Production VIRUS-CELL INTERACTIONS crossm"},{"arc":[[51.5002288818359,-0.178939998149872],[36.4511566162109,127.861145019531]],"countries":["United Kingdom","South Korea"],"title":"Activation of COX-2/PGE 2 Promotes Sapovirus Replication via the Inhibition of Nitric Oxide Production VIRUS-CELL INTERACTIONS crossm"},{"arc":[[51.5002288818359,-0.178939998149872],[34.8679008483887,126.990997314453]],"countries":["United Kingdom","South Korea"],"title":"Activation of COX-2/PGE 2 Promotes Sapovirus Replication via the Inhibition of Nitric Oxide Production VIRUS-CELL INTERACTIONS crossm"},{"arc":[[41.5059089660645,-81.6090927124023],[29.7095108032227,-95.3981781005859]],"countries":["United States"],"title":"Do medical students receive training in correct use of personal protective equipment?"},{"arc":[[41.5059089660645,-81.6090927124023],[36.9433898925781,-82.1553497314453]],"countries":["United States"],"title":"Do medical students receive training in correct use of personal protective equipment?"},{"arc":[[29.7095108032227,-95.3981781005859],[36.9433898925781,-82.1553497314453]],"countries":["United States"],"title":"Do medical students receive training in correct use of personal protective equipment?"},{"arc":[[29.7095108032227,-95.3981781005859],[29.7095108032227,-95.3981781005859]],"countries":["United States"],"title":"Do medical students receive training in correct use of personal protective equipment?"},{"arc":[[36.9433898925781,-82.1553497314453],[36.9433898925781,-82.1553497314453]],"countries":["United States"],"title":"Do medical students receive training in correct use of personal protective equipment?"},{"arc":[[36.9433898925781,-82.1553497314453],[29.7095108032227,-95.3981781005859]],"countries":["United States"],"title":"Do medical students receive training in correct use of personal protective equipment?"},{"arc":[[34.7286605834961,137.739303588867],[34.7286605834961,137.739303588867]],"countries":["Japan"],"title":"Gargling for Oral Hygiene and the Development of Fever in Childhood: A Population Study in Japan"},{"arc":[[34.7286605834961,137.739303588867],[33.6278381347656,130.422973632812]],"countries":["Japan"],"title":"Gargling for Oral Hygiene and the Development of Fever in Childhood: A Population Study in Japan"},{"arc":[[45.4067916870117,11.8769426345825],[45.4067916870117,11.8769426345825]],"countries":["Italy"],"title":"The cellular protein hnRNP A2/ B1 enhances HIV-1 transcription by unfolding LTR promoter G-quadruplexes OPEN"},{"arc":[[45.4067916870117,11.8769426345825],[45.4094390869141,11.8717098236084]],"countries":["Italy"],"title":"The cellular protein hnRNP A2/ B1 enhances HIV-1 transcription by unfolding LTR promoter G-quadruplexes OPEN"},{"arc":[[34.3412704467773,108.939842224121],[40.8620681762695,-73.8864898681641]],"countries":["China","United States"],"title":"NA"},{"arc":[[34.3412704467773,108.939842224121],[35.191234588623,108.873504638672]],"countries":["China"],"title":"NA"},{"arc":[[34.3412704467773,108.939842224121],[34.3412704467773,108.939842224121]],"countries":["China"],"title":"NA"},{"arc":[[34.3412704467773,108.939842224121],[39.9046897888184,116.407173156738]],"countries":["China"],"title":"NA"},{"arc":[[40.8620681762695,-73.8864898681641],[35.191234588623,108.873504638672]],"countries":["China","United States"],"title":"NA"},{"arc":[[40.8620681762695,-73.8864898681641],[34.3412704467773,108.939842224121]],"countries":["China","United States"],"title":"NA"},{"arc":[[40.8620681762695,-73.8864898681641],[39.9046897888184,116.407173156738]],"countries":["China","United States"],"title":"NA"},{"arc":[[35.191234588623,108.873504638672],[34.3412704467773,108.939842224121]],"countries":["China"],"title":"NA"},{"arc":[[35.191234588623,108.873504638672],[39.9046897888184,116.407173156738]],"countries":["China"],"title":"NA"},{"arc":[[39.9046897888184,116.407173156738],[34.3412704467773,108.939842224121]],"countries":["China"],"title":"NA"},{"arc":[[43.0670013427734,-89.4000015258789],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"HIV-1 frameshift efficiency is primarily determined by the stability of base pairs positioned at the mRNA entrance channel of the ribosome"},{"arc":[[43.0670013427734,-89.4000015258789],[44.6417846679688,-89.7367401123047]],"countries":["United States"],"title":"HIV-1 frameshift efficiency is primarily determined by the stability of base pairs positioned at the mRNA entrance channel of the ribosome"},{"arc":[[42.2762107849121,-83.7407531738281],[42.2762107849121,-83.7407531738281]],"countries":["United States"],"title":"Human metapneumovirus and respiratory syncytial virus: subtle differences but comparable severity"},{"arc":[[51.2169990539551,4.40000009536743],[51.506420135498,-0.127210006117821]],"countries":["United Kingdom","Belgium"],"title":"Zoos through the Lens of the IUCN Red List: A Global Metapopulation Approach to Support Conservation Breeding Programs"},{"arc":[[51.2169990539551,4.40000009536743],[-27.6047096252441,151.929931640625]],"countries":["Australia","Belgium"],"title":"Zoos through the Lens of the IUCN Red List: A Global Metapopulation Approach to Support Conservation Breeding Programs"},{"arc":[[51.506420135498,-0.127210006117821],[-27.6047096252441,151.929931640625]],"countries":["United Kingdom","Australia"],"title":"Zoos through the Lens of the IUCN Red List: A Global Metapopulation Approach to Support Conservation Breeding Programs"},{"arc":[[-27.6047096252441,151.929931640625],[-27.6047096252441,151.929931640625]],"countries":["Australia"],"title":"Zoos through the Lens of the IUCN Red List: A Global Metapopulation Approach to Support Conservation Breeding Programs"},{"arc":[[46.7281913757324,-117.006896972656],[39.7744483947754,-86.1732788085938]],"countries":["United States"],"title":"Zika and Flavivirus Shell Disorder: Virulence and Fetal Morbidity"},{"arc":[[46.7281913757324,-117.006896972656],[28.061149597168,-82.4131469726562]],"countries":["United States"],"title":"Zika and Flavivirus Shell Disorder: Virulence and Fetal Morbidity"},{"arc":[[39.7744483947754,-86.1732788085938],[28.061149597168,-82.4131469726562]],"countries":["United States"],"title":"Zika and Flavivirus Shell Disorder: Virulence and Fetal Morbidity"},{"arc":[[43.045539855957,-88.0227737426758],[43.045539855957,-88.0227737426758]],"countries":["United States"],"title":"Picornavirus Subversion of the Autophagy Pathway"},{"arc":[[42.7586784362793,-82.483512878418],[17.33934,78.413]],"countries":["India","United States"],"title":"BMC Microbiology Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections"},{"arc":[[42.7586784362793,-82.483512878418],[31.2988891601562,121.499168395996]],"countries":["China","United States"],"title":"BMC Microbiology Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections"},{"arc":[[42.7586784362793,-82.483512878418],[26.6826496124268,101.853927612305]],"countries":["United States","China"],"title":"BMC Microbiology Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections"},{"arc":[[42.7586784362793,-82.483512878418],[56.2622756958008,9.3363561630249]],"countries":["Denmark","United States"],"title":"BMC Microbiology Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections"},{"arc":[[42.7586784362793,-82.483512878418],[42.4763488769531,-7.98753976821899]],"countries":["Spain","United States"],"title":"BMC Microbiology Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections"},{"arc":[[17.33934,78.413],[31.2988891601562,121.499168395996]],"countries":["China","India"],"title":"BMC Microbiology Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections"},{"arc":[[17.33934,78.413],[26.6826496124268,101.853927612305]],"countries":["India","China"],"title":"BMC Microbiology Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections"},{"arc":[[17.33934,78.413],[56.2622756958008,9.3363561630249]],"countries":["India","Denmark"],"title":"BMC Microbiology Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections"},{"arc":[[17.33934,78.413],[42.4763488769531,-7.98753976821899]],"countries":["Spain","India"],"title":"BMC Microbiology Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections"},{"arc":[[31.2988891601562,121.499168395996],[26.6826496124268,101.853927612305]],"countries":["China"],"title":"BMC Microbiology Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections"},{"arc":[[31.2988891601562,121.499168395996],[56.2622756958008,9.3363561630249]],"countries":["China","Denmark"],"title":"BMC Microbiology Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections"},{"arc":[[31.2988891601562,121.499168395996],[31.2988891601562,121.499168395996]],"countries":["China"],"title":"BMC Microbiology Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections"},{"arc":[[31.2988891601562,121.499168395996],[42.4763488769531,-7.98753976821899]],"countries":["China","Spain"],"title":"BMC Microbiology Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections"},{"arc":[[26.6826496124268,101.853927612305],[56.2622756958008,9.3363561630249]],"countries":["Denmark","China"],"title":"BMC Microbiology Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections"},{"arc":[[26.6826496124268,101.853927612305],[31.2988891601562,121.499168395996]],"countries":["China"],"title":"BMC Microbiology Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections"},{"arc":[[26.6826496124268,101.853927612305],[42.4763488769531,-7.98753976821899]],"countries":["Spain","China"],"title":"BMC Microbiology Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections"},{"arc":[[56.2622756958008,9.3363561630249],[31.2988891601562,121.499168395996]],"countries":["China","Denmark"],"title":"BMC Microbiology Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections"},{"arc":[[56.2622756958008,9.3363561630249],[42.4763488769531,-7.98753976821899]],"countries":["Spain","Denmark"],"title":"BMC Microbiology Structure-based discovery of inhibitors of the YycG histidine kinase: New chemical leads to combat Staphylococcus epidermidis infections"},{"arc":[[43.0670013427734,-89.4000015258789],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Health and Quality of Life Outcomes Validation of a short form Wisconsin Upper Respiratory Symptom Survey (WURSS-21)"},{"arc":[[52.512580871582,13.3267803192139],[52.512580871582,13.3267803192139]],"countries":["Germany"],"title":"Consequences of delays and imperfect implementation of isolation in epidemic control"},{"arc":[[41.8275108337402,-71.4047698974609],[41.8275108337402,-71.4047698974609]],"countries":["United States"],"title":"IL-10 Mediated Regulation of Liver Inflammation during Acute Murine Cytomegalovirus Infection"},{"arc":[[41.8275108337402,-71.4047698974609],[41.3132514953613,-72.931022644043]],"countries":["United States"],"title":"IL-10 Mediated Regulation of Liver Inflammation during Acute Murine Cytomegalovirus Infection"},{"arc":[[41.8275108337402,-71.4047698974609],[40.743293762207,-74.1913299560547]],"countries":["United States"],"title":"IL-10 Mediated Regulation of Liver Inflammation during Acute Murine Cytomegalovirus Infection"},{"arc":[[41.3132514953613,-72.931022644043],[40.743293762207,-74.1913299560547]],"countries":["United States"],"title":"IL-10 Mediated Regulation of Liver Inflammation during Acute Murine Cytomegalovirus Infection"},{"arc":[[41.3132514953613,-72.931022644043],[41.3132514953613,-72.931022644043]],"countries":["United States"],"title":"IL-10 Mediated Regulation of Liver Inflammation during Acute Murine Cytomegalovirus Infection"},{"arc":[[40.743293762207,-74.1913299560547],[41.3132514953613,-72.931022644043]],"countries":["United States"],"title":"IL-10 Mediated Regulation of Liver Inflammation during Acute Murine Cytomegalovirus Infection"},{"arc":[[51.7589988708496,-1.26400005817413],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom"],"title":"Characterization of the African Swine Fever Virus Decapping Enzyme during Infection"},{"arc":[[36.5631141662598,103.735809326172],[39.9046897888184,116.407173156738]],"countries":["China"],"title":"Citation: Rapid and Sensitive Recombinase Polymerase Amplification Combined With Lateral Flow Strip for Detecting African Swine Fever Virus"},{"arc":[[32.9907302856445,112.528511047363],[32.9907302856445,112.528511047363]],"countries":["China"],"title":"Supporting Information Mechanical unfolding kinetics of the SRV-1 gag-pro mRNA pseudoknot: possible implications for −1 ribosomal frameshifting stimulation"},{"arc":[[32.9907302856445,112.528511047363],[52.159309387207,4.48662710189819]],"countries":["Netherlands","China"],"title":"Supporting Information Mechanical unfolding kinetics of the SRV-1 gag-pro mRNA pseudoknot: possible implications for −1 ribosomal frameshifting stimulation"},{"arc":[[52.159309387207,4.48662710189819],[32.9907302856445,112.528511047363]],"countries":["Netherlands","China"],"title":"Supporting Information Mechanical unfolding kinetics of the SRV-1 gag-pro mRNA pseudoknot: possible implications for −1 ribosomal frameshifting stimulation"},{"arc":[[55.9452209472656,-3.18803000450134],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom"],"title":"Antiviral innate immune response in non-myeloid cells is augmented by chloride ions via an increase in intracellular hypochlorous acid levels"},{"arc":[[55.9452209472656,-3.18803000450134],[55.9543800354004,-3.20144009590149]],"countries":["United Kingdom"],"title":"Antiviral innate immune response in non-myeloid cells is augmented by chloride ions via an increase in intracellular hypochlorous acid levels"},{"arc":[[55.9452209472656,-3.18803000450134],[30.6250877380371,102.697288513184]],"countries":["China","United Kingdom"],"title":"Antiviral innate immune response in non-myeloid cells is augmented by chloride ions via an increase in intracellular hypochlorous acid levels"},{"arc":[[55.9543800354004,-3.20144009590149],[55.9543800354004,-3.20144009590149]],"countries":["United Kingdom"],"title":"Antiviral innate immune response in non-myeloid cells is augmented by chloride ions via an increase in intracellular hypochlorous acid levels"},{"arc":[[55.9543800354004,-3.20144009590149],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom"],"title":"Antiviral innate immune response in non-myeloid cells is augmented by chloride ions via an increase in intracellular hypochlorous acid levels"},{"arc":[[55.9543800354004,-3.20144009590149],[30.6250877380371,102.697288513184]],"countries":["China","United Kingdom"],"title":"Antiviral innate immune response in non-myeloid cells is augmented by chloride ions via an increase in intracellular hypochlorous acid levels"},{"arc":[[30.6250877380371,102.697288513184],[55.9452209472656,-3.18803000450134]],"countries":["China","United Kingdom"],"title":"Antiviral innate immune response in non-myeloid cells is augmented by chloride ions via an increase in intracellular hypochlorous acid levels"},{"arc":[[37.7697296142578,-122.466094970703],[37.7697296142578,-122.466094970703]],"countries":["United States"],"title":"PLP2 of Mouse Hepatitis Virus A59 (MHV-A59) Targets TBK1 to Negatively Regulate Cellular Type I Interferon Signaling Pathway"},{"arc":[[53.3750495910645,5.25634002685547],[49.0121917724609,0.703100025653839]],"countries":["France","Netherlands"],"title":"Development of a Single Leg Knee Exoskeleton and Sensing Knee Center of Rotation Change for Intention Detection"},{"arc":[[49.0121917724609,0.703100025653839],[49.0121917724609,0.703100025653839]],"countries":["France"],"title":"Development of a Single Leg Knee Exoskeleton and Sensing Knee Center of Rotation Change for Intention Detection"},{"arc":[[36.5631141662598,103.735809326172],[33.2227516174316,107.54564666748]],"countries":["China"],"title":"Molecular Sciences SARS Coronavirus Papain-Like Protease Inhibits the TLR7 Signaling Pathway through Removing Lys63-Linked Polyubiquitination of TRAF3 and TRAF6"},{"arc":[[36.5631141662598,103.735809326172],[36.5631141662598,103.735809326172]],"countries":["China"],"title":"Molecular Sciences SARS Coronavirus Papain-Like Protease Inhibits the TLR7 Signaling Pathway through Removing Lys63-Linked Polyubiquitination of TRAF3 and TRAF6"},{"arc":[[36.5631141662598,103.735809326172],[18.5423393249512,73.828727722168]],"countries":["China","India"],"title":"Molecular Sciences SARS Coronavirus Papain-Like Protease Inhibits the TLR7 Signaling Pathway through Removing Lys63-Linked Polyubiquitination of TRAF3 and TRAF6"},{"arc":[[33.2227516174316,107.54564666748],[36.5631141662598,103.735809326172]],"countries":["China"],"title":"Molecular Sciences SARS Coronavirus Papain-Like Protease Inhibits the TLR7 Signaling Pathway through Removing Lys63-Linked Polyubiquitination of TRAF3 and TRAF6"},{"arc":[[33.2227516174316,107.54564666748],[18.5423393249512,73.828727722168]],"countries":["China","India"],"title":"Molecular Sciences SARS Coronavirus Papain-Like Protease Inhibits the TLR7 Signaling Pathway through Removing Lys63-Linked Polyubiquitination of TRAF3 and TRAF6"},{"arc":[[18.5423393249512,73.828727722168],[36.5631141662598,103.735809326172]],"countries":["China","India"],"title":"Molecular Sciences SARS Coronavirus Papain-Like Protease Inhibits the TLR7 Signaling Pathway through Removing Lys63-Linked Polyubiquitination of TRAF3 and TRAF6"},{"arc":[[44.6417846679688,-89.7367401123047],[43.0754890441895,-89.4199829101562]],"countries":["United States"],"title":"A Diverse Group of Previously Unrecognized Human Rhinoviruses Are Common Causes of Respiratory Illnesses in Infants"},{"arc":[[44.6417846679688,-89.7367401123047],[44.6417846679688,-89.7367401123047]],"countries":["United States"],"title":"A Diverse Group of Previously Unrecognized Human Rhinoviruses Are Common Causes of Respiratory Illnesses in Infants"},{"arc":[[43.0754890441895,-89.4199829101562],[43.0754890441895,-89.4199829101562]],"countries":["United States"],"title":"A Diverse Group of Previously Unrecognized Human Rhinoviruses Are Common Causes of Respiratory Illnesses in Infants"},{"arc":[[43.0754890441895,-89.4199829101562],[44.6417846679688,-89.7367401123047]],"countries":["United States"],"title":"A Diverse Group of Previously Unrecognized Human Rhinoviruses Are Common Causes of Respiratory Illnesses in Infants"},{"arc":[[51.5235214233398,-0.132312998175621],[51.5235214233398,-0.132312998175621]],"countries":["United Kingdom"],"title":"Lipid interactions during virus entry and infection"},{"arc":[[40.0963249206543,-88.2294921875],[33.9571990966797,-83.3740615844727]],"countries":["United States"],"title":"Equine Arteritis Virus Does Not Induce Interferon Production in Equine Endothelial Cells: Identification of Nonstructural Protein 1 as a Main Interferon Antagonist"},{"arc":[[40.0963249206543,-88.2294921875],[40.0963249206543,-88.2294921875]],"countries":["United States"],"title":"Equine Arteritis Virus Does Not Induce Interferon Production in Equine Endothelial Cells: Identification of Nonstructural Protein 1 as a Main Interferon Antagonist"},{"arc":[[40.0963249206543,-88.2294921875],[38.0390396118164,-84.5066909790039]],"countries":["United States"],"title":"Equine Arteritis Virus Does Not Induce Interferon Production in Equine Endothelial Cells: Identification of Nonstructural Protein 1 as a Main Interferon Antagonist"},{"arc":[[40.0963249206543,-88.2294921875],[39.1860809326172,-96.5832672119141]],"countries":["United States"],"title":"Equine Arteritis Virus Does Not Induce Interferon Production in Equine Endothelial Cells: Identification of Nonstructural Protein 1 as a Main Interferon Antagonist"},{"arc":[[33.9571990966797,-83.3740615844727],[40.0963249206543,-88.2294921875]],"countries":["United States"],"title":"Equine Arteritis Virus Does Not Induce Interferon Production in Equine Endothelial Cells: Identification of Nonstructural Protein 1 as a Main Interferon Antagonist"},{"arc":[[33.9571990966797,-83.3740615844727],[38.0390396118164,-84.5066909790039]],"countries":["United States"],"title":"Equine Arteritis Virus Does Not Induce Interferon Production in Equine Endothelial Cells: Identification of Nonstructural Protein 1 as a Main Interferon Antagonist"},{"arc":[[33.9571990966797,-83.3740615844727],[39.1860809326172,-96.5832672119141]],"countries":["United States"],"title":"Equine Arteritis Virus Does Not Induce Interferon Production in Equine Endothelial Cells: Identification of Nonstructural Protein 1 as a Main Interferon Antagonist"},{"arc":[[38.0390396118164,-84.5066909790039],[38.0390396118164,-84.5066909790039]],"countries":["United States"],"title":"Equine Arteritis Virus Does Not Induce Interferon Production in Equine Endothelial Cells: Identification of Nonstructural Protein 1 as a Main Interferon Antagonist"},{"arc":[[38.0390396118164,-84.5066909790039],[39.1860809326172,-96.5832672119141]],"countries":["United States"],"title":"Equine Arteritis Virus Does Not Induce Interferon Production in Equine Endothelial Cells: Identification of Nonstructural Protein 1 as a Main Interferon Antagonist"},{"arc":[[39.1860809326172,-96.5832672119141],[39.1860809326172,-96.5832672119141]],"countries":["United States"],"title":"Equine Arteritis Virus Does Not Induce Interferon Production in Equine Endothelial Cells: Identification of Nonstructural Protein 1 as a Main Interferon Antagonist"},{"arc":[[43.383487701416,142.571090698242],[43.383487701416,142.571090698242]],"countries":["Japan"],"title":"Journal Pre-proof Serial interval of novel coronavirus (COVID-19) infections Title: Serial interval of novel coronavirus (COVID-19) infections Authors"},{"arc":[[42.373161315918,-71.1181182861328],[51.5235214233398,-0.132312998175621]],"countries":["United Kingdom","United States"],"title":"NA"},{"arc":[[42.373161315918,-71.1181182861328],[39.8294792175293,-79.3749694824219]],"countries":["United States"],"title":"NA"},{"arc":[[42.373161315918,-71.1181182861328],[-69.1330032348633,-63.6669998168945]],"countries":["Argentina","United States"],"title":"NA"},{"arc":[[42.373161315918,-71.1181182861328],[47.8529090881348,8.76863956451416]],"countries":["United States","Germany"],"title":"NA"},{"arc":[[42.373161315918,-71.1181182861328],[49.2774200439453,-122.919738769531]],"countries":["United States","Canada"],"title":"NA"},{"arc":[[51.5235214233398,-0.132312998175621],[39.8294792175293,-79.3749694824219]],"countries":["United Kingdom","United States"],"title":"NA"},{"arc":[[51.5235214233398,-0.132312998175621],[-69.1330032348633,-63.6669998168945]],"countries":["Argentina","United Kingdom"],"title":"NA"},{"arc":[[51.5235214233398,-0.132312998175621],[47.8529090881348,8.76863956451416]],"countries":["United Kingdom","Germany"],"title":"NA"},{"arc":[[51.5235214233398,-0.132312998175621],[49.2774200439453,-122.919738769531]],"countries":["United Kingdom","Canada"],"title":"NA"},{"arc":[[39.8294792175293,-79.3749694824219],[-69.1330032348633,-63.6669998168945]],"countries":["Argentina","United States"],"title":"NA"},{"arc":[[39.8294792175293,-79.3749694824219],[47.8529090881348,8.76863956451416]],"countries":["United States","Germany"],"title":"NA"},{"arc":[[39.8294792175293,-79.3749694824219],[49.2774200439453,-122.919738769531]],"countries":["Canada","United States"],"title":"NA"},{"arc":[[-69.1330032348633,-63.6669998168945],[47.8529090881348,8.76863956451416]],"countries":["Argentina","Germany"],"title":"NA"},{"arc":[[-69.1330032348633,-63.6669998168945],[49.2774200439453,-122.919738769531]],"countries":["Argentina","Canada"],"title":"NA"},{"arc":[[47.8529090881348,8.76863956451416],[49.2774200439453,-122.919738769531]],"countries":["Canada","Germany"],"title":"NA"},{"arc":[[37.7697296142578,-122.466094970703],[23.2024116516113,113.38606262207]],"countries":["United States","China"],"title":"Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in Kenya"},{"arc":[[37.7697296142578,-122.466094970703],[37.7697296142578,-122.466094970703]],"countries":["United States"],"title":"Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in Kenya"},{"arc":[[37.7697296142578,-122.466094970703],[39.2892150878906,117.349395751953]],"countries":["United States","China"],"title":"Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in Kenya"},{"arc":[[37.7697296142578,-122.466094970703],[20.2663593292236,85.8105697631836]],"countries":["United States","India"],"title":"Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in Kenya"},{"arc":[[23.2024116516113,113.38606262207],[37.7697296142578,-122.466094970703]],"countries":["United States","China"],"title":"Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in Kenya"},{"arc":[[23.2024116516113,113.38606262207],[39.2892150878906,117.349395751953]],"countries":["China"],"title":"Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in Kenya"},{"arc":[[23.2024116516113,113.38606262207],[20.2663593292236,85.8105697631836]],"countries":["India","China"],"title":"Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in Kenya"},{"arc":[[39.2892150878906,117.349395751953],[37.7697296142578,-122.466094970703]],"countries":["United States","China"],"title":"Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in Kenya"},{"arc":[[39.2892150878906,117.349395751953],[20.2663593292236,85.8105697631836]],"countries":["India","China"],"title":"Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in Kenya"},{"arc":[[22.2802925109863,114.142951965332],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Complete Genome Sequence of a Novel Feline Astrovirus from a Domestic Cat in Hong Kong"},{"arc":[[-25.1099891662598,30.7521800994873],[45.7491493225098,4.83716011047363]],"countries":["South Africa","France"],"title":"Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy"},{"arc":[[-25.1099891662598,30.7521800994873],[45.7594299316406,4.82885980606079]],"countries":["South Africa","France"],"title":"Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy"},{"arc":[[45.7491493225098,4.83716011047363],[45.7594299316406,4.82885980606079]],"countries":["France"],"title":"Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy"},{"arc":[[22.6201400756836,120.31226348877],[40.5150184631348,20.8693809509277]],"countries":["Albania","Taiwan"],"title":"Dengue Virus Serotype 2 Blocks Extracellular Signal- Regulated Kinase and Nuclear Factor-kB Activation to Downregulate Cytokine Production"},{"arc":[[22.6201400756836,120.31226348877],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Taiwan"],"title":"Dengue Virus Serotype 2 Blocks Extracellular Signal- Regulated Kinase and Nuclear Factor-kB Activation to Downregulate Cytokine Production"},{"arc":[[22.6201400756836,120.31226348877],[22.6201400756836,120.31226348877]],"countries":["Taiwan"],"title":"Dengue Virus Serotype 2 Blocks Extracellular Signal- Regulated Kinase and Nuclear Factor-kB Activation to Downregulate Cytokine Production"},{"arc":[[40.5150184631348,20.8693809509277],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Albania"],"title":"Dengue Virus Serotype 2 Blocks Extracellular Signal- Regulated Kinase and Nuclear Factor-kB Activation to Downregulate Cytokine Production"},{"arc":[[40.5150184631348,20.8693809509277],[22.6201400756836,120.31226348877]],"countries":["Albania","Taiwan"],"title":"Dengue Virus Serotype 2 Blocks Extracellular Signal- Regulated Kinase and Nuclear Factor-kB Activation to Downregulate Cytokine Production"},{"arc":[[40.5150184631348,20.8693809509277],[40.5150184631348,20.8693809509277]],"countries":["Albania"],"title":"Dengue Virus Serotype 2 Blocks Extracellular Signal- Regulated Kinase and Nuclear Factor-kB Activation to Downregulate Cytokine Production"},{"arc":[[40.9437103271484,40.2619209289551],[22.6201400756836,120.31226348877]],"countries":["Turkey","Taiwan"],"title":"Dengue Virus Serotype 2 Blocks Extracellular Signal- Regulated Kinase and Nuclear Factor-kB Activation to Downregulate Cytokine Production"},{"arc":[[40.9437103271484,40.2619209289551],[40.5150184631348,20.8693809509277]],"countries":["Turkey","Albania"],"title":"Dengue Virus Serotype 2 Blocks Extracellular Signal- Regulated Kinase and Nuclear Factor-kB Activation to Downregulate Cytokine Production"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Dengue Virus Serotype 2 Blocks Extracellular Signal- Regulated Kinase and Nuclear Factor-kB Activation to Downregulate Cytokine Production"},{"arc":[[-37.7949981689453,144.949722290039],[-37.7949981689453,144.949722290039]],"countries":["Australia"],"title":"Nasal swab samples and real-time polymerase chain reaction assays in community-based, longitudinal studies of respiratory viruses: the importance of sample integrity and quality control"},{"arc":[[22.5428600311279,114.059562683105],[41.7278709411621,44.764778137207]],"countries":["Georgia","China"],"title":"the association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females OPEN"},{"arc":[[22.5428600311279,114.059562683105],[34,-85]],"countries":["United States","China"],"title":"the association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females OPEN"},{"arc":[[22.5428600311279,114.059562683105],[22.5428600311279,114.059562683105]],"countries":["China"],"title":"the association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females OPEN"},{"arc":[[22.5428600311279,114.059562683105],[45.188892364502,-91.2747573852539]],"countries":["United States","China"],"title":"the association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females OPEN"},{"arc":[[22.5428600311279,114.059562683105],[33.8806037902832,113.619728088379]],"countries":["China"],"title":"the association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females OPEN"},{"arc":[[41.7278709411621,44.764778137207],[34,-85]],"countries":["Georgia","United States"],"title":"the association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females OPEN"},{"arc":[[41.7278709411621,44.764778137207],[22.5428600311279,114.059562683105]],"countries":["Georgia","China"],"title":"the association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females OPEN"},{"arc":[[41.7278709411621,44.764778137207],[45.188892364502,-91.2747573852539]],"countries":["Georgia","United States"],"title":"the association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females OPEN"},{"arc":[[41.7278709411621,44.764778137207],[33.8806037902832,113.619728088379]],"countries":["Georgia","China"],"title":"the association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females OPEN"},{"arc":[[34,-85],[22.5428600311279,114.059562683105]],"countries":["United States","China"],"title":"the association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females OPEN"},{"arc":[[34,-85],[45.188892364502,-91.2747573852539]],"countries":["United States"],"title":"the association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females OPEN"},{"arc":[[34,-85],[33.8806037902832,113.619728088379]],"countries":["United States","China"],"title":"the association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females OPEN"},{"arc":[[45.188892364502,-91.2747573852539],[45.188892364502,-91.2747573852539]],"countries":["United States"],"title":"the association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females OPEN"},{"arc":[[45.188892364502,-91.2747573852539],[22.5428600311279,114.059562683105]],"countries":["United States","China"],"title":"the association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females OPEN"},{"arc":[[45.188892364502,-91.2747573852539],[33.8806037902832,113.619728088379]],"countries":["United States","China"],"title":"the association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females OPEN"},{"arc":[[33.8806037902832,113.619728088379],[45.188892364502,-91.2747573852539]],"countries":["United States","China"],"title":"the association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females OPEN"},{"arc":[[53.5228881835938,-113.526268005371],[53.5228881835938,-113.526268005371]],"countries":["Canada"],"title":"biomedicines Skipping Multiple Exons to Treat DMD-Promises and Challenges"},{"arc":[[52.1658325195312,4.47749996185303],[52.1658325195312,4.47749996185303]],"countries":["Netherlands"],"title":"SUPPLEMENTARY INFORMATION accompanying the main manuscript entitled A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[52.1658325195312,4.47749996185303],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","Netherlands"],"title":"SUPPLEMENTARY INFORMATION accompanying the main manuscript entitled A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[52.1658325195312,4.47749996185303],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom","Netherlands"],"title":"SUPPLEMENTARY INFORMATION accompanying the main manuscript entitled A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[52.1658325195312,4.47749996185303],[39.1860809326172,-96.5832672119141]],"countries":["Netherlands","United States"],"title":"SUPPLEMENTARY INFORMATION accompanying the main manuscript entitled A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[52.2025413513184,0.119549997150898],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"SUPPLEMENTARY INFORMATION accompanying the main manuscript entitled A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[52.2025413513184,0.119549997150898],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom"],"title":"SUPPLEMENTARY INFORMATION accompanying the main manuscript entitled A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[52.2025413513184,0.119549997150898],[39.1860809326172,-96.5832672119141]],"countries":["United Kingdom","United States"],"title":"SUPPLEMENTARY INFORMATION accompanying the main manuscript entitled A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[51.5002288818359,-0.178939998149872],[39.1860809326172,-96.5832672119141]],"countries":["United Kingdom","United States"],"title":"SUPPLEMENTARY INFORMATION accompanying the main manuscript entitled A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[51.5002288818359,-0.178939998149872],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"SUPPLEMENTARY INFORMATION accompanying the main manuscript entitled A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[39.1860809326172,-96.5832672119141],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","United States"],"title":"SUPPLEMENTARY INFORMATION accompanying the main manuscript entitled A novel role for poly(C) binding proteins in programmed ribosomal frameshifting"},{"arc":[[19.8148403167725,-101.590026855469],[19.8148403167725,-101.590026855469]],"countries":["Mexico"],"title":"molecules In Vitro and Ex Vivo Selection Procedures for Identifying Potentially Therapeutic DNA and RNA Molecules"},{"arc":[[37.8056831359863,-122.268104553223],[53.5228881835938,-113.526268005371]],"countries":["United States","Canada"],"title":"The Rubella Virus E2 and E1 Spike Glycoproteins Are Targeted to the Golgi Complex"},{"arc":[[37.8056831359863,-122.268104553223],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"The Rubella Virus E2 and E1 Spike Glycoproteins Are Targeted to the Golgi Complex"},{"arc":[[53.5228881835938,-113.526268005371],[37.8056831359863,-122.268104553223]],"countries":["United States","Canada"],"title":"The Rubella Virus E2 and E1 Spike Glycoproteins Are Targeted to the Golgi Complex"},{"arc":[[14.3596153259277,-14.4684610366821],[14.3596153259277,-14.4684610366821]],"countries":["Senegal"],"title":"Intranasal immunization with Mycobacterium tuberculosis Rv3615c induces sustained adaptive CD4 + T-cell and antibody responses in the respiratory tract"},{"arc":[[14.3596153259277,-14.4684610366821],[30.6250877380371,102.697288513184]],"countries":["China","Senegal"],"title":"Intranasal immunization with Mycobacterium tuberculosis Rv3615c induces sustained adaptive CD4 + T-cell and antibody responses in the respiratory tract"},{"arc":[[14.3596153259277,-14.4684610366821],[33.8806037902832,113.619728088379]],"countries":["China","Senegal"],"title":"Intranasal immunization with Mycobacterium tuberculosis Rv3615c induces sustained adaptive CD4 + T-cell and antibody responses in the respiratory tract"},{"arc":[[30.6250877380371,102.697288513184],[33.8806037902832,113.619728088379]],"countries":["China"],"title":"Intranasal immunization with Mycobacterium tuberculosis Rv3615c induces sustained adaptive CD4 + T-cell and antibody responses in the respiratory tract"},{"arc":[[30.6250877380371,102.697288513184],[14.3596153259277,-14.4684610366821]],"countries":["China","Senegal"],"title":"Intranasal immunization with Mycobacterium tuberculosis Rv3615c induces sustained adaptive CD4 + T-cell and antibody responses in the respiratory tract"},{"arc":[[33.8806037902832,113.619728088379],[14.3596153259277,-14.4684610366821]],"countries":["China","Senegal"],"title":"Intranasal immunization with Mycobacterium tuberculosis Rv3615c induces sustained adaptive CD4 + T-cell and antibody responses in the respiratory tract"},{"arc":[[42.4463500976562,-76.4826889038086],[42.4463500976562,-76.4826889038086]],"countries":["United States"],"title":"Title 4 Spike-based phylogenetically defined clades within the Alphacoronavirus 1 species 5 6 Authors 7"},{"arc":[[52.5251808166504,13.3792200088501],[52.5251808166504,13.3792200088501]],"countries":["Germany"],"title":"The Rho ADP-ribosylating C3 exoenzyme binds cells via an Arg-Gly-Asp motif"},{"arc":[[40.9437103271484,40.2619209289551],[14.3596153259277,-14.4684610366821]],"countries":["Turkey","Senegal"],"title":"Real-time fluorescence loop-mediated isothermal amplification assay for direct detection of egg drop syndrome virus"},{"arc":[[40.9437103271484,40.2619209289551],[44.9734497070312,-93.2378997802734]],"countries":["Turkey","United States"],"title":"Real-time fluorescence loop-mediated isothermal amplification assay for direct detection of egg drop syndrome virus"},{"arc":[[14.3596153259277,-14.4684610366821],[44.9734497070312,-93.2378997802734]],"countries":["United States","Senegal"],"title":"Real-time fluorescence loop-mediated isothermal amplification assay for direct detection of egg drop syndrome virus"},{"arc":[[45.186767578125,9.15610694885254],[45.186767578125,9.15610694885254]],"countries":["Italy"],"title":"cancers Endolysosomal Ca 2+ Signalling and Cancer Hallmarks: Two-Pore Channels on the Move, TRPML1 Lags Behind!"},{"arc":[[45.186767578125,9.15610694885254],[41.6843185424805,14.5951976776123]],"countries":["Italy"],"title":"cancers Endolysosomal Ca 2+ Signalling and Cancer Hallmarks: Two-Pore Channels on the Move, TRPML1 Lags Behind!"},{"arc":[[45.186767578125,9.15610694885254],[36.1910514831543,44.0121383666992]],"countries":["Italy","Iraq"],"title":"cancers Endolysosomal Ca 2+ Signalling and Cancer Hallmarks: Two-Pore Channels on the Move, TRPML1 Lags Behind!"},{"arc":[[41.6843185424805,14.5951976776123],[36.1910514831543,44.0121383666992]],"countries":["Italy","Iraq"],"title":"cancers Endolysosomal Ca 2+ Signalling and Cancer Hallmarks: Two-Pore Channels on the Move, TRPML1 Lags Behind!"},{"arc":[[-37.7035598754883,145.180358886719],[-37.7035598754883,145.180358886719]],"countries":["Australia"],"title":"Lyon-IARC Polyomavirus DNA in Feces of Diarrheic Cats"},{"arc":[[-37.7035598754883,145.180358886719],[-85.0169982910156,-167.5]],"countries":["Australia","NOCOUNTRY"],"title":"Lyon-IARC Polyomavirus DNA in Feces of Diarrheic Cats"},{"arc":[[37.6757011413574,-121.758560180664],[37.6757011413574,-121.758560180664]],"countries":["United States"],"title":"Ultra-Deep Sequencing of Intra-host Rabies Virus Populations during Cross-species Transmission"},{"arc":[[30.5927600860596,114.305252075195],[23.2024116516113,113.38606262207]],"countries":["China"],"title":"When will the battle against novel coronavirus end in Wuhan: a SEIR modeling analysis"},{"arc":[[30.5927600860596,114.305252075195],[30.5927600860596,114.305252075195]],"countries":["China"],"title":"When will the battle against novel coronavirus end in Wuhan: a SEIR modeling analysis"},{"arc":[[23.2024116516113,113.38606262207],[30.5927600860596,114.305252075195]],"countries":["China"],"title":"When will the battle against novel coronavirus end in Wuhan: a SEIR modeling analysis"},{"arc":[[13.0853099822998,80.2666397094727],[13.0853099822998,80.2666397094727]],"countries":["India"],"title":"Prevalence of enteropathogens and their antibiotic sensitivity pattern in puppies with hemorrhagic gastroenteritis"},{"arc":[[22.2802925109863,114.142951965332],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Profiling of Substrate Specificity of SARS-CoV 3CL pro"},{"arc":[[40.0059814453125,116.326812744141],[41.7219505310059,-87.6093215942383]],"countries":["China","United States"],"title":"A novel fast vector method for genetic sequence comparison"},{"arc":[[40.0059814453125,116.326812744141],[40.0059814453125,116.326812744141]],"countries":["China"],"title":"A novel fast vector method for genetic sequence comparison"},{"arc":[[41.7219505310059,-87.6093215942383],[40.0059814453125,116.326812744141]],"countries":["China","United States"],"title":"A novel fast vector method for genetic sequence comparison"},{"arc":[[62.5360412597656,-96.3883514404297],[62.5360412597656,-96.3883514404297]],"countries":["Canada"],"title":"The scanning electron microscope in microbiology and diagnosis of infectious disease OPEN"},{"arc":[[37.3264389038086,-121.877601623535],[36.3269996643066,127.432685852051]],"countries":["United States","South Korea"],"title":"Article history: Analysis of Women's Health Online News Articles Using Topic Modeling Osong Public Health and Research Perspectives"},{"arc":[[37.3264389038086,-121.877601623535],[60.68994140625,9.03203964233398]],"countries":["United States","Norway"],"title":"Article history: Analysis of Women's Health Online News Articles Using Topic Modeling Osong Public Health and Research Perspectives"},{"arc":[[36.3269996643066,127.432685852051],[60.68994140625,9.03203964233398]],"countries":["Norway","South Korea"],"title":"Article history: Analysis of Women's Health Online News Articles Using Topic Modeling Osong Public Health and Research Perspectives"},{"arc":[[49.787841796875,9.93556022644043],[41.7278709411621,44.764778137207]],"countries":["Georgia","Germany"],"title":"INDUCIBILITY OF la ANTIGEN ON ASTROCYTES BY MURINE CORONAVIRUS JHM IS RAT STRAIN DEPENDENT"},{"arc":[[37.6757011413574,-121.758560180664],[37.6757011413574,-121.758560180664]],"countries":["United States"],"title":"Mapping a viral phylogeny onto outbreak trees to improve host transmission inference"},{"arc":[[30.2633018493652,120.122261047363],[30.2633018493652,120.122261047363]],"countries":["China"],"title":"Full-text PDF: Word count: SR21 Special Report"},{"arc":[[51.4559898376465,-0.24176000058651],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United Kingdom"],"title":"A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households"},{"arc":[[51.4559898376465,-0.24176000058651],[35.876606,126.8157]],"countries":["South Korea","United Kingdom"],"title":"A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households"},{"arc":[[22.2802925109863,114.142951965332],[35.876606,126.8157]],"countries":["Hong Kong SAR","South Korea"],"title":"A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households"},{"arc":[[34.6854705810547,33.0122184753418],[34.6854705810547,33.0122184753418]],"countries":["Cyprus"],"title":"Aetiology of Acute Respiratory Tract Infections in Hospitalised Children in Cyprus"},{"arc":[[11.2745704650879,75.8362274169922],[11.2745704650879,75.8362274169922]],"countries":["India"],"title":"Title: Clinical features and progression of acute respiratory distress syndrome in Nutrition and Safety, Ministry of Education Key Lab of Environment and # Corresponding authors: 1 7 Word count: 2,681 (including Research in context) 2 0"},{"arc":[[11.2745704650879,75.8362274169922],[37.7697296142578,-122.466094970703]],"countries":["United States","India"],"title":"Title: Clinical features and progression of acute respiratory distress syndrome in Nutrition and Safety, Ministry of Education Key Lab of Environment and # Corresponding authors: 1 7 Word count: 2,681 (including Research in context) 2 0"},{"arc":[[37.7697296142578,-122.466094970703],[11.2745704650879,75.8362274169922]],"countries":["United States","India"],"title":"Title: Clinical features and progression of acute respiratory distress syndrome in Nutrition and Safety, Ministry of Education Key Lab of Environment and # Corresponding authors: 1 7 Word count: 2,681 (including Research in context) 2 0"},{"arc":[[36.1670608520508,-86.8253326416016],[53.4706993103027,-2.23559999465942]],"countries":["United States","United Kingdom"],"title":"The outcomes and controversies of transplant tourism-Lessons of an 11-year retrospective cohort study from Taiwan"},{"arc":[[36.1670608520508,-86.8253326416016],[23.7489929199219,120.971282958984]],"countries":["Taiwan","United States"],"title":"The outcomes and controversies of transplant tourism-Lessons of an 11-year retrospective cohort study from Taiwan"},{"arc":[[36.1670608520508,-86.8253326416016],[58.6313705444336,25.7337398529053]],"countries":["United States","Estonia"],"title":"The outcomes and controversies of transplant tourism-Lessons of an 11-year retrospective cohort study from Taiwan"},{"arc":[[36.1670608520508,-86.8253326416016],[36.1670608520508,-86.8253326416016]],"countries":["United States"],"title":"The outcomes and controversies of transplant tourism-Lessons of an 11-year retrospective cohort study from Taiwan"},{"arc":[[36.1670608520508,-86.8253326416016],[23.6997394561768,120.526443481445]],"countries":["United States","Taiwan"],"title":"The outcomes and controversies of transplant tourism-Lessons of an 11-year retrospective cohort study from Taiwan"},{"arc":[[53.4706993103027,-2.23559999465942],[23.7489929199219,120.971282958984]],"countries":["Taiwan","United Kingdom"],"title":"The outcomes and controversies of transplant tourism-Lessons of an 11-year retrospective cohort study from Taiwan"},{"arc":[[53.4706993103027,-2.23559999465942],[58.6313705444336,25.7337398529053]],"countries":["United Kingdom","Estonia"],"title":"The outcomes and controversies of transplant tourism-Lessons of an 11-year retrospective cohort study from Taiwan"},{"arc":[[53.4706993103027,-2.23559999465942],[36.1670608520508,-86.8253326416016]],"countries":["United States","United Kingdom"],"title":"The outcomes and controversies of transplant tourism-Lessons of an 11-year retrospective cohort study from Taiwan"},{"arc":[[53.4706993103027,-2.23559999465942],[23.6997394561768,120.526443481445]],"countries":["United Kingdom","Taiwan"],"title":"The outcomes and controversies of transplant tourism-Lessons of an 11-year retrospective cohort study from Taiwan"},{"arc":[[23.7489929199219,120.971282958984],[58.6313705444336,25.7337398529053]],"countries":["Taiwan","Estonia"],"title":"The outcomes and controversies of transplant tourism-Lessons of an 11-year retrospective cohort study from Taiwan"},{"arc":[[23.7489929199219,120.971282958984],[36.1670608520508,-86.8253326416016]],"countries":["Taiwan","United States"],"title":"The outcomes and controversies of transplant tourism-Lessons of an 11-year retrospective cohort study from Taiwan"},{"arc":[[23.7489929199219,120.971282958984],[23.6997394561768,120.526443481445]],"countries":["Taiwan"],"title":"The outcomes and controversies of transplant tourism-Lessons of an 11-year retrospective cohort study from Taiwan"},{"arc":[[58.6313705444336,25.7337398529053],[36.1670608520508,-86.8253326416016]],"countries":["United States","Estonia"],"title":"The outcomes and controversies of transplant tourism-Lessons of an 11-year retrospective cohort study from Taiwan"},{"arc":[[58.6313705444336,25.7337398529053],[23.6997394561768,120.526443481445]],"countries":["Estonia","Taiwan"],"title":"The outcomes and controversies of transplant tourism-Lessons of an 11-year retrospective cohort study from Taiwan"},{"arc":[[40.8216972351074,-96.7002792358398],[40.8216972351074,-96.7002792358398]],"countries":["United States"],"title":"Sustainability of High-Level Isolation Capabilities among US Ebola Treatment Centers DISPATCHES"},{"arc":[[40.8216972351074,-96.7002792358398],[39.173511505127,-86.5160522460938]],"countries":["United States"],"title":"Sustainability of High-Level Isolation Capabilities among US Ebola Treatment Centers DISPATCHES"},{"arc":[[40.8216972351074,-96.7002792358398],[41.2542190551758,-95.9790191650391]],"countries":["United States"],"title":"Sustainability of High-Level Isolation Capabilities among US Ebola Treatment Centers DISPATCHES"},{"arc":[[39.173511505127,-86.5160522460938],[41.2542190551758,-95.9790191650391]],"countries":["United States"],"title":"Sustainability of High-Level Isolation Capabilities among US Ebola Treatment Centers DISPATCHES"},{"arc":[[39.173511505127,-86.5160522460938],[39.173511505127,-86.5160522460938]],"countries":["United States"],"title":"Sustainability of High-Level Isolation Capabilities among US Ebola Treatment Centers DISPATCHES"},{"arc":[[41.2542190551758,-95.9790191650391],[39.173511505127,-86.5160522460938]],"countries":["United States"],"title":"Sustainability of High-Level Isolation Capabilities among US Ebola Treatment Centers DISPATCHES"},{"arc":[[41.2542190551758,-95.9790191650391],[41.2542190551758,-95.9790191650391]],"countries":["United States"],"title":"Sustainability of High-Level Isolation Capabilities among US Ebola Treatment Centers DISPATCHES"},{"arc":[[52.4488296508789,-1.93190002441406],[52.4488296508789,-1.93190002441406]],"countries":["United Kingdom"],"title":"The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action"},{"arc":[[43.383487701416,142.571090698242],[43.383487701416,142.571090698242]],"countries":["Japan"],"title":"Assessing the impact of reduced travel on exportation dynamics of novel coronavirus infection (COVID-19)"},{"arc":[[43.383487701416,142.571090698242],[35.6895027160645,138.68879699707]],"countries":["Japan"],"title":"Assessing the impact of reduced travel on exportation dynamics of novel coronavirus infection (COVID-19)"},{"arc":[[23.1290798187256,113.264358520508],[14.3596153259277,-14.4684610366821]],"countries":["China","Senegal"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[23.1290798187256,113.264358520508],[-37.797981262207,144.959045410156]],"countries":["China","Australia"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[23.1290798187256,113.264358520508],[27.6111698150635,115.727165222168]],"countries":["China"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[23.1290798187256,113.264358520508],[23.1290798187256,113.264358520508]],"countries":["China"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[23.1290798187256,113.264358520508],[39.9925537109375,116.310485839844]],"countries":["China"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[23.1290798187256,113.264358520508],[39.9046897888184,116.407173156738]],"countries":["China"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[14.3596153259277,-14.4684610366821],[-37.797981262207,144.959045410156]],"countries":["Australia","Senegal"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[14.3596153259277,-14.4684610366821],[27.6111698150635,115.727165222168]],"countries":["Senegal","China"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[14.3596153259277,-14.4684610366821],[23.1290798187256,113.264358520508]],"countries":["China","Senegal"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[14.3596153259277,-14.4684610366821],[14.3596153259277,-14.4684610366821]],"countries":["Senegal"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[14.3596153259277,-14.4684610366821],[39.9925537109375,116.310485839844]],"countries":["China","Senegal"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[14.3596153259277,-14.4684610366821],[39.9046897888184,116.407173156738]],"countries":["China","Senegal"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[-37.797981262207,144.959045410156],[27.6111698150635,115.727165222168]],"countries":["Australia","China"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[-37.797981262207,144.959045410156],[23.1290798187256,113.264358520508]],"countries":["China","Australia"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[-37.797981262207,144.959045410156],[14.3596153259277,-14.4684610366821]],"countries":["Australia","Senegal"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[-37.797981262207,144.959045410156],[39.9925537109375,116.310485839844]],"countries":["Australia","China"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[-37.797981262207,144.959045410156],[39.9046897888184,116.407173156738]],"countries":["China","Australia"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[27.6111698150635,115.727165222168],[23.1290798187256,113.264358520508]],"countries":["China"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[27.6111698150635,115.727165222168],[14.3596153259277,-14.4684610366821]],"countries":["Senegal","China"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[27.6111698150635,115.727165222168],[39.9925537109375,116.310485839844]],"countries":["China"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[27.6111698150635,115.727165222168],[39.9046897888184,116.407173156738]],"countries":["China"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[39.9925537109375,116.310485839844],[39.9925537109375,116.310485839844]],"countries":["China"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[39.9925537109375,116.310485839844],[23.1290798187256,113.264358520508]],"countries":["China"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[39.9925537109375,116.310485839844],[39.9046897888184,116.407173156738]],"countries":["China"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[39.9046897888184,116.407173156738],[23.1290798187256,113.264358520508]],"countries":["China"],"title":"ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism"},{"arc":[[47.3191909790039,5.06463003158569],[47.3191909790039,5.06463003158569]],"countries":["France"],"title":"Proteomic Profiling of the TRAF3 Interactome Network Reveals a New Role for the ER-to-Golgi Transport Compartments in Innate Immunity"},{"arc":[[47.3191909790039,5.06463003158569],[43.6576881408691,-79.3900375366211]],"countries":["France","Canada"],"title":"Proteomic Profiling of the TRAF3 Interactome Network Reveals a New Role for the ER-to-Golgi Transport Compartments in Innate Immunity"},{"arc":[[43.6576881408691,-79.3900375366211],[43.6576881408691,-79.3900375366211]],"countries":["Canada"],"title":"Proteomic Profiling of the TRAF3 Interactome Network Reveals a New Role for the ER-to-Golgi Transport Compartments in Innate Immunity"},{"arc":[[43.6576881408691,-79.3900375366211],[47.3191909790039,5.06463003158569]],"countries":["France","Canada"],"title":"Proteomic Profiling of the TRAF3 Interactome Network Reveals a New Role for the ER-to-Golgi Transport Compartments in Innate Immunity"},{"arc":[[40.0963249206543,-88.2294921875],[40.0963249206543,-88.2294921875]],"countries":["United States"],"title":"Differential Host Cell Gene Expression and Regulation of Cell Cycle Progression by Nonstructural Protein 11 of Porcine Reproductive and Respiratory Syndrome Virus"},{"arc":[[-25.4304790496826,-49.2845115661621],[39.1410217285156,-84.5021362304688]],"countries":["Brazil","United States"],"title":"Preliminary epidemiological analysis on children and adolescents with novel coronavirus disease 2019 outside Hubei Province, China: an observational study utilizing crowdsourced data"},{"arc":[[7.39997005462646,3.76873993873596],[7.39997005462646,3.76873993873596]],"countries":["Nigeria"],"title":"Etiology, Seasonality, and Clinical Features of Viral Respiratory Tract Infections in Children Hospitalized With Acute Bronchiolitis: A Single-Center Study"},{"arc":[[40.9437103271484,40.2619209289551],[51.9100685119629,4.46534013748169]],"countries":["Turkey","Netherlands"],"title":"Open Forum Infectious Diseases ® Multihospital Outbreak of a Middle East Respiratory Syndrome Coronavirus Deletion Variant, Jordan: A Molecular, Serologic, and Epidemiologic Investigation"},{"arc":[[40.9437103271484,40.2619209289551],[39.4959106445312,-98.9899826049805]],"countries":["Turkey","United States"],"title":"Open Forum Infectious Diseases ® Multihospital Outbreak of a Middle East Respiratory Syndrome Coronavirus Deletion Variant, Jordan: A Molecular, Serologic, and Epidemiologic Investigation"},{"arc":[[51.9100685119629,4.46534013748169],[39.4959106445312,-98.9899826049805]],"countries":["Netherlands","United States"],"title":"Open Forum Infectious Diseases ® Multihospital Outbreak of a Middle East Respiratory Syndrome Coronavirus Deletion Variant, Jordan: A Molecular, Serologic, and Epidemiologic Investigation"},{"arc":[[39.4959106445312,-98.9899826049805],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"Open Forum Infectious Diseases ® Multihospital Outbreak of a Middle East Respiratory Syndrome Coronavirus Deletion Variant, Jordan: A Molecular, Serologic, and Epidemiologic Investigation"},{"arc":[[26.029390335083,118.138877868652],[26.029390335083,118.138877868652]],"countries":["China"],"title":"Development and characterization of a continuous cell line (EL) from the liver of European eel Anguilla anguilla"},{"arc":[[26.029390335083,118.138877868652],[32.9052963256836,-117.243560791016]],"countries":["United States","China"],"title":"Development and characterization of a continuous cell line (EL) from the liver of European eel Anguilla anguilla"},{"arc":[[32.9052963256836,-117.243560791016],[26.029390335083,118.138877868652]],"countries":["United States","China"],"title":"Development and characterization of a continuous cell line (EL) from the liver of European eel Anguilla anguilla"},{"arc":[[40.8081588745117,-73.9636535644531],[44.3204612731934,-96.7883377075195]],"countries":["United States"],"title":"Characterization of a Novel Influenza Virus in Cattle and Swine: Proposal for a New Genus in the Orthomyxoviridae Family"},{"arc":[[40.8081588745117,-73.9636535644531],[40.8081588745117,-73.9636535644531]],"countries":["United States"],"title":"Characterization of a Novel Influenza Virus in Cattle and Swine: Proposal for a New Genus in the Orthomyxoviridae Family"},{"arc":[[40.8081588745117,-73.9636535644531],[41.492561340332,-71.3108901977539]],"countries":["United States"],"title":"Characterization of a Novel Influenza Virus in Cattle and Swine: Proposal for a New Genus in the Orthomyxoviridae Family"},{"arc":[[44.3204612731934,-96.7883377075195],[40.8081588745117,-73.9636535644531]],"countries":["United States"],"title":"Characterization of a Novel Influenza Virus in Cattle and Swine: Proposal for a New Genus in the Orthomyxoviridae Family"},{"arc":[[44.3204612731934,-96.7883377075195],[41.492561340332,-71.3108901977539]],"countries":["United States"],"title":"Characterization of a Novel Influenza Virus in Cattle and Swine: Proposal for a New Genus in the Orthomyxoviridae Family"},{"arc":[[41.492561340332,-71.3108901977539],[40.8081588745117,-73.9636535644531]],"countries":["United States"],"title":"Characterization of a Novel Influenza Virus in Cattle and Swine: Proposal for a New Genus in the Orthomyxoviridae Family"},{"arc":[[40.6830215454102,-76.2544097900391],[40.6830215454102,-76.2544097900391]],"countries":["United States"],"title":"Bovine coronavirus in naturally and experimentally exposed calves; viral shedding and the potential for transmission"},{"arc":[[34.3412704467773,108.939842224121],[31.0254402160645,121.436302185059]],"countries":["China"],"title":"Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China"},{"arc":[[34.3412704467773,108.939842224121],[32.0583801269531,118.79647064209]],"countries":["China"],"title":"Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China"},{"arc":[[31.0254402160645,121.436302185059],[32.0583801269531,118.79647064209]],"countries":["China"],"title":"Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China"},{"arc":[[31.0254402160645,121.436302185059],[31.0254402160645,121.436302185059]],"countries":["China"],"title":"Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China"},{"arc":[[32.0583801269531,118.79647064209],[31.0254402160645,121.436302185059]],"countries":["China"],"title":"Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China"},{"arc":[[29.2472057342529,120.442726135254],[29.2472057342529,120.442726135254]],"countries":["China"],"title":"iTRAQ-based Proteomic Analysis of Porcine Kidney Epithelial PK15 cells Infected with Pseudorabies virus OPEN"},{"arc":[[1.29718005657196,103.77774810791],[1.29718005657196,103.77774810791]],"countries":["Singapore"],"title":"Dengue Virus Glycosylation: What Do We Know?"}]